{
  "meta": {
    "title": "Btr_Obg_-_13-10-2025",
    "url": "https://brainandscalpel.vercel.app/btr-obg-13-10-2025-bb19d12a.html",
    "scrapedAt": "2025-11-29T17:23:07.186Z"
  },
  "questions": [
    {
      "id": 95001,
      "choices": [
        {
          "id": 378200,
          "text": "<p><span style=\"font-size:14.0pt;\">Works as a vaginal pH regulator</span></p>"
        },
        {
          "id": 378201,
          "text": "<p><span style=\"font-size:14.0pt;\">Contains lactic acid, citric acid, and potassium bitartrate</span></p>"
        },
        {
          "id": 378202,
          "text": "<p><span style=\"font-size:14.0pt;\">Provides long-term hormonal contraception</span></p>"
        },
        {
          "id": 378203,
          "text": "<p><span style=\"font-size:14.0pt;\">Creates an acidic vaginal environment inhospitable for sperms</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">Phexxi, a newly approved contraceptive gel, has the following properties except:</span></p>",
      "unique_key": "Q5791123",
      "question_audio": null,
      "question_video": null,
      "map_id": 35125560,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Provides long-term hormonal contraception</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Phexxi is a <strong>non-hormonal contraceptive vaginal gel</strong> approved by the FDA. It acts locally within the vagina to <strong>maintain an acidic pH (around 3.5–4.5)</strong>, which is unfavorable for sperm motility and function. Its effect is <strong>temporary and used immediately before intercourse</strong>, not long-term.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Mechanism of Action:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Phexxi contains <strong>lactic acid, citric acid, and potassium bitartrate</strong>, which help maintain vaginal acidity even in the presence of semen (which is alkaline).</span></li><li><span style=\"font-size:14.0pt;\">This <strong>acidic environment immobilizes sperms</strong>, preventing fertilization.</span></li></ul>",
      "correct_choice_id": 378202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95002,
      "choices": [
        {
          "id": 378204,
          "text": "<p><span style=\"font-size:14.0pt;\">Total abdominal hysterectomy + BSO without lymph node dissection</span></p>"
        },
        {
          "id": 378205,
          "text": "<p><span style=\"font-size:14.0pt;\">Total abdominal hysterectomy + BSO + lymph node dissection</span></p>"
        },
        {
          "id": 378206,
          "text": "<p><span style=\"font-size:14.0pt;\">Total abdominal hysterectomy + BSO + lymph node dissection + Adjuvant RT</span></p>"
        },
        {
          "id": 378207,
          "text": "<p><span style=\"font-size:14.0pt;\">Neoadjuvant Chemotherapy with Cisplatin and Paclitaxel</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old postmenopausal woman is diagnosed with endometrial cancer, FIGO stage IA, tumor size 1.5 cm, grade 2 adenocarcinoma. What is the most appropriate management?</span></p>",
      "unique_key": "Q8734331",
      "question_audio": null,
      "question_video": null,
      "map_id": 35125581,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Total abdominal hysterectomy + BSO without lymph node dissection</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>early-stage endometrial carcinoma (FIGO Stage IA, Grade 1–2, &lt;50% myometrial invasion)</strong>, the standard management is <strong>surgical removal of the uterus with bilateral salpingo-oophorectomy (TAH + BSO)</strong> without the need for lymph node dissection or adjuvant radiotherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Lymph node dissection is generally reserved for <strong>higher-grade (G3)</strong> tumors or when <strong>&gt;50% myometrial invasion</strong> is suspected (Stage IB or higher).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Total abdominal hysterectomy + BSO + lymph node dissection:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Lymph node dissection is done in <strong>Grade 3</strong> or <strong>deeply invasive</strong> tumors (≥50% myometrial invasion).</span></li><li><span style=\"font-size:14.0pt;\">In this case, both grade and invasion are low, so unnecessary.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Total abdominal hysterectomy + BSO + lymph node dissection + Adjuvant RT:&nbsp;</strong>Incorrect.</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Adjuvant radiotherapy is indicated only for <strong>high-intermediate risk</strong> or <strong>advanced disease (Stage IB G3 or higher)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Not recommended in early, low-grade cases due to overtreatment risk.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Neoadjuvant Chemotherapy with Cisplatin and Paclitaxel:&nbsp;</strong>Incorrect.</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Chemotherapy is used for <strong>advanced or metastatic disease</strong>, not in early-stage IA tumors.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Summary Table:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_eU01kZK.png\" width=\"673\" height=\"188\"></strong></span></p>",
      "correct_choice_id": 378204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 87035,
      "choices": [
        {
          "id": 346624,
          "text": "<p><span style=\"font-size:14.0pt;\">Mesosalpinx</span></p>"
        },
        {
          "id": 346625,
          "text": "<p><span style=\"font-size:14.0pt;\">Ovarian ligament&nbsp;</span></p>"
        },
        {
          "id": 346626,
          "text": "<p><span style=\"font-size:14.0pt;\">Round ligament of the uterus&nbsp;</span></p>"
        },
        {
          "id": 346627,
          "text": "<p><span style=\"font-size:14.0pt;\">Suspensory ligament of the ovary&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 63-year-old woman has a right-sided ovarian mass found incidentally on transvaginal ultrasound. Surgery is planned to remove the right ovary, including the mass. To avoid excessive bleeding during the oophorectomy, the surgeon should ligate which of the following structures?&nbsp;</span></p>",
      "unique_key": "Q7602406",
      "question_audio": null,
      "question_video": null,
      "map_id": 35125582,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Suspensory ligament of the ovary&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The suspensory ligament of the ovary (infundibulopelvic ligament) contains the ovarian vessels (ovarian artery and vein), lymphatics, and nerves.</span><br><span style=\"font-size:14.0pt;\">During oophorectomy (removal of the ovary), this ligament must be ligated to prevent excessive bleeding from these vessels.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The ovarian artery arises directly from the abdominal aorta (at L2 level).</span></li><li><span style=\"font-size:14.0pt;\">The ovarian vein drains into the IVC (right) or left renal vein (left).</span><br><span style=\"font-size:14.0pt;\">Hence, controlling this vascular pedicle is essential before the ovary is excised.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mesosalpinx:&nbsp;</strong>Incorrect.</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is the portion of the broad ligament that encloses the fallopian tube.</span></li><li><span style=\"font-size:14.0pt;\">It contains small branches of the uterine and ovarian arteries supplying the tube, not the main ovarian vessels.</span></li><li><span style=\"font-size:14.0pt;\">Ligation here is done during salpingectomy, not oophorectomy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ovarian ligament:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This connects the ovary to the lateral wall of the uterus (near uterine cornu).</span></li><li><span style=\"font-size:14.0pt;\">It contains utero-ovarian anastomosis.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Round ligament of the uterus:&nbsp;</strong>Incorrect.</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This runs from the uterine cornu through the inguinal canal to the labia majora.</span></li><li><span style=\"font-size:14.0pt;\">It maintains the anteverted position of the uterus, contains the Sampson’s artery, branch of inferior epigastric artery.&nbsp;</span></li></ul>",
      "correct_choice_id": 346627,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95003,
      "choices": [
        {
          "id": 378208,
          "text": "<p><span style=\"font-size:14.0pt;\">Streak gonads and male internal genitalia</span></p>"
        },
        {
          "id": 378209,
          "text": "<p><span style=\"font-size:14.0pt;\">Streak gonads and female internal genitalia</span></p>"
        },
        {
          "id": 378210,
          "text": "<p><span style=\"font-size:14.0pt;\">Empty pelvis (no gonads or internal genitalia)</span></p>"
        },
        {
          "id": 378211,
          "text": "<p><span style=\"font-size:14.0pt;\">Bilateral abdominal testes and male internal genitalia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old nulligravida presents with primary amenorrhea. She is diagnosed with 46XY gonadal dysgenesis. During pelvic laparoscopy, what is the expected finding?</span></p>",
      "unique_key": "Q4508563",
      "question_audio": null,
      "question_video": null,
      "map_id": 35125793,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Streak gonads and female internal genitalia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In 46,XY gonadal dysgenesis (Swyer syndrome), there is a mutation or deletion of the SRY gene (on the Y chromosome) that normally initiates testis differentiation.</span></p><p><br><span style=\"font-size:14.0pt;\">Because the SRY gene is nonfunctional, the primitive gonads fail to develop into testes, and instead form streak gonads (fibrous tissue).</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Since no functional testes develop, anti-Müllerian hormone (AMH) and testosterone are both absent.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the Müllerian ducts persist, leading to female internal genitalia (uterus, fallopian tubes, upper vagina).</span></li><li><span style=\"font-size:14.0pt;\">The external genitalia also develop as female due to the absence of androgens.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Thus, on laparoscopy, we find:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Streak gonads (fibrous, non-functional structures)</span></li><li><span style=\"font-size:14.0pt;\">Normal/hypoplastic female internal genitalia (uterus, tubes, vagina)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Streak gonads and male internal genitalia:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Male internal genitalia (epididymis, vas deferens, seminal vesicles) develop only under testosterone influence.</span></li><li><span style=\"font-size:14.0pt;\">In this syndrome, testes (and hence testosterone) are absent, so male ducts don’t form.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Empty pelvis (no gonads or internal genitalia):&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Seen in Müllerian agenesis (MRKH syndrome): 46,XX karyotype, normal ovaries, but absent uterus and upper vagina.</span></li><li><span style=\"font-size:14.0pt;\">In Swyer syndrome, uterus is present.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Bilateral abdominal testes and male internal genitalia: </strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Seen in Androgen Insensitivity Syndrome (AIS) — testes present (often intra-abdominal), but due to androgen receptor defect, external genitalia are female and internal male ducts are absent due to AMH.</span></li><li><span style=\"font-size:14.0pt;\">Not seen in gonadal dysgenesis.</span></li></ul>",
      "correct_choice_id": 378209,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 75797,
      "choices": [
        {
          "id": 302069,
          "text": "<p><span style=\"font-size:14.0pt;\">Robert's sign may be seen&nbsp;</span></p>"
        },
        {
          "id": 302070,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperflexion of spine may be seen &nbsp;</span></p>"
        },
        {
          "id": 302071,
          "text": "<p><span style=\"font-size:14.0pt;\">Spontaneous expulsion rarely occurs in these patients and induction is required&nbsp;</span></p>"
        },
        {
          "id": 302072,
          "text": "<p><span style=\"font-size:14.0pt;\">Infection by gas-forming organisms is likely after rupture of membranes&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A&nbsp;32-year-old primigravida at 32 weeks of gestation comes with complaints of absent fetal movements over the last week. Examination shows absent fetal heart sounds. Ultrasonographic examination shows overlapping of skull bones and absent FHR. Which of the following is false about this likely condition?</span></p>",
      "unique_key": "Q4292042",
      "question_audio": null,
      "question_video": null,
      "map_id": 35125794,
      "difficulty_level": "beginner",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Spontaneous expulsion rarely occurs in these patients and induction is required</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The clinical picture indicates intrauterine fetal demise (IUFD) — also known as a missed intrauterine death.</span></p><p><br><span style=\"font-size:14.0pt;\">Ultrasound findings like overlapping of skull bones (Spalding sign), absence of fetal cardiac activity, and possibly Robert’s sign (gas in great vessels or heart) confirm fetal death.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In most cases, spontaneous expulsion of the dead fetus occurs within 2 weeks due to uterine irritability and prostaglandin release. Hence, the statement that “spontaneous expulsion rarely occurs and induction is required” is false.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Spontaneous expulsion commonly occurs within 2 weeks; if not, induction is then undertaken to prevent DIC and infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Robert’s sign may be seen:&nbsp;</strong>Correct. Refers to gas shadow in the heart or great vessels seen on X-ray or ultrasound after fetal death. Appears usually within 12–24 hours of demise.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hyperflexion of spine may be seen:&nbsp;</strong>Correct. Due to loss of muscle tone and maceration, fetal spine often shows abnormal postures like hyperflexion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Infection by gas-forming organisms is likely after rupture of membranes:&nbsp;</strong>Correct. Once membranes rupture, the retained dead fetus predisposes to infection with Clostridium and other gas-forming bacteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Summary Table:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_rFDkvfl.png\" width=\"732\" height=\"260\"></strong></span></p>",
      "correct_choice_id": 302071,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95004,
      "choices": [
        {
          "id": 378212,
          "text": "<p><span style=\"font-size:14.0pt;\">11-13 weeks</span></p>"
        },
        {
          "id": 378213,
          "text": "<p><span style=\"font-size:14.0pt;\">18-20 weeks</span></p>"
        },
        {
          "id": 378214,
          "text": "<p><span style=\"font-size:14.0pt;\">6-8 weeks</span></p>"
        },
        {
          "id": 378215,
          "text": "<p><span style=\"font-size:14.0pt;\">15-18 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">What is the best time to perform the following procedure?</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Bv1OOw9.png\" width=\"284\" height=\"278\"></span></p>",
      "unique_key": "Q7103067",
      "question_audio": null,
      "question_video": null,
      "map_id": 35126115,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 11-13 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The image shows <strong>Chorionic Villus Sampling (CVS)</strong> — a prenatal diagnostic procedure in which a sample of <strong>chorionic villi from the placenta</strong> is aspirated under <strong>ultrasound guidance</strong>.</span></p><p><br><span style=\"font-size:14.0pt;\">It is used for <strong>early genetic diagnosis</strong> of chromosomal or metabolic abnormalities (e.g., Down syndrome, thalassemia, Tay-Sachs).</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Best timing:</strong> <strong>11–13 weeks of gestation</strong> (ideally around 11 weeks).</span></li><li><span style=\"font-size:14.0pt;\">Performing CVS <strong>before 10 weeks</strong> increases the risk of <strong>limb reduction defects and oromandibular hypogenesis</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Summary Table:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_9ENgHIf.png\" width=\"675\" height=\"214\"></strong></span></p>",
      "correct_choice_id": 378212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95005,
      "choices": [
        {
          "id": 378216,
          "text": "<p><span style=\"font-size:14.0pt;\">Second Pelvic grip</span></p>"
        },
        {
          "id": 378217,
          "text": "<p><span style=\"font-size:14.0pt;\">﻿﻿﻿4th Leopold</span></p>"
        },
        {
          "id": 378218,
          "text": "<p><span style=\"font-size:14.0pt;\">﻿﻿﻿First Pelvic grip</span></p>"
        },
        {
          "id": 378219,
          "text": "<p><span style=\"font-size:14.0pt;\">﻿﻿﻿Fundal grip</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the grip in the image given below:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_kLIcghZ.png\" width=\"231\" height=\"317\"></span></p>",
      "unique_key": "Q5620051",
      "question_audio": null,
      "question_video": null,
      "map_id": 35126176,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) First Pelvic grip</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The image shows the <strong>Third Leopold’s Maneuver</strong> (also called the <strong>First Pelvic Grip or Pawlik grip</strong>).</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Leopold’s Maneuvers:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_jzAhSuc.png\" width=\"737\" height=\"246\"></strong></span></p>",
      "correct_choice_id": 378218,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24958,
      "choices": [
        {
          "id": 99790,
          "text": "<p><span style=\"font-size:18px;\">Dysgerminoma</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/18/1_fI999DQ.jpg\" alt=\"\" width=\"300\" height=\"262\"></span></p>"
        },
        {
          "id": 99791,
          "text": "<p><span style=\"font-size:18px;\">Granulosa cell tumor</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/18/2_aU6R2pt.jpg\" alt=\"\" width=\"300\" height=\"258\"></span></p>"
        },
        {
          "id": 99792,
          "text": "<p><span style=\"font-size:18px;\">Teratoma</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/18/3_2aeWEQM.jpg\" alt=\"\" width=\"300\" height=\"264\"></span></p>"
        },
        {
          "id": 99793,
          "text": "<p><span style=\"font-size:18px;\">Embryonal cell tumor</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/18/4_al5quii.jpg\" alt=\"\" width=\"300\" height=\"223\"></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">Identify the incorrect pair:</span></p>",
      "unique_key": "Q7978733",
      "question_audio": null,
      "question_video": null,
      "map_id": 35126197,
      "difficulty_level": "difficult",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Embryonal cell tumor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/18/4_al5quii.jpg\" alt=\"\" width=\"300\" height=\"223\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Image 1 → Dysgerminoma:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Microscopy: Sheets of uniform round cells with clear cytoplasm, central nuclei (“fried-egg appearance”), fibrous septa infiltrated by lymphocytes.</span></li><li><span style=\"font-size:14.0pt;\">Analogous to: Seminoma of testis.</span></li><li><span style=\"font-size:14.0pt;\">Marker: ↑ LDH, PLAP.</span><br><span style=\"font-size:14.0pt;\">&nbsp;Diagnosis: Dysgerminoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Image 2 → Granulosa cell tumor:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Microscopy: Superfical cells seen on Pap smear indicating Estrogen production by GCT.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Image 3 → Teratoma:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Microscopy: Contains mature elements from multiple germ layers—skin, hair follicles, sebaceous glands, etc.</span></li><li><span style=\"font-size:14.0pt;\">Grossly: May show “dermoid cyst” with hair and teeth.Diagnosis: Mature cystic teratoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Image 4 → (Incorrectly labeled as Embryonal cell tumor):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">It actually shows biphasic trophoblastic proliferation — cytotrophoblasts (clear cells) and syncytiotrophoblasts (multinucleated, eosinophilic cells) surrounding hemorrhage and necrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This is characteristic of Choriocarcinoma — a malignant germ cell tumor of trophoblastic origin, not embryonal cell tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note:&nbsp;</strong>Embryonal cell carcinoma histology shows&nbsp;primitive, anaplastic cells arranged in various architectural patterns like solid sheets, tubular/glandular structures, or papillary formations. Key features include large, pleomorphic cells with abundant cytoplasm, prominent nucleoli, and a high rate of mitotic activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_swh1SN5.png\" width=\"458\" height=\"490\"></span></p>",
      "correct_choice_id": 99793,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95006,
      "choices": [
        {
          "id": 378220,
          "text": "<p><span style=\"font-size:14.0pt;\">LMWH</span></p>"
        },
        {
          "id": 378221,
          "text": "<p><span style=\"font-size:14.0pt;\">Warfarin</span></p>"
        },
        {
          "id": 378222,
          "text": "<p><span style=\"font-size:14.0pt;\">Early ambulation</span></p>"
        },
        {
          "id": 378223,
          "text": "<p><span style=\"font-size:14.0pt;\">Compression stockings</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A P1L1 mother with BMI of 35 diagnosed with pre-eclampsia underwent LSCS. What is the ideal agent for prophylaxis post-partum venous thromboembolism?</span></p>",
      "unique_key": "Q7614351",
      "question_audio": null,
      "question_video": null,
      "map_id": 35126298,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) LMWH</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Women who are <strong>postpartum</strong>, especially after <strong>cesarean section</strong> and with additional risk factors like <strong>obesity (BMI &gt;30)</strong> and <strong>preeclampsia</strong>, are at <strong>high risk of venous thromboembolism (VTE)</strong>.</span></p><p><br><span style=\"font-size:14.0pt;\">In such high-risk patients, <strong>pharmacologic prophylaxis</strong> is required in addition to mechanical measures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>agent of choice</strong> for postpartum VTE prophylaxis is <strong>Low Molecular Weight Heparin (LMWH)</strong>, started <strong>6–12 hours after cesarean delivery</strong> (once hemostasis is assured).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>LMWH is preferred because:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Predictable anticoagulant effect</span></li><li><span style=\"font-size:14.0pt;\">No need for routine monitoring</span></li><li><span style=\"font-size:14.0pt;\">Safe in breastfeeding</span></li><li><span style=\"font-size:14.0pt;\">Lower risk of HIT (heparin-induced thrombocytopenia) compared to unfractionated heparin</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Note: Given for <strong>at least 7 days</strong>, or longer if risk persists</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Warfarin:&nbsp;</strong>Incorrect.</span><br><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Not used for initial postpartum prophylaxis; it is used for long-term anticoagulation.</span></li><li><span style=\"font-size:14.0pt;\">Requires INR monitoring and slower onset of action.</span></li><li><span style=\"font-size:14.0pt;\">Though safe in lactation, it’s not ideal immediately after delivery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Early ambulation:&nbsp;</strong>Incorrect. Recommended for all postpartum women, but <strong>not sufficient</strong> in high-risk cases like obesity + preeclampsia + LSCS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Compression stockings:&nbsp;</strong>Incorrect. Useful as an <strong>adjunct</strong>, but <strong>insufficient</strong> without pharmacologic prophylaxis in high-risk patients.</span></p>",
      "correct_choice_id": 378220,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95007,
      "choices": [
        {
          "id": 378224,
          "text": "<p><span style=\"font-size:14.0pt;\">Empty the bladder</span></p>"
        },
        {
          "id": 378225,
          "text": "<p><span style=\"font-size:14.0pt;\">Reverse tredelenburg</span></p>"
        },
        {
          "id": 378226,
          "text": "<p><span style=\"font-size:14.0pt;\">LSCS</span></p>"
        },
        {
          "id": 378227,
          "text": "<p><span style=\"font-size:14.0pt;\">Funic maneouver</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A G2P1L1 suffers cord prolapse during labour. Cervix was 5 cm dilated and cord pulsations were present. What is the next best step in management?</span></p>",
      "unique_key": "Q3595487",
      "question_audio": null,
      "question_video": null,
      "map_id": 35126299,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) LSCS</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Umbilical cord prolapse</strong> is an <strong>obstetric emergency</strong> in which the <strong>umbilical cord slips below the presenting part</strong>, leading to <strong>cord compression and fetal hypoxia</strong>.</span></p><p><br><span style=\"font-size:14.0pt;\">In this case, since:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>cervix is only 5 cm dilated (not fully dilated)</strong>, and</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cord pulsations are still present (fetus is alive)</strong>,</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">the <strong>immediate priority</strong> is to <strong>deliver the baby as quickly as possible</strong> — and the <strong>safest and fastest method</strong> in this scenario is an <strong>emergency LSCS</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gdOeOCq.png\" width=\"683\" height=\"218\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Empty the bladder:&nbsp;</strong>Incorrect (but can be a temporary measure). Filling the bladder (not emptying) using <strong>Vesicovaginal Bladder Filling or Vago–Bladder Lift technique (O’Driscoll’s method)</strong> can temporarily relieve cord compression, but definitive management is <strong>delivery by LSCS</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Reverse Trendelenburg:&nbsp;</strong>Incorrect. The recommended position is <strong>knee–chest</strong> or <strong>steep Trendelenburg</strong>, not reverse. These postures relieve cord compression by gravity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Funic maneuver:&nbsp;</strong>Incorrect.&nbsp; Refers to manually pushing the cord above the presenting part. Not recommended now.&nbsp;</span></p>",
      "correct_choice_id": 378226,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95008,
      "choices": [
        {
          "id": 378228,
          "text": "<p><span style=\"font-size:14.0pt;\">Pap smear</span></p>"
        },
        {
          "id": 378229,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate referral to a cardiologist to control BP</span></p>"
        },
        {
          "id": 378230,
          "text": "<p><span style=\"font-size:14.0pt;\">TVS</span></p>"
        },
        {
          "id": 378231,
          "text": "<p><span style=\"font-size:14.0pt;\">Hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year post-menopausal woman presents to the OPD for a routine BP checkup. Her BP was 170/100 mmHg. She also complains of bloodstained discharge per vagina. What is the next best step of management?</span></p>",
      "unique_key": "Q1332993",
      "question_audio": null,
      "question_video": null,
      "map_id": 35126320,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) TVS</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a <strong>postmenopausal woman</strong> presenting with <strong>blood-stained vaginal discharge or bleeding</strong>, the <strong>first and most appropriate investigation</strong> is <strong>Transvaginal Sonography (TVS)</strong> to assess <strong>endometrial thickness</strong> and morphology.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>TVS helps to:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Measure <strong>endometrial thickness (ET)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Identify <strong>focal lesions</strong> (e.g., polyps, hyperplasia, carcinoma).</span></li><li><span style=\"font-size:14.0pt;\">Guide the need for <strong>endometrial sampling or biopsy</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Interpretation of endometrial thickness:</span></li><li><span style=\"font-size:14.0pt;\"><strong>ET ≤ 4 mm:</strong> Low risk of malignancy → Observation or follow-up.</span></li><li><span style=\"font-size:14.0pt;\"><strong>ET &gt; 4 mm:</strong> Suspicious → Proceed to <strong>endometrial biopsy / sampling</strong> for histopathology.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, the next best step is <strong>TVS</strong> before planning further evaluation or surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pap smear:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pap smear screens for <strong>cervical carcinoma</strong>, not endometrial pathology.</span></li><li><span style=\"font-size:14.0pt;\">Postmenopausal bleeding is more suggestive of <strong>endometrial disease</strong>; Pap smear is not diagnostic here.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Immediate referral to a cardiologist to control BP:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While hypertension (170/100 mmHg) needs attention, it is <strong>not the immediate priority</strong> in the context of <strong>postmenopausal bleeding</strong>, which could indicate malignancy.</span></li><li><span style=\"font-size:14.0pt;\">BP control can be done concurrently, but <strong>evaluation of bleeding comes first.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hysterectomy:&nbsp;</strong>Incorrect.</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Not done without prior <strong>diagnostic confirmation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Indicated only <strong>after</strong> confirming malignancy or severe premalignant lesion on biopsy.</span></li></ul>",
      "correct_choice_id": 378230,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95009,
      "choices": [
        {
          "id": 378232,
          "text": "<p><span style=\"font-size:14.0pt;\">PCOS</span></p>"
        },
        {
          "id": 378233,
          "text": "<p><span style=\"font-size:14.0pt;\">Premature ovarian insufficiency</span></p>"
        },
        {
          "id": 378234,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperprolactinaemia</span></p>"
        },
        {
          "id": 378235,
          "text": "<p><span style=\"font-size:14.0pt;\">Sheehan syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 22-year-old woman presents with amenorrhea for 1 year. She had elevated gonadotropic hormones and decreased AMH. What is the likely diagnosis?</span></p>",
      "unique_key": "Q1487422",
      "question_audio": null,
      "question_video": null,
      "map_id": 35126421,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Premature ovarian insufficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The combination of <strong>amenorrhea</strong>, <strong>high gonadotropin levels (↑ FSH, ↑ LH)</strong>, and <strong>low AMH (Anti-Müllerian Hormone)</strong> indicates <strong>ovarian failure</strong> — i.e., the ovaries are no longer producing adequate estrogen or viable follicles despite the young age of the woman.</span></p><p><br><span style=\"font-size:14.0pt;\">This condition is known as <strong>Premature Ovarian Insufficiency (POI)</strong> (also called premature ovarian failure).</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Diagnostic criteria:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Age <strong>&lt;40 years</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Amenorrhea &gt;4–6 months</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Elevated FSH (&gt;40 IU/L)</strong> on two occasions, 4 weeks apart</span></li><li><span style=\"font-size:14.0pt;\"><strong>Low estradiol and low AMH</strong> (reflecting reduced ovarian reserve)</span></li></ul></li></ul><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Etiologies include:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Genetic (Turner’s, Fragile X premutation)</span></li><li><span style=\"font-size:14.0pt;\">Autoimmune (thyroid, adrenal, ovarian antibodies)</span></li><li><span style=\"font-size:14.0pt;\">Iatrogenic (chemotherapy, radiotherapy)</span></li><li><span style=\"font-size:14.0pt;\">Idiopathic</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. PCOS:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In Polycystic Ovary Syndrome, <strong>AMH is elevated</strong> due to increased small antral follicles.</span></li><li><span style=\"font-size:14.0pt;\">Gonadotropins show <strong>normal or mildly elevated LH</strong>, but <strong>FSH is low/normal</strong> — not high.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hyperprolactinaemia:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Causes <strong>hypogonadotropic hypogonadism</strong> (↓FSH, ↓LH) due to prolactin inhibition of GnRH.</span></li><li><span style=\"font-size:14.0pt;\">AMH levels are usually normal.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Sheehan syndrome:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Postpartum pituitary necrosis → <strong>low gonadotropins</strong> (↓FSH, ↓LH) due to pituitary failure.</span></li><li><span style=\"font-size:14.0pt;\">AMH may remain normal initially as ovarian reserve is not directly destroyed.</span></li></ul>",
      "correct_choice_id": 378233,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95010,
      "choices": [
        {
          "id": 378236,
          "text": "<p><span style=\"font-size:14.0pt;\">Start OCPs</span></p>"
        },
        {
          "id": 378237,
          "text": "<p><span style=\"font-size:14.0pt;\">Wait and watch for 6 months</span></p>"
        },
        {
          "id": 378238,
          "text": "<p><span style=\"font-size:14.0pt;\">Hysterectomy</span></p>"
        },
        {
          "id": 378239,
          "text": "<p><span style=\"font-size:14.0pt;\">Endometrial biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman presents with delayed cycles and heavy bleeding for the past year. Ultrasonography shows an endometrial thickness of 16 mm. What is the next best step in management?</span></p>",
      "unique_key": "Q4292458",
      "question_audio": null,
      "question_video": null,
      "map_id": 35126442,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Endometrial biopsy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A <strong>45-year-old woman</strong> with <strong>heavy menstrual bleeding and thickened endometrium (16 mm)</strong> on ultrasound is most likely in the <strong>perimenopausal</strong> age group.</span></p><p><br><span style=\"font-size:14.0pt;\">At this age, <strong>anovulatory cycles</strong> and <strong>unopposed estrogen exposure</strong> increase the risk of <strong>endometrial hyperplasia or carcinoma</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Therefore, the <strong>next best step</strong> is to perform an <strong>endometrial biopsy</strong> to rule out <strong>endometrial hyperplasia or malignancy</strong> before initiating any hormonal or surgical treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Indications for endometrial biopsy in abnormal uterine bleeding (AUB):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Age ≥45 years with AUB</span></li><li><span style=\"font-size:14.0pt;\">Endometrial thickness &gt;12 mm in premenopausal or &gt;4–5 mm in postmenopausal women</span></li><li><span style=\"font-size:14.0pt;\">Risk factors: obesity, diabetes, PCOS, chronic anovulation, tamoxifen use, unopposed estrogen</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Start OCPs: </strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hormonal therapy (like OCPs or progestins) may be used for dysfunctional uterine bleeding, <strong>but only after excluding malignancy</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Starting OCPs before histologic confirmation risks delaying diagnosis of endometrial carcinoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Wait and watch for 6 months: </strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Observation is unsafe when <strong>ET &gt;16 mm</strong> and the patient is <strong>&gt;40 years</strong> with <strong>heavy bleeding</strong>.</span></li><li><span style=\"font-size:14.0pt;\">There is a significant risk of endometrial pathology.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hysterectomy: </strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is definitive treatment <strong>only after diagnosis</strong> (e.g., confirmed hyperplasia with atypia or carcinoma).</span></li><li><span style=\"font-size:14.0pt;\">Not the next immediate step.</span></li></ul>",
      "correct_choice_id": 378239,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95011,
      "choices": [
        {
          "id": 378240,
          "text": "<p><span style=\"font-size:14.0pt;\">Most commonly spreads directly from fallopian tubes</span></p>"
        },
        {
          "id": 378241,
          "text": "<p><span style=\"font-size:14.0pt;\">Hematogenous spread can occur from pulmonary focus</span></p>"
        },
        {
          "id": 378242,
          "text": "<p><span style=\"font-size:14.0pt;\">Hematogeneous spread is the commonest mode of transmission</span></p>"
        },
        {
          "id": 378243,
          "text": "<p><span style=\"font-size:14.0pt;\">May rarely occur due to infected semen from partner with genitourinary TB</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman presents with infertility. Endometrial biopsy reveals tuberculosis. Regarding the mode of spread of endometrial tuberculosis, all of the following are true&nbsp;except:</span></p>",
      "unique_key": "Q7495645",
      "question_audio": null,
      "question_video": null,
      "map_id": 35126613,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Hematogeneous spread is the commonest mode of transmission</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Although <strong>genital tuberculosis as a whole</strong> is usually <strong>seeded hematogenously</strong> from a distant focus(usually-lungs),the <strong>endometrial involvement specifically</strong> is <strong>secondary</strong>, caused by <strong>direct spread from the fallopian tubes</strong>, not primarily hematogenous.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In other words:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The genital tract gets infected by <strong>hematogenous spread</strong> initially (starting in tubes).</span></li><li><span style=\"font-size:14.0pt;\">But the <strong>endometrium</strong> itself gets infected <strong>by direct extension from the tubal lesion</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hence, when the question asks about <strong>endometrial tuberculosis</strong>,</span><br><span style=\"font-size:14.0pt;\">the <strong>commonest mode of spread</strong> to the endometrium is <strong>direct spread from infected tubes</strong>, and not hematogenous spread.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Most commonly spreads directly from fallopian tubes:&nbsp;</strong>True.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Endometrial TB almost always follows <strong>tubal infection</strong> via <strong>direct extension</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The endometrium is rarely the initial site.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hematogenous spread can occur from pulmonary focus:&nbsp;</strong>True. That is the <strong>initial route</strong> for infection reaching the genital tract, but not the main route for endometrial involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. May rarely occur due to infected semen from partner with genitourinary TB:&nbsp;</strong>True. A very rare but documented route (venereal transmission).</span></p>",
      "correct_choice_id": 378242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95012,
      "choices": [
        {
          "id": 378244,
          "text": "<p><span style=\"font-size:14.0pt;\">Aromatase deficiency</span></p>"
        },
        {
          "id": 378245,
          "text": "<p><span style=\"font-size:14.0pt;\">Congenital adrenal hyperplasia</span></p>"
        },
        {
          "id": 378246,
          "text": "<p><span style=\"font-size:14.0pt;\">Kallmann syndrome</span></p>"
        },
        {
          "id": 378247,
          "text": "<p><span style=\"font-size:14.0pt;\">Swyer James syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An 18-year-old woman comes to the OPD due to primary amenorrhea. The patient had ambiguous external genitalia noted at birth, and laparotomy performed at 17 months of age revealed a normal uterus and fallopian tubes. Ovarian biopsy performed at that time revealed normal-appearing primordial follicles. Blood pressure is 120/78 mm Hg and height is 160 cm (5 ft 3 in). The patient has nodulocystic acne over the chest and back. No breast development, normal pubic and axillary hair, and marked clitoromegaly are present. Laboratory results show a normal female karyotype and normal glucose and serum electrolytes. Serum FSH, LH, testosterone, and androstenedione concentrations are high. Pelvic imaging reveals multiple ovarian cysts. Which of the following is the most likely diagnosis in this patient?</span></p>",
      "unique_key": "Q9599947",
      "question_audio": null,
      "question_video": null,
      "map_id": 35126614,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Aromatase deficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>This 18-year-old woman has:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Primary amenorrhea</span></li><li><span style=\"font-size:14.0pt;\">Normal female karyotype (46,XX)</span></li><li><span style=\"font-size:14.0pt;\">Normal uterus and ovaries with follicles</span></li><li><span style=\"font-size:14.0pt;\">Virilization (clitoromegaly, acne, no breast development)</span></li><li><span style=\"font-size:14.0pt;\">High FSH, LH, testosterone, and androstenedione</span></li><li><span style=\"font-size:14.0pt;\">Normal electrolytes and blood pressure</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These findings are <strong>classical of Aromatase Deficiency</strong>, a rare cause of primary amenorrhea with virilization in 46,XX females.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathophysiology:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Aromatase enzyme (CYP19 gene) converts <strong>androgens → estrogens</strong> in:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ovaries</strong> (granulosa cells)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Placenta</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Adipose tissue</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>In Aromatase deficiency:</strong></span></li></ul><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Conversion of <strong>testosterone and androstenedione to estrogen fails</strong> → ↓ estrogen.</span></li><li><span style=\"font-size:14.0pt;\">Excess androgens accumulate → <strong>virilization</strong> in female fetus and after puberty.</span></li><li><span style=\"font-size:14.0pt;\">Lack of estrogen → <strong>no breast development, primary amenorrhea, high gonadotropins</strong> (FSH, LH) due to loss of negative feedback.</span></li><li><span style=\"font-size:14.0pt;\">Ovaries become <strong>multicystic</strong> due to chronic stimulation by FSH/LH.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Congenital adrenal hyperplasia: Incorrect.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Usually presents with <strong>electrolyte disturbances (low Na⁺, high K⁺)</strong> if 21-hydroxylase deficiency.</span></li><li><span style=\"font-size:14.0pt;\">Elevated <strong>17-hydroxyprogesterone</strong>, not seen here.</span></li><li><span style=\"font-size:14.0pt;\">Ovaries are normal; uterus normal but <strong>androgen excess is adrenal in origin</strong>, not ovarian.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Kallmann syndrome: Incorrect.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Caused by <strong>GnRH deficiency</strong> → low FSH, low LH, low estrogen.</span></li><li><span style=\"font-size:14.0pt;\">No virilization, no acne, no androgen excess. Associated with <strong>anosmia</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Swyer syndrome (46,XY gonadal dysgenesis): Incorrect.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Karyotype is <strong>46,XY</strong>, not 46,XX.</span></li><li><span style=\"font-size:14.0pt;\">Has <strong>streak gonads</strong>, not normal ovaries.</span></li><li><span style=\"font-size:14.0pt;\">No virilization, since no androgen production.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Summary Table:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_iSXSphG.png\" width=\"765\" height=\"365\"></strong></span></p>",
      "correct_choice_id": 378244,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95013,
      "choices": [
        {
          "id": 378248,
          "text": "<p><span style=\"font-size:14.0pt;\">266 days</span></p>"
        },
        {
          "id": 378249,
          "text": "<p><span style=\"font-size:14.0pt;\">263 days</span></p>"
        },
        {
          "id": 378250,
          "text": "<p><span style=\"font-size:14.0pt;\">261 days</span></p>"
        },
        {
          "id": 378251,
          "text": "<p><span style=\"font-size:14.0pt;\">280 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman undergoes in vitro fertilization (IVF) and Embryo transfer is performed after the third day of fertilization. Based on this information, what is the estimated date of delivery (EDD) from the date of embryo transfer?</span></p>",
      "unique_key": "Q7228820",
      "question_audio": null,
      "question_video": null,
      "map_id": 35126635,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 263 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>In Vitro Fertilization (IVF)</strong>, the <strong>Embryo Transfer (ET)</strong> date is not equivalent to the <strong>date of conception</strong>, because fertilization has already occurred <strong>in vitro</strong> before the embryo is transferred back to the uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>Estimated Date of Delivery (EDD)</strong> in IVF cases is therefore <strong>calculated from the date of embryo transfer</strong>, adjusted for the embryo’s developmental age.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Concept:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_NL3kyVL.png\" width=\"731\" height=\"166\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">So, in this case —</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Embryo transfer = Day 3 embryo</strong>,</span><br><span style=\"font-size:14.0pt;\">→ Expected due date = <strong>Embryo transfer date + 261 days</strong>.</span></li></ul>",
      "correct_choice_id": 378249,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95014,
      "choices": [
        {
          "id": 378252,
          "text": "<p><span style=\"font-size:14.0pt;\">Instrumental delivery</span></p>"
        },
        {
          "id": 378253,
          "text": "<p><span style=\"font-size:14.0pt;\">Emergency Lower segment caesarean section</span></p>"
        },
        {
          "id": 378254,
          "text": "<p><span style=\"font-size:14.0pt;\">Stop oxytocin</span></p>"
        },
        {
          "id": 378255,
          "text": "<p><span style=\"font-size:14.0pt;\">Artificial rupture of membranes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A G2P1L1 with a history of previous caesarean section presented in active labour. During trial of labour, there was foetal bradycardia and maternal tachycardia. Persistent suprapubic pain between contractions was also noted. On examination, cervix was 8 cm dilated and the vertex was at –1 station. What is the next best step of management?</span></p>",
      "unique_key": "Q1400807",
      "question_audio": null,
      "question_video": null,
      "map_id": 35126686,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Emergency Lower segment caesarean section</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The woman is a <strong>G2P1L1 with previous caesarean section</strong>, now <strong>in active labour</strong> and showing signs of scar dehiscence— a <strong>life-threatening obstetric emergency</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key clues in the question:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Previous LSCS</strong> → uterine scar present (risk of rupture during TOLAC).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fetal bradycardia</strong> → most sensitive and early sign of uterine rupture.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Maternal tachycardia</strong> → suggests maternal shock or concealed bleeding.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Persistent suprapubic pain between contractions</strong> → classic sign of <strong>impending or actual rupture</strong> (constant, non-labour pain).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cervix 8 cm, vertex –1 station</strong> → not imminent vaginal delivery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, this is a case of <strong>suspected uterine rupture</strong>, requiring <strong>immediate emergency laparotomy and LSCS</strong> to deliver the baby and control bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Instrumental delivery:&nbsp;</strong>Incorrect. Cervix is <strong>8 cm dilated</strong> and vertex is <strong>–1 station</strong> — Instrumental contraindicated when <strong>uterine rupture</strong> is suspected; vaginal delivery attempts can worsen rupture.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Stop oxytocin: Incorrect (but supportive step).</strong> Oxytocin should indeed be stopped if being used, but this <strong>alone is not sufficient</strong>. Definitive management is <strong>emergency surgery</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Artificial rupture of membranes:</strong> Incorrect. Contraindicated; can precipitate <strong>complete rupture</strong> and worsen maternal/foetal compromise.</span></p>",
      "correct_choice_id": 378253,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95016,
      "choices": [
        {
          "id": 378256,
          "text": "<p><span style=\"font-size:14.0pt;\">Induce labour immediately</span></p>"
        },
        {
          "id": 378257,
          "text": "<p><span style=\"font-size:14.0pt;\">Repeat NST</span></p>"
        },
        {
          "id": 378258,
          "text": "<p><span style=\"font-size:14.0pt;\">USG doppler for umbilical artery</span></p>"
        },
        {
          "id": 378259,
          "text": "<p><span style=\"font-size:14.0pt;\">Modified BPP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A primigravida at 37 weeks presents with decreased foetal movements for 1 day. NST showed one acceleration in 20 minutes and no decelerations. What is the next step in management?</span></p>",
      "unique_key": "Q1807582",
      "question_audio": null,
      "question_video": null,
      "map_id": 35126823,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Repeat NST</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>In this case:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient is <strong>37 weeks pregnant</strong>,</span></li><li><span style=\"font-size:14.0pt;\">Complains of <strong>decreased fetal movements</strong>,</span></li><li><span style=\"font-size:14.0pt;\"><strong>NST (Non-Stress Test)</strong> shows <strong>1 acceleration in 20 minutes</strong>, and <strong>no decelerations</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This finding means the <strong>NST is “non-reactive but non-reassuring”</strong> — it is <strong>equivocal</strong>, <strong>not abnormal</strong>, and therefore <strong>requires repeat testing</strong> before further interventions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A <strong>reactive NST</strong> requires <strong>≥2 accelerations</strong> (each ≥15 bpm above baseline lasting ≥15 seconds) within 20 minutes.</span></p><p><br><span style=\"font-size:14.0pt;\">If this criterion is not met, but there are <strong>no decelerations</strong>, the test is <strong>indeterminate</strong>, and the next appropriate step is to <strong>extend or repeat the NST</strong> (up to 40 minutes or after some time).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Rationale for Next Step:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fetus may be in a <strong>sleep cycle</strong> lasting 20–40 minutes → causing reduced accelerations.</span></li><li><span style=\"font-size:14.0pt;\">Repeating the NST after a short interval or extending it for another 20 minutes helps confirm reactivity.</span></li><li><span style=\"font-size:14.0pt;\">Immediate interventions (like induction or Doppler) are done <strong>only if NST remains non-reactive or abnormal</strong> on repetition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Induce labour immediately:&nbsp;</strong>Incorrect.</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Immediate induction is indicated only if <strong>NST remains persistently non-reactive</strong> with <strong>abnormal BPP or Doppler findings</strong> suggesting foetal compromise.</span></li><li><span style=\"font-size:14.0pt;\">Here, the NST is non-reactive but not ominous.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. USG Doppler for umbilical artery:&nbsp;</strong>Incorrect.</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Umbilical artery Doppler is indicated if <strong>repeated NSTs are non-reactive or suspicious</strong> or if <strong>IUGR / preeclampsia</strong> is suspected.</span></li><li><span style=\"font-size:14.0pt;\">Not the immediate next step.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Modified BPP:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Modified Biophysical Profile (NST + Amniotic Fluid Index) is done <strong>after</strong> a repeated non-reactive NST.</span></li><li><span style=\"font-size:14.0pt;\">It is the next investigation if NST remains non-reactive.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>REACTIVE NST</strong>:-&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_XLJ8rOP.png\" width=\"970\" height=\"460\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_3Xkt9QP.png\" width=\"995\" height=\"806\"></span></p>",
      "correct_choice_id": 378257,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95017,
      "choices": [
        {
          "id": 378260,
          "text": "<p><span style=\"font-size:14.0pt;\">Cesarean delivery</span></p>"
        },
        {
          "id": 378261,
          "text": "<p><span style=\"font-size:14.0pt;\">Continue expectant management&nbsp;</span></p>"
        },
        {
          "id": 378262,
          "text": "<p><span style=\"font-size:14.0pt;\">Oxytocin infusion</span></p>"
        },
        {
          "id": 378263,
          "text": "<p><span style=\"font-size:14.0pt;\">Vaginal misoprostol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old woman, gravida 1 para 0, at 40 weeks gestation comes to the hospital due to painful contractions for the past few hours. The patient has had no leakage of fluid or vaginal bleeding. Fetal movement has been normal. On admission, the cervix is 5 cm dilated and 90% effaced with the fetal head at -1 station. She received epidural analgesia; on repeat cervical examination, the cervix is 6 cm dilated and 100% effaced with the fetal head at -1 station. Two hours later, the cervix is unchanged. Fetal heart rate monitoring shows a baseline of 130/min, moderate variability, accelerations, and occasional early decelerations. The tocodynamometer shows contractions every 5-7 minutes. Which of the following is the best next step is management of this patient?</span></p>",
      "unique_key": "Q2942789",
      "question_audio": null,
      "question_video": null,
      "map_id": 35126904,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Oxytocin infusion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient is in <strong>active labor (≥6 cm dilatation)</strong> but has had <strong>no cervical progress for 2 hours</strong>.</span></p><p><br><span style=\"font-size:14.0pt;\">Fetal heart tracing is <strong>reassuring</strong>, and contractions are <strong>infrequent (every 5–7 minutes)</strong> — this indicates <strong>inadequate uterine activity</strong> rather than true arrest.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hence, the <strong>best next step</strong> is to <strong>augment labor with oxytocin infusion</strong> to increase contraction frequency and strength.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Stepwise Reasoning</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Labor phase:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">At 6 cm → she is in <strong>active phase</strong> of the <strong>first stage of labor</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Definition of arrest vs protraction (per ACOG 2020):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_BnbKpHM.png\" width=\"695\" height=\"166\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Here:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cervix unchanged for <strong>2 hours</strong></span></li><li><span style=\"font-size:14.0pt;\">Contractions <strong>inadequate (every 5–7 min)</strong></span><br><span style=\"font-size:14.0pt;\">→ <strong>Protraction of active phase</strong>, not yet arrest.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Hence</strong>, the appropriate management is <strong>oxytocin augmentation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Findings Supporting This Decision</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>FHR tracing:</strong> Baseline 130/min, moderate variability, accelerations, and early decelerations → <strong>Category I (normal)</strong> → fetus is fine.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Epidural analgesia:</strong> Can sometimes <strong>decrease contraction frequency</strong>, which can be corrected by oxytocin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cesarean delivery:&nbsp;</strong>Incorrect.</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Indicated only if <strong>active phase arrest</strong> (no progress for ≥4 hrs with adequate contractions or ≥6 hrs with inadequate contractions).</span></li><li><span style=\"font-size:14.0pt;\">Here only 2 hrs have passed with poor contractions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Continue expectant management:&nbsp;</strong>Incorrect.</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">She already shows <strong>slow progress and weak contractions</strong>; continuing without augmentation prolongs labor and increases risk of infection and exhaustion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Vaginal misoprostol:&nbsp;</strong>Incorrect.</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Used for <strong>cervical ripening in induction</strong>, not for <strong>augmentation in active labor</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Contraindicated once in active phase and with regular contractions.</span></li></ul>",
      "correct_choice_id": 378262,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95018,
      "choices": [
        {
          "id": 378264,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate cesarean section</span></p>"
        },
        {
          "id": 378265,
          "text": "<p><span style=\"font-size:14.0pt;\">Start LMWH followed by LSCS</span></p>"
        },
        {
          "id": 378266,
          "text": "<p><span style=\"font-size:14.0pt;\">Vaginal delivery by forceps extraction</span></p>"
        },
        {
          "id": 378267,
          "text": "<p><span style=\"font-size:14.0pt;\">Wait for spontaneous onset of labor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old pregnant woman at term is admitted for normal vaginal delivery. Her per vaginal examination shows a cervix dilatation of 5 cm and cord prolapse with absent FHR on examination. What is the next step of management?</span></p>",
      "unique_key": "Q7132163",
      "question_audio": null,
      "question_video": null,
      "map_id": 35126965,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Wait for spontaneous onset of labor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>cord prolapse</strong> with <strong>absent fetal heart sounds</strong>, the <strong>fetus is dead</strong>.</span><br><span style=\"font-size:14.0pt;\">So, the goal is <strong>safe delivery for the mother</strong>, <strong>not</strong> fetal rescue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">However — in this case:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>cervix is only 5 cm dilated</strong>,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Active labor has begun</strong>, but not yet full dilatation,</span></li><li><span style=\"font-size:14.0pt;\">The fetus is <strong>dead</strong>,</span><br><span style=\"font-size:14.0pt;\">→ Hence, there is <strong>no need for cesarean section</strong> or operative acceleration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The safest management is to <strong>allow labor to progress naturally</strong> (expectant management) until full dilatation, followed by <strong>spontaneous vaginal delivery</strong>.</span><br><span style=\"font-size:14.0pt;\">No active induction or instrumentation is required at this stage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Stepwise Logic</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ZZEjnoS.png\" width=\"664\" height=\"141\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">➡ Therefore, <strong>wait for spontaneous progress of labor</strong> and deliver vaginally.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Immediate cesarean section:&nbsp;</strong>Incorrect.</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Indicated only when <strong>fetus is alive</strong> and can be saved.</span></li><li><span style=\"font-size:14.0pt;\">Not indicated once FHR is absent (IUFD).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Start LMWH followed by LSCS:&nbsp;</strong>Incorrect.</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Irrelevant to obstetric emergency; LMWH has <strong>no role</strong> in cord prolapse. It is used in cases of thromboprophylaxis in pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Vaginal delivery by forceps extraction:&nbsp;</strong>Incorrect.</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cervix only 5 cm — not fully dilated, so forceps delivery <strong>cannot be done</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Forceps may be used later <strong>after full dilatation</strong> if delivery needs to be expedited, but <strong>not immediately</strong>.</span></li></ul>",
      "correct_choice_id": 378267,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95019,
      "choices": [
        {
          "id": 378268,
          "text": "<p><span style=\"font-size:14.0pt;\">Pregnancy is contraindicated</span></p>"
        },
        {
          "id": 378269,
          "text": "<p><span style=\"font-size:14.0pt;\">Pregnancy is safe with lifestyle modifications</span></p>"
        },
        {
          "id": 378270,
          "text": "<p><span style=\"font-size:14.0pt;\">Pregnancy is safe with close monitoring and medical management</span></p>"
        },
        {
          "id": 378271,
          "text": "<p><span style=\"font-size:14.0pt;\">Pregnancy is safe as any general population</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old woman with a history of peripartum cardiomyopathy following a previous pregnancy presents for preconception counselling. Her current ECHO reveals an ejection fraction of 45%.&nbsp;What would be the best advice for her regarding upcoming pregnancy?</span></p>",
      "unique_key": "Q6362482",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127006,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Pregnancy is contraindicated</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Peripartum cardiomyopathy (PPCM)</strong> is a type of <strong>dilated cardiomyopathy</strong> that occurs during the <strong>last month of pregnancy or within 5 months postpartum</strong>, in a woman with no prior cardiac disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The most important predictor of maternal outcome in future pregnancies is <strong>left ventricular ejection fraction (LVEF)</strong> after recovery from the initial episode.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Risk Stratification Based on Current Ejection Fraction (ECHO):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_2dp4l0d.png\" width=\"677\" height=\"187\"></strong></span></p>",
      "correct_choice_id": 378268,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85567,
      "choices": [
        {
          "id": 340820,
          "text": "<p><span style=\"font-size:14.0pt;\">4 &gt; 5 &gt; 2 &gt; 1 &gt; 3</span></p>"
        },
        {
          "id": 340821,
          "text": "<p><span style=\"font-size:14.0pt;\">4 &gt; 1 &gt; 3 &gt; 2 &gt; 5</span></p>"
        },
        {
          "id": 340822,
          "text": "<p><span style=\"font-size:14.0pt;\">4 &gt; 5 &gt; 1 &gt; 3 &gt; 2</span></p>"
        },
        {
          "id": 340823,
          "text": "<p><span style=\"font-size:14.0pt;\">5 &gt; 4 &gt; 2 &gt; 3 &gt; 1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Arrange the following sites of endometriosis in decreasing order of frequency of involvement:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Pouch of Douglas</span></li><li><span style=\"font-size:14.0pt;\">Uterosacral ligament</span></li><li><span style=\"font-size:14.0pt;\">Broad ligament</span></li><li><span style=\"font-size:14.0pt;\">Ovary</span></li><li><span style=\"font-size:14.0pt;\">Fallopian tube</span></li></ol>",
      "unique_key": "Q3412239",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127099,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) 4 &gt; 1 &gt; 3 &gt; 2 &gt; 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Endometriosis refers to the <strong>presence of functional endometrial glands and stroma outside the uterine cavity</strong>.</span></p><p><br><span style=\"font-size:14.0pt;\">It most commonly involves <strong>dependent pelvic structures</strong> where retrograde menstrual blood tends to collect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>most frequent sites of endometriosis</strong>, in <strong>decreasing order of involvement</strong>, are:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_nfWC8Tv.png\" width=\"890\" height=\"381\"></span></p>",
      "correct_choice_id": 340821,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95020,
      "choices": [
        {
          "id": 378272,
          "text": "<p><span style=\"font-size:14.0pt;\">It is associated with obesity and diabetes</span></p>"
        },
        {
          "id": 378273,
          "text": "<p><span style=\"font-size:14.0pt;\">Smoking is a high-risk factor</span></p>"
        },
        {
          "id": 378274,
          "text": "<p><span style=\"font-size:14.0pt;\">Endometrioid morphology is typical</span></p>"
        },
        {
          "id": 378275,
          "text": "<p><span style=\"font-size:14.0pt;\">Associated with PTEN mutation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements is incorrect regarding Type I endometrial carcinoma?</span></p>",
      "unique_key": "Q8231678",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127170,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Smoking is a high-risk factor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Type I Endometrial Carcinoma</strong> (also called <strong>Endometrioid type</strong>) is the <strong>most common</strong> type of endometrial cancer, accounting for about <strong>80–85%</strong> of cases.</span></p><p><br><span style=\"font-size:14.0pt;\">It is <strong>estrogen-dependent</strong> and arises from <strong>endometrial hyperplasia</strong> due to <strong>unopposed estrogen exposure</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Smoking and Endometrial Cancer</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">Smoking is NOT a risk factor for endometrial carcinoma.</span></li><li><span style=\"font-size:14.0pt;\">In fact, smoking is paradoxically associated with a reduced risk of Type I endometrial cancer due to anti-estrogenic effects of smoking (it increases hepatic metabolism of estrogen).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hence, the statement “Smoking is a high-risk factor” is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_SfanVNa.png\" width=\"705\" height=\"196\"></span></p>",
      "correct_choice_id": 378273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76458,
      "choices": [
        {
          "id": 304701,
          "text": "<p><span style=\"font-size:14.0pt;\">Pubarche&nbsp;</span></p>"
        },
        {
          "id": 304702,
          "text": "<p><span style=\"font-size:14.0pt;\">Thelarche&nbsp;</span></p>"
        },
        {
          "id": 304703,
          "text": "<p><span style=\"font-size:14.0pt;\">Menarche</span></p>"
        },
        {
          "id": 304704,
          "text": "<p><span style=\"font-size:14.0pt;\">Growth spurt&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In which of the following stages of puberty does estrogen not have a major role?</span></p>",
      "unique_key": "Q6062675",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127191,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Pubarche</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Puberty is the sequence of events leading to sexual maturation and reproductive capability, regulated by activation of the hypothalamic–pituitary–gonadal (HPG) axis.</span></p><p><br><span style=\"font-size:14.0pt;\">Different hormones dominate at different stages of pubertal development.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pubarche results from adrenarche — increased secretion of adrenal androgens (DHEA, DHEAS, androstenedione) from the zona reticularis of adrenal cortex. Responsible for pubic and axillary hair growth, body odor, and mild acne.</span></li><li><span style=\"font-size:14.0pt;\">Estrogen does not play a major role here.</span></li><li><span style=\"font-size:14.0pt;\">Estrogen dominates in thelarche, menarche, and growth spurt (through its skeletal and endometrial effects).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Stages of Puberty and Their Hormonal Control:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_BWA3T4N.png\" width=\"679\" height=\"265\"></strong></span></p>",
      "correct_choice_id": 304701,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95021,
      "choices": [
        {
          "id": 378276,
          "text": "<p><span style=\"font-size:14.0pt;\">Fetal fibronectin and lung maturity testing</span></p>"
        },
        {
          "id": 378277,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate induction of labor</span></p>"
        },
        {
          "id": 378278,
          "text": "<p><span style=\"font-size:14.0pt;\">Tocolysis</span></p>"
        },
        {
          "id": 378279,
          "text": "<p><span style=\"font-size:14.0pt;\">Serial fetal-ultrasounds and amnioinfusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old woman, gravida 2 para 1, at 26 weeks gestation comes to the emergency department due to intermittent leakage of fluid for the past 6 hours. She has had no vaginal bleeding or contractions. The patient's previous pregnancy was complicated by preterm prelabor rupture of membranes at 29 weeks gestation; she delivered at 34 weeks gestation after inpatient management with corticosteroids and latency antibiotics. Temperature is 39.4°C (103°F), blood pressure is 100/70 mm Hg, and pulse is 114/min. Fetal heart rate is 170/min. The cervix is 2 cm dilated. In addition to antibiotics and steroids which of the following is the best next step in management of this patient?</span></p>",
      "unique_key": "Q8630309",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127282,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Immediate induction of labor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient has <strong>preterm prelabor rupture of membranes (PPROM)</strong> at <strong>26 weeks gestation</strong>, now complicated by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>High-grade fever (39.4°C)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Maternal tachycardia (114/min)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Fetal tachycardia (170/min)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These are <strong>classic signs of chorioamnionitis (intraamniotic infection)</strong> — the <strong>most serious complication</strong> of PPROM.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Once <strong>chorioamnionitis</strong> is diagnosed, <strong>immediate delivery is indicated</strong>, irrespective of gestational age, because continued pregnancy endangers both mother and fetus. Continue <strong>broad-spectrum IV antibiotics</strong> (ampicillin + gentamicin ± clindamycin/metronidazole).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Stepwise Reasoning</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Diagnosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>PPROM:</strong> Leakage of amniotic fluid before labor and before 37 weeks.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chorioamnionitis indicators:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Maternal fever ≥38°C</span></li><li><span style=\"font-size:14.0pt;\">Maternal tachycardia (&gt;100/min)</span></li><li><span style=\"font-size:14.0pt;\">Fetal tachycardia (&gt;160/min)</span></li><li><span style=\"font-size:14.0pt;\">Uterine tenderness or foul-smelling amniotic fluid</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Here, the patient meets multiple criteria → <strong>confirmed chorioamnionitis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Management of PPROM&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_yJzqrV0.png\" width=\"700\" height=\"172\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, since infection is present, <strong>delivery is mandatory now</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fetal fibronectin and lung maturity testing:&nbsp;</strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Used to assess risk of preterm delivery or fetal readiness when <strong>no infection</strong> is present.</span></li><li><span style=\"font-size:14.0pt;\">In chorioamnionitis, there’s <strong>no role for delaying delivery</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tocolysis:&nbsp;</strong>Incorrect. Contraindicated in the presence of <strong>infection</strong>; it worsens maternal sepsis risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Serial fetal ultrasounds and amnioinfusion:&nbsp;</strong>Incorrect. Used in <strong>expectant management without infection</strong>, not indicated when chorioamnionitis is suspected.</span></p>",
      "correct_choice_id": 378277,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33463,
      "choices": [
        {
          "id": 133698,
          "text": "<p><span style=\"font-size:18px;\">Fetal malpresentation</span></p>"
        },
        {
          "id": 133699,
          "text": "<p><span style=\"font-size:18px;\">Maternal hypoglycemia</span></p>"
        },
        {
          "id": 133700,
          "text": "<p><span style=\"font-size:18px;\">Placental insufficiency</span></p>"
        },
        {
          "id": 133701,
          "text": "<p><span style=\"font-size:18px;\">Placental location</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">An ultrasound confirms an anterior placenta covering the cervical os and an amniotic fluid index of 1.5 with a single fluid pocket measuring 1.5 x 1 cm. Over a period of 45 minutes, there are 4 episodes of fetal movement, 3 flexion/extension events, and no fetal breathing movements. The fetus is breech. Which of the following is the most likely cause of the patient's biophysical ultrasound findings?</span></p>",
      "unique_key": "Q8402429",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127283,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. C) Placental insufficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Chronic placental insufficiency results from poor uteroplacental perfusion, leading to progressive fetal hypoxemia and nutrient deprivation. The fetus prioritizes vital organ perfusion (brain, heart, adrenals) through blood flow redistribution, causing decreased renal perfusion and reduced urine production, resulting in oligohydramnios. Diminished fetal breathing and movements on biophysical profile reflect adaptive hypometabolic activity in response to hypoxia, characteristic of placental dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fetal malpresentation:&nbsp;</strong>Such as breech affects only the orientation of the fetus within the uterus and does not impair fetal oxygenation, tone, or amniotic fluid production. The observed abnormal BPP parameters cannot be explained by fetal lie alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Maternal hypoglycemia:&nbsp;</strong>can transiently decrease fetal movements due to temporary energy deprivation but resolves once glucose levels normalize. It does not cause sustained low amniotic fluid or persistent abnormal biophysical findings, which suggest chronic pathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Placental location:&nbsp;</strong>(anterior placenta) influences where the placenta attaches within the uterus and may make fetal movements harder to feel or visualize. However, it has no physiological impact on fetal oxygenation, breathing activity, or amniotic fluid volume, and therefore cannot account for the abnormal BPP findings.</span></p>",
      "correct_choice_id": 133700,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33462,
      "choices": [
        {
          "id": 133694,
          "text": "<p><span style=\"font-size:18px;\">Biophysical profile</span></p>"
        },
        {
          "id": 133695,
          "text": "<p><span style=\"font-size:18px;\">Cesarean delivery</span></p>"
        },
        {
          "id": 133696,
          "text": "<p><span style=\"font-size:18px;\">Contraction stress test</span></p>"
        },
        {
          "id": 133697,
          "text": "<p><span style=\"font-size:18px;\">Umbilical artery flow velocimetry</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 40-year-old woman, gravida 5 para 0 aborta 4, at 35 weeks gestation comes to labor and delivery triage because she has not felt her baby move for the past 24 hours. The patient has not eaten much all day and skipped dinner due to nausea. She has a 25-pack-year history of cigarette use but has cut down on her smoking during her pregnancy. Her last ultrasound at 32 weeks gestation showed a fetus in breech position measuring at the 15th percentile and placenta previa. A nonstress test shows a baseline fetal heart rate in the 130s with moderate variability and no decelerations. There are no accelerations after an hour of monitoring despite vibroacoustic stimulation. Tocometry shows no contractions. Which of the following is the most appropriate next step in management of this patient?</span></p>",
      "unique_key": "Q3624488",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127384,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) Biophysical profile</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A nonstress test (NST) without accelerations after adequate observation and vibroacoustic stimulation is considered nonreactive. In this patient at 35 weeks with risk factors such as cigarette use, fetal growth restriction, and placenta previa, the next step is to assess overall fetal well-being using a biophysical profile (BPP). BPP evaluates five parameters—NST, fetal breathing, body movements, tone, and amniotic fluid volume—to determine if fetal hypoxemia or placental insufficiency is present. It helps decide whether to continue expectant management or proceed with delivery based on the score.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cesarean delivery:&nbsp;</strong>Is not indicated immediately because the current NST shows no decelerations, suggesting no acute fetal distress. Delivery is reserved for evidence of fetal compromise on further testing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Contraction stress test:&nbsp;</strong>Assesses fetal heart rate response to uterine contractions but is contraindicated in placenta previa because contractions may cause bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Umbilical artery flow velocimetry:&nbsp;</strong>Is mainly used for monitoring known growth-restricted fetuses to assess placental resistance, but it is not the next step after a nonreactive NST; BPP provides a more comprehensive assessment first.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_lTKVxeH.png\" width=\"507\" height=\"378\"></span></p>",
      "correct_choice_id": 133694,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95022,
      "choices": [
        {
          "id": 378280,
          "text": "<p><span style=\"font-size:14.0pt;\">Drug-drug interaction</span></p>"
        },
        {
          "id": 378281,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypocalcemia</span></p>"
        },
        {
          "id": 378282,
          "text": "<p><span style=\"font-size:14.0pt;\">Oxytocin toxicity</span></p>"
        },
        {
          "id": 378283,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal insufficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 21-year-old woman, gravida 1 para 0, at 36 weeks gestation presents to the hospital for a blood pressure of 190/110 mm Hg in the office. Initial laboratory results show elevated serum creatinine and transaminases. Nifedipine, magnesium sulfate, are administered. Induction of labor is started with oxytocin. Six hours later, the patient's blood pressure is 150/90 mm Hg. The patient now complaints of nausea, headache, generalized muscle weakness and respiratory distress. DTRs are absent. What is the likely cause of the findings?</span></p>",
      "unique_key": "Q6641154",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127595,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Renal insufficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient with severe preeclampsia was treated with magnesium sulfate for seizure prophylaxis. Magnesium is excreted almost entirely by the kidneys, and her elevated creatinine indicates renal impairment, causing reduced magnesium clearance. Accumulation of magnesium leads to toxicity characterized by nausea, weakness, loss of deep tendon reflexes, respiratory depression, and potentially cardiac arrest. Therefore, renal insufficiency is the likely cause of these findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Drug-drug interaction:</strong> Is unlikely because nifedipine and magnesium are commonly co-administered in preeclampsia and do not produce this classical toxicity pattern at therapeutic doses.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hypocalcemia:</strong> May cause muscle cramps and tetany but not generalized muscle weakness with absent reflexes and respiratory depression. Moreover, it would not develop so acutely after magnesium therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Oxytocin toxicity:</strong> Presents with hyponatremia and water intoxication symptoms such as seizures and confusion, not absent reflexes or respiratory muscle paralysis as seen here with magnesium toxicity secondary to renal dysfunction.</span></p>",
      "correct_choice_id": 378283,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95023,
      "choices": [
        {
          "id": 378284,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of maintenance of corpus luteum</span></p>"
        },
        {
          "id": 378285,
          "text": "<p><span style=\"font-size:14.0pt;\">Interference with sperm penetration</span></p>"
        },
        {
          "id": 378286,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of ovulation by suppressing LH surge</span></p>"
        },
        {
          "id": 378287,
          "text": "<p><span style=\"font-size:14.0pt;\">Thickening of the endometrium to prevent implantation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is the primary mode of action of ulipristal 30mg in emergency contraception?</span></p>",
      "unique_key": "Q3112424",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127596,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Inhibition of ovulation by suppressing LH surge</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ulipristal acetate (30 mg), a selective progesterone receptor modulator (SPRM), acts primarily by delaying or inhibiting ovulation. It works by binding to progesterone receptors and blocking the preovulatory luteinizing hormone (LH) surge, thereby preventing follicular rupture and ovum release. When taken before ovulation, it is highly effective as an emergency contraceptive, preventing fertilization by stopping ovulation altogether.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Inhibition of maintenance of corpus luteum:</strong> Is not the main mechanism; corpus luteum suppression is more relevant to long-term progesterone antagonism, not single-dose emergency use.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Interference with sperm penetration</strong>: Is the mechanism of levonorgestrel or copper IUD, not ulipristal, which acts primarily at the level of ovulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Thickening of the endometrium to prevent implantation:</strong>&nbsp;Ulipristal may alter endometrial receptivity secondarily, but this is not its primary or reliable mechanism for Emergency contraception. Thickening of endometrium (making it less receptive for implantation) is the MOA of Combined estrogen–progestin OCPs (secondary effect).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>LIST OF CONTRACEPTIVES and their MOA:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>HORMONAL CONTRACEPTIVES MOA:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xGLjrkT.png\" width=\"614\" height=\"697\"></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDs) MOA:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_LBEUAar.png\" width=\"617\" height=\"219\"></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>BARRIER METHODS MOA:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_XIf7e8W.png\" width=\"613\" height=\"172\"></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>OTHER / SPECIAL METHODS and their MOA:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_uUakl35.png\" width=\"619\" height=\"171\"></strong></span></p>",
      "correct_choice_id": 378286,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95024,
      "choices": [
        {
          "id": 378288,
          "text": "<p><span style=\"font-size:18px;\">Ectopic pregnancy</span></p>"
        },
        {
          "id": 378289,
          "text": "<p><span style=\"font-size:18px;\">Hydatidiform mole</span></p>"
        },
        {
          "id": 378290,
          "text": "<p><span style=\"font-size:18px;\">Missed abortion</span></p>"
        },
        {
          "id": 378291,
          "text": "<p><span style=\"font-size:18px;\">Threatened abortion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 37-year-old woman, gravida 2 para 1, at 8 weeks gestation comes to the office for a follow-up visit. Earlier in the pregnancy, the patient had nausea and breast tenderness that resolved several days ago. At her initial prenatal visit a week ago, ultrasound revealed an intrauterine gestational sac with a yolk sac but no fetal pole. Pelvic examination reveals a closed cervix and no vaginal discharge or bleeding. A transvaginal ultrasound is repeated and is unchanged from the prior visit. Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "Q2755647",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127617,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. C) Missed abortion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A missed abortion refers to intrauterine fetal death before 20 weeks gestation without expulsion of the products of conception. This patient initially had early pregnancy symptoms (nausea, breast tenderness) that have resolved, suggesting loss of hormonal support. Ultrasound showing a gestational sac with a yolk sac but no fetal pole on two scans a week apart confirms absence of fetal development, indicating embryonic demise. The closed cervix and absence of bleeding or tissue passage further support the diagnosis of a missed abortion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Early pregnancy failure:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Gsac &gt; 25mm with no fetal pole</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">CRL &gt;7mm with no FHR</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ectopic pregnancy:</strong> Typically shows no intrauterine gestational sac and often presents with abdominal pain, vaginal bleeding, or an adnexal mass; an intrauterine sac rules this out.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hydatidiform mole:</strong> Presents with markedly elevated β-hCG, uterine size greater than gestational age, and a “snowstorm” pattern on ultrasound, not a gestational sac with yolk sac and no fetal pole.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Threatened abortion:</strong> Involves vaginal bleeding with a closed cervix and viable embryo; this patient has no bleeding and no fetal pole, indicating nonviable pregnancy rather than a threatened one.</span></p>",
      "correct_choice_id": 378290,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 70728,
      "choices": [
        {
          "id": 281953,
          "text": "<p><span style=\"font-size:14.0pt;\">Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome</span></p>"
        },
        {
          "id": 281954,
          "text": "<p><span style=\"font-size:14.0pt;\">Asherman's Syndrome</span></p>"
        },
        {
          "id": 281955,
          "text": "<p><span style=\"font-size:14.0pt;\">Herlyn-Werner-Wunderlich syndrome</span></p>"
        },
        {
          "id": 281956,
          "text": "<p><span style=\"font-size:14.0pt;\">Endometriosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 17-year-old adolescent presents to the gynecology clinic with a history of severe menstrual pain and recurrent pelvic infections since the onset of menstruation. She reports cyclical pain coinciding with her menstrual periods and has experienced occasional urinary tract infections. On physical examination, there is a palpable pelvic mass. Ultrasound imaging reveals a duplicated uterine cavity with one side showing an hematometra and absence of the left kidney. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3956729",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127638,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Herlyn-Werner-Wunderlich syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Herlyn-Werner-Wunderlich syndrome, also known as Obstructed Hemivagina and Ipsilateral Renal Agenesis (OHVIRA) syndrome, is a rare congenital Müllerian duct anomaly. It is characterized by a triad of uterus didelphys (double uterus), obstructed hemivagina leading to hematometra or hematocolpos, and absence of the ipsilateral kidney. The patient’s cyclical pain since menarche, pelvic mass due to hematometra, and ultrasound showing uterine duplication with unilateral renal agenesis are classic features of this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome:</strong> Presents with congenital absence of the uterus and upper two-thirds of the vagina, leading to primary amenorrhea, not cyclical pain or hematometra.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Asherman’s Syndrome:</strong> Occurs due to intrauterine adhesions following uterine curettage or infection, causing secondary amenorrhea and infertility, not congenital anomalies.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Endometriosis:</strong> Results from ectopic endometrial tissue causing dysmenorrhea and infertility, but it does not present with uterine duplication or renal agenesis on imaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Below is an example of a patient who was diagnosed with OHVIRA syndrome:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_29LAz3O.png\" width=\"940\" height=\"777\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>A to D:</strong>&nbsp;(A) and (B) Contrast-enhanced axial CT image of pelvis shows two separate uterine cavities suggestive of didelphic uterus&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">(C) Inferior section of the pelvis showing two vaginal cavities separated by a longitudinal septum with distended right hemivagina suggestive of right hematocolpos</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">(D)-Coronal reconstructed image of CT abdomen with absent right kidney</span></p>",
      "correct_choice_id": 281955,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 70035,
      "choices": [
        {
          "id": 279213,
          "text": "<p><span style=\"font-size:14.0pt;\">Primary ovarian failure</span></p>"
        },
        {
          "id": 279214,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypogonadotropic hypogonadism</span></p>"
        },
        {
          "id": 279215,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypergonadotropic hypogonadism&nbsp;</span></p>"
        },
        {
          "id": 279216,
          "text": "<p><span style=\"font-size:14.0pt;\">Normogonadotropic normogonadism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An athlete with a BMI of 17.5 kg/m2 presents with secondary amenorrhea and primary infertility. Her laboratory investigations reveal FSH 2; LH 0.3; TSH 1.2; Prolactin 20 ng/ml. What is the underlying cause of this condition?&nbsp;</span></p>",
      "unique_key": "Q1396047",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127652,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Hypogonadotropic hypogonadism</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient’s low BMI, secondary amenorrhea, and infertility suggest functional hypothalamic amenorrhea due to energy deficiency from excessive exercise or inadequate caloric intake. The laboratory findings show low FSH and LH with normal TSH and prolactin, confirming suppression of the hypothalamic–pituitary–gonadal axis. Decreased pulsatile GnRH secretion leads to reduced gonadotropin levels, causing anovulation and hypoestrogenism—typical of hypogonadotropic hypogonadism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Primary ovarian failure:&nbsp;</strong>Would present with elevated FSH and LH due to loss of ovarian feedback inhibition, unlike the low levels seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hypergonadotropic hypogonadism:&nbsp;</strong>Also features high gonadotropins with low estrogen, commonly due to ovarian failure or gonadal dysgenesis, not seen in this athlete.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Normogonadotropic normogonadism:&nbsp;</strong>Occurs in conditions such as polycystic ovary syndrome (PCOS), where FSH and LH levels are normal or mildly elevated, not suppressed as in this case.</span></p>",
      "correct_choice_id": 279214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 70001,
      "choices": [
        {
          "id": 279077,
          "text": "<p><span style=\"font-size:14.0pt;\">Attachment of the placenta onto the myometrium&nbsp;</span></p>"
        },
        {
          "id": 279078,
          "text": "<p><span style=\"font-size:14.0pt;\">Injury to the fetal placental vessels</span></p>"
        },
        {
          "id": 279079,
          "text": "<p><span style=\"font-size:14.0pt;\">Placental implantation over the cervix</span></p>"
        },
        {
          "id": 279080,
          "text": "<p><span style=\"font-size:14.0pt;\">Premature placental separation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old primigravida at 37 weeks gestation is brought to the emergency department with constant, excruciating abdominal pain and sudden vaginal bleeding for the past 3 hours. The patient is Rh negative and received Rh(D) immunoglobulin at 28 weeks gestation. Blood pressure is 160/100 mm Hg and pulse is 118/min. Physical examination shows a firm and tender uterus. Speculum examination reveals a moderate amount of bleeding coming from an open cervical os. Fetal heart tracing shows a baseline of 105/min and no variability. Which of the following is the most likely cause of this patient's bleeding?</span></p>",
      "unique_key": "Q7089765",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127713,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Premature placental separation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Premature placental separation, or placental abruption, occurs when the placenta detaches from the uterine wall before delivery, leading to painful vaginal bleeding, uterine tenderness, and fetal distress. The patient’s severe, constant abdominal pain, firm tender uterus, hypertension, and non-reassuring foetal heart pattern (bradycardia with absent variability) are classic findings. The bleeding is typically dark and may be accompanied by concealed hemorrhage, making the uterus tense and rigid. Chronic hypertension and preeclampsia are key risk factors, as seen here with elevated blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4vDx1GO.png\" width=\"640\" height=\"333\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Abruptio&nbsp;placentae:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A. Mild abruption with concealed hemorrhage. B. Severe abruption with external hemorrhage. C, Complete separation with concealed hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Attachment of the placenta onto the myometrium (placenta accreta):&nbsp;</strong>Presents with adherent placenta and severe postpartum hemorrhage at delivery, not antepartum pain or bleeding.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Injury to fetal placental vessels (vasa previa):&nbsp;</strong>Causes painless, rapid fetal exsanguination with bright red bleeding at membrane rupture, not a tender, firm uterus.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Placental implantation over the cervix (placenta previa):&nbsp;</strong>Results in painless, bright red bleeding and a soft, nontender uterus; pain and uterine rigidity are absent.</span></p>",
      "correct_choice_id": 279080,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 69997,
      "choices": [
        {
          "id": 279061,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute interstitial nephritis</span></p>"
        },
        {
          "id": 279062,
          "text": "<p><span style=\"font-size:14.0pt;\">Bleeding esophageal varices&nbsp;</span></p>"
        },
        {
          "id": 279063,
          "text": "<p><span style=\"font-size:14.0pt;\">lntraamniotic infection</span></p>"
        },
        {
          "id": 279064,
          "text": "<p><span style=\"font-size:14.0pt;\">Seizures</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An 18-year-old primigravida at 27 weeks gestation comes to the emergency department due to severe right upper quadrant pain. The pain started 2 hours ago, and the patient has also had nausea, vomiting, and irregular uterine contractions. Aspartate aminotransferase (SGOT) is 220 U/L and alanine aminotransferase (SGPT) is 240 U/L. CECT is shown below. This patient is most likely at risk for which of the following complications?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ssIONBd.png\" width=\"573\" height=\"393\"></span></p>",
      "unique_key": "Q6113519",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127734,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Seizures</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The CT image shows a subcapsular hepatic hematoma, which is a severe complication of HELLP syndrome (Hemolysis, Elevated Liver enzymes, and Low Platelets)—a variant of severe preeclampsia. The patient’s presentation of right upper quadrant pain, elevated transaminases, nausea, and vomiting during pregnancy strongly suggests this diagnosis. The hematoma results from hepatic sinusoidal distention and rupture of subcapsular vessels due to endothelial damage. As HELLP is a manifestation of severe preeclampsia, the patient is at high risk of developing eclampsia (seizures) if not promptly managed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acute interstitial nephritis:&nbsp;</strong>Is a hypersensitivity reaction caused by medications such as antibiotics or NSAIDs, characterized by fever, rash, and eosinophiluria. In HELLP syndrome, renal injury results instead from preeclampsia-induced vasospasm and glomerular endotheliosis, not from an allergic or drug-related mechanism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Bleeding esophageal varices:&nbsp;</strong>Occur as a consequence of portal hypertension from chronic liver disease such as cirrhosis. HELLP syndrome causes acute hepatic injury and subcapsular hematoma but not chronic fibrosis or portal hypertension, so variceal bleeding is not a risk here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Intraamniotic infection (chorioamnionitis):&nbsp;</strong>Typically presents with maternal fever, uterine tenderness, foul-smelling amniotic fluid, and fetal tachycardia. This patient’s presentation of severe right upper quadrant pain and elevated liver enzymes is unrelated to infection and instead points toward hepatic vascular injury secondary to preeclampsia.</span></p>",
      "correct_choice_id": 279064,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95025,
      "choices": [
        {
          "id": 378292,
          "text": "<p><span style=\"font-size:14.0pt;\">a, b and c</span></p>"
        },
        {
          "id": 378293,
          "text": "<p><span style=\"font-size:14.0pt;\">b and c</span></p>"
        },
        {
          "id": 378294,
          "text": "<p><span style=\"font-size:14.0pt;\">a, b and d</span></p>"
        },
        {
          "id": 378295,
          "text": "<p><span style=\"font-size:14.0pt;\">a, b, c and d</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 19-year-old girl presents with irregular menstrual cycles. According to the Rotterdam criteria, which of the following are diagnostic for PCOS?</span></p><p><br><span style=\"font-size:14.0pt;\">a. Obesity</span><br><span style=\"font-size:14.0pt;\">b. Delayed periods</span><br><span style=\"font-size:14.0pt;\">c. Hirsutism</span><br><span style=\"font-size:14.0pt;\">d. Insulin resistance</span></p>",
      "unique_key": "Q3122260",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127875,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) b and c</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">According to the <strong>Rotterdam criteria&nbsp;</strong>, a diagnosis of <strong>Polycystic Ovary Syndrome (PCOS)</strong> requires at least <strong>two of the following three features</strong> after exclusion of other causes:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Oligo- or anovulation</strong> → manifests as <strong>irregular or delayed periods</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Clinical or biochemical hyperandrogenism</strong> → presents as <strong>hirsutism, acne, or androgenic alopecia</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Polycystic ovaries</strong> on ultrasound (≥12 follicles measuring 2–9 mm in diameter and/or increased ovarian volume &gt;10 cm³)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">While obesity and insulin resistance are commonly associated with PCOS, they are <strong>not diagnostic criteria</strong> per Rotterdam. Therefore, delayed periods and hirsutism are the defining features from the options given.</span></p>",
      "correct_choice_id": 378293,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25104,
      "choices": [
        {
          "id": 100370,
          "text": "<p><span style=\"font-size:18px;\">Placenta previa should be ruled out</span></p>"
        },
        {
          "id": 100371,
          "text": "<p><span style=\"font-size:18px;\">Uterine diadelphys is likely in the patient</span></p>"
        },
        {
          "id": 100372,
          "text": "<p><span style=\"font-size:18px;\">There are high chances of cord prolapse in the patient</span></p>"
        },
        {
          "id": 100373,
          "text": "<p><span style=\"font-size:18px;\">Elective LSCS should be performed</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A multiparous woman is in labor at 38 weeks of gestation. On examination, the uterus appears asymmetrical. In fundal grip, the fetal pole is not palpable and in pelvic grip, the lower pole of the uterus is empty. All of the following are true about the given presentation except:</span></p>",
      "unique_key": "Q5481005",
      "question_audio": null,
      "question_video": null,
      "map_id": 35127916,
      "difficulty_level": "beginner",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Uterine diadelphys is likely in the patient</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The findings described—an asymmetrical uterus, absent fetal pole in both fundal and pelvic grips, and an empty lower uterine segment—are characteristic of a transverse lie presentation. In this condition, the fetus lies horizontally in the uterus, with the shoulder presenting at the pelvic inlet. Uterine diadelphys (a congenital anomaly with a double uterus) is not associated with this typical presentation and is therefore not the likely cause. The asymmetry seen here results from the abnormal fetal lie, not a uterine malformation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A) Placenta previa should be ruled out:&nbsp;</strong>Because low-lying placenta can prevent fetal engagement and predispose to transverse lie, warranting ultrasound confirmation.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C) There are high chances of cord prolapse in the patient:&nbsp;</strong>As the presenting part does not fill the pelvic inlet, allowing the cord to slip past the fetus during membrane rupture.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D) Elective LSCS should be performed:&nbsp;</strong>Because transverse lie at term is not compatible with vaginal delivery; cesarean section is the safest mode of delivery.</span></p>",
      "correct_choice_id": 100371,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95026,
      "choices": [
        {
          "id": 378296,
          "text": "<p><span style=\"font-size:14.0pt;\">Reassurance</span></p>"
        },
        {
          "id": 378297,
          "text": "<p><span style=\"font-size:14.0pt;\">FSH Ievel</span></p>"
        },
        {
          "id": 378298,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum B-HCG</span></p>"
        },
        {
          "id": 378299,
          "text": "<p><span style=\"font-size:14.0pt;\">Karyotype analysis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 12-year-old girl is brought to the OPD by her mother because she has not started menstruating. Height is at the 15th percentile and weight is at the 20th percentile for age. Vital signs are normal. There is no breast development or axillary hair. Pelvic examination reveals normal external female genitalia and no pubic hair. Ultrasound confirms the presence of a uterus. Which of the following is the best next step in management of this patient?</span></p>",
      "unique_key": "Q7392811",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128137,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Reassurance</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a 12-year-old girl with no breast development or menstruation but otherwise normal growth parameters and normal uterine anatomy on ultrasound, reassurance and continued observation are appropriate. Pubertal onset (thelarche) typically occurs between <strong>8–13 years</strong>, and menarche follows about <strong>2–3 years later</strong>. At 12 years, this patient is still within the normal age range for pubertal onset. Since she has normal external genitalia, no signs of systemic disease, and no evidence of delayed skeletal or linear growth, it is best to observe and reassess after some months rather than begin investigations prematurely.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. FSH level:</strong> Measurement is indicated if the girl shows <strong>no pubertal development by age 13</strong> or <strong>no menarche by age 15</strong> with normal secondary sexual characteristics. At 12, this evaluation is still early.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Serum β-Hcg:</strong> Testing is used when <strong>secondary amenorrhea</strong> or suspected pregnancy exists, not in a prepubertal girl who has not begun menstruating.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Karyotype analysis:</strong> Is done when <strong>gonadal dysgenesis or Turner syndrome</strong> is suspected, typically if FSH is elevated or other clinical features like short stature or streak gonads are present, which are not seen in this case.</span></p>",
      "correct_choice_id": 378296,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95028,
      "choices": [
        {
          "id": 378300,
          "text": "<p><span style=\"font-size:14.0pt;\">Involvement of three or more organs</span></p>"
        },
        {
          "id": 378301,
          "text": "<p><span style=\"font-size:14.0pt;\">Development of manifestations in less than a week</span></p>"
        },
        {
          "id": 378302,
          "text": "<p><span style=\"font-size:14.0pt;\">Histological evidence of hydropic degeneration of villi</span></p>"
        },
        {
          "id": 378303,
          "text": "<p><span style=\"font-size:14.0pt;\">Presence of antiphospholipid antibodies on two occasions six weeks apart</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Diagnostic criteria for Catastrophic antiphospholipid syndrome includes all except:</span></p>",
      "unique_key": "Q2477189",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128208,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Histological evidence of hydropic degeneration of villi</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">molar pregnancy and has no role in the diagnosis of CAPS, hence it is the incorrect statement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Catastrophic Antiphospholipid Syndrome (CAPS) is a rare, severe, and life-threatening variant of <strong>antiphospholipid antibody syndrome (APS)</strong>. It is characterized by <strong>widespread microvascular thrombosis</strong> leading to <strong>multiorgan failure</strong> over a very short time (usually less than one week). The underlying mechanism involves <strong>excessive activation of endothelial cells, platelets, and the coagulation cascade</strong> triggered by antiphospholipid antibodies, resulting in diffuse small-vessel occlusion. CAPS is often precipitated by infections, surgery, trauma, or discontinuation of anticoagulation therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clinically, patients develop <strong>rapid organ dysfunction</strong>—commonly affecting the kidneys (renal failure), lungs (ARDS), brain (stroke or encephalopathy), heart (myocardial infarction), skin (livedo reticularis), and adrenal glands (insufficiency). <strong>Laboratory findings</strong> include thrombocytopenia, elevated D-dimer, prolonged APTT (due to lupus anticoagulant), and high titers of antiphospholipid antibodies (anticardiolipin, lupus anticoagulant, or anti-β2 glycoprotein I).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Diagnostic criteria for CAPS (Modified Asherson’s Criteria):</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Involvement of <strong>three or more organs, systems, or tissues</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Development of manifestations within one week.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Histopathological evidence</strong> of small-vessel occlusion (thrombosis).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Presence of antiphospholipid antibodies</strong> on two or more occasions at least six weeks apart.</span></li></ol>",
      "correct_choice_id": 378302,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95029,
      "choices": [
        {
          "id": 378304,
          "text": "<p><span style=\"font-size:14.0pt;\">Complete androgen insensitivity syndrome</span></p>"
        },
        {
          "id": 378305,
          "text": "<p><span style=\"font-size:14.0pt;\">Mayer Rokitansky Küster Hauser syndrome</span></p>"
        },
        {
          "id": 378306,
          "text": "<p><span style=\"font-size:14.0pt;\">Partial androgen insensitivity syndrome</span></p>"
        },
        {
          "id": 378307,
          "text": "<p><span style=\"font-size:14.0pt;\">Gonadal dysgenesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 14-year-old female presented to you with primary amenorrhea. Examination reveals normal breast development and absent axillary and pubic hairs. Pelvic examination shows a normally developed vagina with clitoromegaly and micro-phallus. On ultrasound, masses are visible in the inguinal region. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q3665447",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128209,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Partial androgen insensitivity syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Partial Androgen Insensitivity Syndrome (PAIS) occurs due to a <strong>partial defect in the androgen receptor gene</strong> on the X chromosome (X-linked recessive). Individuals have a <strong>46,XY karyotype</strong> with normal testes producing testosterone, but the body’s tissues respond incompletely to androgens. The degree of masculinization varies depending on the severity of receptor dysfunction. This patient’s presentation—<strong>primary amenorrhea, normal breast development (from aromatization of testosterone to estrogen), clitoromegaly/microphallus, absent pubic and axillary hair</strong>, and <strong>inguinal masses representing undescended testes</strong>—fits the clinical picture of PAIS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Complete androgen insensitivity syndrome:</strong> Presents with normal breast development, <strong>completely female external genitalia</strong>, and absent uterus or upper vagina, without any clitoromegaly or ambiguous features.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Mayer-Rokitansky-Küster-Hauser syndrome:</strong> Occurs in <strong>46,XX females</strong> with normal secondary sexual characteristics but <strong>absent uterus and upper vagina</strong>; there is no clitoromegaly or inguinal testes.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Gonadal dysgenesis (e.g., Swyer syndrome):</strong> Features streak gonads and absence of secondary sexual development due to lack of estrogen; patients have no breast development and present with a normal uterus, which differs from the findings here.</span></p>",
      "correct_choice_id": 378306,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95030,
      "choices": [
        {
          "id": 378308,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2</span></p>"
        },
        {
          "id": 378309,
          "text": "<p><span style=\"font-size:14.0pt;\">3, 4</span></p>"
        },
        {
          "id": 378310,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 378311,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following are indications of LSCS?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">1. Brow presentation</span></p><p><span style=\"font-size:14.0pt;\">2. Mentoposterior position</span></p><p><span style=\"font-size:14.0pt;\">3. Breech presentation</span></p><p><span style=\"font-size:14.0pt;\">4. Occipitoposterior position</span></p><p><span style=\"font-size:14.0pt;\">5. Mentoanterior position</span></p>",
      "unique_key": "Q8362272",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128210,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) 1, 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Both <strong>brow presentation</strong> and <strong>mentoposterior position</strong> are absolute indications for cesarean section because vaginal delivery is mechanically impossible due to the fetal head’s unfavorable attitude and position.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>brow presentation</strong>, the fetal head is midway between full flexion and full extension, resulting in the largest diameter (mentovertical diameter—13.5 cm) presenting to the birth canal. This diameter cannot pass through the maternal pelvis, so cesarean section is mandatory.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>mentoposterior position</strong>, the fetal chin (mentum) points posteriorly toward the maternal sacrum. With this orientation, the fetal head cannot extend further to pass under the pubic symphysis, preventing vaginal delivery. Cesarean section is required in all such cases unless spontaneous mentoanterior rotation occurs (which is rare).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Explanation of the remaining statements:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>3. Breech presentation:</strong> This is not an absolute indication for LSCS. Vaginal breech delivery may be possible, especially in multiparous women, small fetuses, or frank breech presentations. However, in primigravidas, large fetuses, or cases with fetal distress, cesarean section is preferred for safety.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Occipitoposterior position:</strong> In this position, the fetal occiput lies posteriorly toward the maternal sacrum. Most cases rotate anteriorly during labor (long anterior rotation) and deliver vaginally. Only persistent occipitoposterior positions with arrest of descent may require LSCS, but it is not a routine indication.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>5. Mentoanterior position:</strong> Here, the fetal chin is directed anteriorly toward the maternal symphysis pubis. This is the only <strong>favorable face presentation</strong> in which vaginal delivery is possible, as the head can extend under the pubic arch. Thus, it does not require cesarean delivery.</span></p>",
      "correct_choice_id": 378308,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95031,
      "choices": [
        {
          "id": 378312,
          "text": "<p><span style=\"font-size:14.0pt;\">Pituitary dysfunction</span></p>"
        },
        {
          "id": 378313,
          "text": "<p><span style=\"font-size:14.0pt;\">Ovarian dysfunction</span></p>"
        },
        {
          "id": 378314,
          "text": "<p><span style=\"font-size:14.0pt;\">First pregnancy</span></p>"
        },
        {
          "id": 378315,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine synechiae</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A young female has history of a spontaneous abortion. She has had amenorrhea since then. Her FSH now is 6 mlU/ml. Which of the following can be a cause for her amenorrhea?</span></p>",
      "unique_key": "Q8905560",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128320,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Uterine synechiae</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Uterine synechiae (Asherman’s syndrome)</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">It refers to <strong>intrauterine adhesions</strong> or fibrosis that develop when the endometrium is damaged, most commonly after <strong>dilatation and curettage (D&amp;C)</strong> following a <strong>spontaneous or induced abortion</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The endometrium fails to regenerate properly, leading to <strong>obliteration of the uterine cavity</strong>.</span></li><li><span style=\"font-size:14.0pt;\">As a result, menstrual blood cannot form or exit → <strong>secondary amenorrhea</strong> occurs.</span></li><li><span style=\"font-size:14.0pt;\"><strong>FSH level (6 mIU/mL)</strong> is <strong>normal</strong>, showing that the hypothalamic–pituitary–ovarian axis is intact and functioning normally; the defect is <strong>anatomical (uterine)</strong>, not hormonal.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pituitary dysfunction:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pituitary lesions (e.g., Sheehan’s syndrome, adenoma) reduce gonadotropin release → <strong>low FSH and LH</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Here, FSH is <strong>normal</strong>, hence pituitary dysfunction is excluded.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ovarian dysfunction:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In ovarian failure, estrogen production drops → loss of negative feedback → <strong>high FSH and LH</strong> levels.</span></li><li><span style=\"font-size:14.0pt;\">Since FSH here is <strong>normal</strong>, ovarian dysfunction is unlikely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. First pregnancy:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During pregnancy, high estrogen and progesterone levels suppress FSH and LH → <strong>very low FSH</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This patient has <strong>post-abortion amenorrhea</strong>, not ongoing pregnancy.</span></li></ul>",
      "correct_choice_id": 378315,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95032,
      "choices": [
        {
          "id": 378316,
          "text": "<p><span style=\"font-size:14.0pt;\">Human-papillomavirus-co-testing</span></p>"
        },
        {
          "id": 378317,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate colposcopy</span></p>"
        },
        {
          "id": 378318,
          "text": "<p><span style=\"font-size:14.0pt;\">Loop electrosurgical excision procedure</span></p>"
        },
        {
          "id": 378319,
          "text": "<p><span style=\"font-size:14.0pt;\">Repeat Pap test postpartum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old woman, gravida 2 para 1, at 28 weeks gestation comes to the office for follow-up of an abnormal Pap test. The Pap test showed a high-grade squamous intraepithelial lesion. Which of the following is the best next step in management of this patient?</span></p>",
      "unique_key": "Q8111927",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128321,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Immediate colposcopy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>High-grade squamous intraepithelial lesion (HSIL)</strong> on Pap smear indicates a <strong>high risk for underlying CIN 2/3 or invasive cervical cancer.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>During pregnancy</strong>, the management aims to <strong>rule out invasive carcinoma</strong> while <strong>avoiding harm to the pregnancy.</strong></span></li><li><span style=\"font-size:14.0pt;\">The <strong>next best step</strong> is <strong>colposcopic evaluation with directed biopsy</strong> (if needed).</span></li><li><span style=\"font-size:14.0pt;\">Colposcopy is <strong>safe in pregnancy</strong>, and helps identify whether immediate treatment is necessary or can be deferred until after delivery.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Endocervical curettage (ECC)</strong> is <strong>contraindicated</strong> during pregnancy due to risk of miscarriage or preterm labor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Therefore, <strong>Immediate colposcopy</strong> is the correct next step.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Human papillomavirus (HPV) co-testing:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">HPV testing is used in <strong>low-grade</strong> lesions or for <strong>screening</strong> in women ≥30 years, not for HSIL.</span></li><li><span style=\"font-size:14.0pt;\">HSIL already indicates significant abnormality; <strong>diagnostic evaluation (colposcopy)</strong> is required immediately, not HPV triage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Loop electrosurgical excision procedure (LEEP):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">LEEP is a <strong>therapeutic</strong> procedure for confirmed CIN 2/3 or carcinoma in situ.</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>not done during pregnancy</strong> unless there is <strong>strong suspicion of invasive cancer</strong>, because it increases risk of <strong>preterm labor and pregnancy loss</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In this case, we first need to confirm the diagnosis by <strong>colposcopy</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Repeat Pap test postpartum:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This may be done for <strong>low-grade lesions</strong> (ASC-US, LSIL) found during pregnancy, not for HSIL.</span></li><li><span style=\"font-size:14.0pt;\">Deferring evaluation until postpartum can <strong>miss an invasive lesion</strong>, which can progress rapidly.</span></li></ul>",
      "correct_choice_id": 378317,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95033,
      "choices": [
        {
          "id": 378320,
          "text": "<p><span style=\"font-size:14.0pt;\">Reassure</span></p>"
        },
        {
          "id": 378321,
          "text": "<p><span style=\"font-size:14.0pt;\">Hysterectomy + BSO</span></p>"
        },
        {
          "id": 378322,
          "text": "<p><span style=\"font-size:14.0pt;\">Ovarian drilling</span></p>"
        },
        {
          "id": 378323,
          "text": "<p><span style=\"font-size:14.0pt;\">CA-125</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old female presented with mild pain in lower abdomen. She has had 2 full-term normal deliveries earlier. Her last menstrual period was 3 weeks back. On pelvic examination, you find a palpable mass in the adnexa. USG pelvis is shown here. What is the next step?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_MGTgTLO.png\" width=\"481\" height=\"367\"></span></p>",
      "unique_key": "Q9657572",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128342,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Reassure</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The ultrasound image shows a <strong>thin-walled, unilocular cyst</strong> in the ovary measuring about <strong>2 cm</strong>, with <strong>clear anechoic (black) fluid</strong> inside and <strong>no solid areas or septations</strong> — typical of a <strong>functional ovarian (follicular) cyst</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Follicular cysts</strong> develop when a <strong>Graafian follicle fails to rupture</strong> and continues to enlarge.</span></li><li><span style=\"font-size:14.0pt;\">They are <strong>common in reproductive-age women</strong>, usually <strong>asymptomatic or cause mild pain</strong>, and are <strong>self-limiting</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>size (&lt;3 cm)</strong> and <strong>simple appearance</strong> strongly favor a <strong>benign, physiological cyst</strong> that resolves spontaneously in 1–2 menstrual cycles.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Therefore, the appropriate next step is <strong>observation and reassurance</strong>.</span><br><span style=\"font-size:14.0pt;\">A repeat ultrasound can be done after 6 weeks if symptoms persist.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hysterectomy + BSO:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Reserved for <strong>postmenopausal women</strong> or when <strong>malignant features</strong> (solid components, septations, papillary projections, ascites) are present.</span></li><li><span style=\"font-size:14.0pt;\">This patient is <strong>young, premenopausal</strong>, and the cyst is benign-looking — hence, <strong>not indicated</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ovarian drilling:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Done in <strong>polycystic ovary syndrome (PCOS)</strong> as a fertility treatment to induce ovulation.</span></li><li><span style=\"font-size:14.0pt;\">Not relevant here, as this is a <strong>single functional cyst</strong>, not multiple small peripheral cysts typical of PCOS.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. CA-125:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Tumor marker for epithelial ovarian carcinoma.</span></li><li><span style=\"font-size:14.0pt;\">Has <strong>low specificity</strong> in premenopausal women (can rise in endometriosis, PID, menstruation).</span></li><li><span style=\"font-size:14.0pt;\">Indicated only if the cyst shows <strong>complex or suspicious features</strong> — not for a simple, small, anechoic cyst.</span></li></ul>",
      "correct_choice_id": 378320,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95034,
      "choices": [
        {
          "id": 378324,
          "text": "<p><span style=\"font-size:14.0pt;\">Exposure to child with a rash</span></p>"
        },
        {
          "id": 378325,
          "text": "<p><span style=\"font-size:14.0pt;\">Inadequate maternal folate supplementation</span></p>"
        },
        {
          "id": 378326,
          "text": "<p><span style=\"font-size:14.0pt;\">Lack of Rh(D) immunization in prior pregnancy</span></p>"
        },
        {
          "id": 378327,
          "text": "<p><span style=\"font-size:14.0pt;\">Nonadherence to vaccination schedule</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 24-year-old woman, G2P0A1, at 26 weeks gestation comes to the OPD for an initial prenatal visit. Maternal blood type is O, Rh negative. Indirect Coombs test is negative. Abdominal circumference measures at 34 weeks gestation. USG is shown below. Which of the following factors most likely contributed to this fetal presentation?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_vCNkNk3.png\" width=\"1098\" height=\"464\"></span></p>",
      "unique_key": "Q4902569",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128483,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Exposure to child with a rash</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The fetus has hydrops on ultrasound (ascites with grossly enlarged abdominal circumference at 26 wks, likely skin/scalp edema ± effusions).</span></li><li><span style=\"font-size:14.0pt;\">Mother is Rh-negative with a negative indirect Coombs, so this is non-immune hydrops.</span></li><li><span style=\"font-size:14.0pt;\">Maternal exposure to a child with a rash suggests parvovirus B19 (erythema infectiosum) → fetal aplastic anemia → high-output cardiac failure → hydrops.</span></li><li><span style=\"font-size:14.0pt;\">This precisely fits the presentation of markedly increased AC and hydrops on USG in mid-pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Inadequate maternal folate supplementation:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Folate deficiency is linked to neural tube defects (anencephaly, spina bifida).</span></li><li><span style=\"font-size:14.0pt;\">NTDs do not cause non-immune hydrops or isolated massive AC increase.</span></li><li><span style=\"font-size:14.0pt;\">Ultrasound would show CNS structural defects rather than ascites/edema.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lack of Rh(D) immunization in prior pregnancy:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Would predispose to Rh alloimmunization and immune hydrops.</span></li><li><span style=\"font-size:14.0pt;\">However, this patient’s indirect Coombs is negative, arguing against Rh antibodies.</span></li><li><span style=\"font-size:14.0pt;\">Therefore immune hemolysis is unlikely here.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Nonadherence to vaccination schedule:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Missing vaccines (e.g., rubella) risk congenital rubella (PDA, cataracts, deafness), not classic hydrops.</span></li><li><span style=\"font-size:14.0pt;\">Rubella is not typically associated with severe fetal anemia leading to hydrops.</span></li><li><span style=\"font-size:14.0pt;\">Does not explain the negative Coombs and hydropic ultrasound picture.</span></li></ul>",
      "correct_choice_id": 378324,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25038,
      "choices": [
        {
          "id": 100106,
          "text": "<p><span style=\"font-size:18px;\">1, 6, 5</span></p>"
        },
        {
          "id": 100107,
          "text": "<p><span style=\"font-size:18px;\">2, 3, 4, 6, 7</span></p>"
        },
        {
          "id": 100108,
          "text": "<p><span style=\"font-size:18px;\">2, 3, 4, 7</span></p>"
        },
        {
          "id": 100109,
          "text": "<p><span style=\"font-size:18px;\">1, 4, 5, 6</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">All of the following are causes of this appearance except:</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/18/18_VgvSC1f.jpg\" alt=\"\" width=\"300\" height=\"228\"></span></p><p>&nbsp;</p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\">Posterior urethral valve</span></li><li><span style=\"font-size:18px;\">Esophageal atresia</span></li><li><span style=\"font-size:18px;\">Anencephaly</span></li><li><span style=\"font-size:18px;\">Maternal Diabetes</span></li><li><span style=\"font-size:18px;\">Renal agenesis</span></li><li><span style=\"font-size:18px;\">PUJO</span></li><li><span style=\"font-size:18px;\">Duodenal atresia</span></li></ol>",
      "unique_key": "Q8595721",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128484,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) 1, 6, 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The ultrasound shows polyhydramnios (large vertical pockets; AFI is markedly elevated in Q2,Q3,Q4).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Conditions that reduce fetal urine output (posterior urethral valves, PUJ obstruction) or eliminate kidneys (renal agenesis) cause oligohydramnios—not polyhydramnios—so they are the exceptions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Brief reasoning for each item:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_n8vye0T.png\" width=\"615\" height=\"497\"></strong></span></p>",
      "correct_choice_id": 100106,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95035,
      "choices": [
        {
          "id": 378328,
          "text": "<p><span style=\"font-size:14.0pt;\">Manual repositioning of the uterus</span></p>"
        },
        {
          "id": 378329,
          "text": "<p><span style=\"font-size:14.0pt;\">Application of manual pressure</span></p>"
        },
        {
          "id": 378330,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer tocolytics</span></p>"
        },
        {
          "id": 378331,
          "text": "<p><span style=\"font-size:14.0pt;\">Placement of a Bakri balloon</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What is the next appropriate management in uterine inversion with partially removed placenta?</span></p>",
      "unique_key": "Q1020494",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128485,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Manual repositioning of the uterus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Uterine inversion is a <strong>life-threatening obstetric emergency</strong> in which the uterine fundus collapses into or through the cervix, often following placental delivery or excessive cord traction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When the <strong>placenta is still attached (fully or partially)</strong>, <strong>attempting to remove it</strong> or <strong>manipulating the uterus</strong> before uterine relaxation can <strong>exacerbate hemorrhage</strong> and worsen inversion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Stepwise Management:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Initial stabilization:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Call for help and start <strong>resuscitation</strong> (IV fluids, blood if needed).</span></li><li><span style=\"font-size:14.0pt;\">Give <strong>oxygen</strong> and monitor vitals.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Uterine relaxation:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Stop oxytocin if ongoing.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. Repositioning (Johnson’s maneuver):</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Push the <strong>inverted fundus upward</strong> through the cervix toward the umbilicus using the palm/fingertips.</span></li><li><span style=\"font-size:14.0pt;\">After successful reposition, give <strong>uterotonics</strong> (oxytocin, methylergometrine) to maintain tone and prevent reinversion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. Control bleeding:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">If bleeding persists → insert <strong>Bakri balloon</strong> or perform surgical correction (Huntington/Haultain procedure).</span></li></ul>",
      "correct_choice_id": 378328,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95036,
      "choices": [
        {
          "id": 378332,
          "text": "<p><span style=\"font-size:14.0pt;\">Radical vulvectomy with unilateral LN dissection</span></p>"
        },
        {
          "id": 378333,
          "text": "<p><span style=\"font-size:14.0pt;\">Radical vulvectomy with bilateral LN dissection</span></p>"
        },
        {
          "id": 378334,
          "text": "<p><span style=\"font-size:14.0pt;\">Simple vulvectomy</span></p>"
        },
        {
          "id": 378335,
          "text": "<p><span style=\"font-size:14.0pt;\">Chemoradiation with resection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 76-year-old female presented with a non-healing ulcer on the labia majora midline for a period of 6 months, measuring 2 cm x 3 cm. No lymph nodes were palpable. Biopsy shows squamous cell carcinoma. How do you manage this case?</span></p>",
      "unique_key": "Q1688363",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128526,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Radical vulvectomy with bilateral LN dissection</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient is an elderly woman (76 years) presenting with a <strong>non-healing vulvar ulcer</strong> confirmed as <strong>squamous cell carcinoma (SCC)</strong> — the <strong>most common</strong> type of vulvar cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>lesion is midline (labia majora midline)</strong> and measures <strong>2 × 3 cm</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In vulvar carcinoma, <strong>the pattern of lymphatic drainage</strong> determines the extent of lymph node dissection:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Lateral lesion (≥1 cm from midline)</strong> → drains <strong>ipsilateral</strong> nodes → <strong>unilateral LN dissection</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Midline lesion</strong> (clitoris, perineum, posterior fourchette, or labia minora/majora midline) → <strong>bilateral drainage</strong> → <strong>bilateral LN dissection</strong> is mandatory.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Stepwise Management:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Surgical principle:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Radical vulvectomy</strong> = wide local excision of vulvar lesion + removal of skin, subcutaneous tissue, and deep fascia up to the perineal body.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Bilateral inguinofemoral lymphadenectomy</strong> = removal of superficial and deep inguinal nodes from both sides.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Staging context (FIGO – simplified):</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8tPUkpU.png\" width=\"610\" height=\"217\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This case (2×3 cm, midline, no nodes) corresponds to <strong>Stage IB</strong> → requires <strong>radical vulvectomy with bilateral node dissection.</strong></span></p>",
      "correct_choice_id": 378333,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25049,
      "choices": [
        {
          "id": 100150,
          "text": "<p><span style=\"font-size:18px;\">Acrania</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/18/21_vqArWeo.jpg\" alt=\"\" width=\"300\" height=\"272\"></span></p>"
        },
        {
          "id": 100151,
          "text": "<p><span style=\"font-size:18px;\">Holoprosencephaly</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/19/picture1.jpg\" alt=\"\" width=\"300\" height=\"230\"></span></p>"
        },
        {
          "id": 100152,
          "text": "<p><span style=\"font-size:18px;\">Dandy Walker malformation</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/18/23_DTAozsF.jpg\" alt=\"\" width=\"300\" height=\"253\"></span></p>"
        },
        {
          "id": 100153,
          "text": "<p><span style=\"font-size:18px;\">Omphalocele</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/18/24_5gDIwou.jpg\" alt=\"\" width=\"300\" height=\"375\"></span></p><p>&nbsp;</p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">Identify the correct pair of malformations:</span></p>",
      "unique_key": "Q9639558",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128527,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. C) Dandy Walker malformation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/18/23_DTAozsF.jpg\" alt=\"\" width=\"300\" height=\"253\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The ultrasound images show posterior fossa abnormality — a large cystic space posteriorly that communicates with the fourth ventricle, along with elevated tentorium and cerebellar hypoplasia.</span><br><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These are classic features of Dandy–Walker malformation (DWM).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Sonographic Features of Dandy–Walker Malformation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_tuApZTA.png\" width=\"616\" height=\"223\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acrania:</strong> The image shows a fetal ultrasound with a \"lemon sign.\" Typical frontal 'pinching' of calvarium gives&nbsp;a 'lemon' appearance of the skull,&nbsp;This is a&nbsp;tell tale signs of a shallow posterior fossa anomalies or Chiari malformation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Holoprosencephaly:</strong> The image is a fetal ultrasound showing a cystic hygroma, which is a congenital lymphatic malformation.&nbsp;The red arrow points to the fluid-filled sac, which is typically found in the neck or head region of a fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Omphalocele:&nbsp;</strong>The image is an ultrasound showing a fetus with gastroschisis.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In this birth defect, baby's intestines and abdominal organs protrude through a para umbilical outpouching.</span></li><li><span style=\"font-size:14.0pt;\">The exposed organs are not covered by a protective membrane and float in the amniotic fluid, which can cause irritation and swelling.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">On the other hand, Omphalocele&nbsp;is a birth defect in which an infant's intestine or other abdominal organs protrude through the umbilicus and are covered by a thin sac.</span></li></ul>",
      "correct_choice_id": 100152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95037,
      "choices": [
        {
          "id": 378336,
          "text": "<p><span style=\"font-size:14.0pt;\">Miscarriage</span></p>"
        },
        {
          "id": 378337,
          "text": "<p><span style=\"font-size:14.0pt;\">Preterm labour</span></p>"
        },
        {
          "id": 378338,
          "text": "<p><span style=\"font-size:14.0pt;\">Foetal hypoxia</span></p>"
        },
        {
          "id": 378339,
          "text": "<p><span style=\"font-size:14.0pt;\">Chorioamnionitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A primigravida came for regular antenatal care in her first trimester. She has no complaints of dysuria or increased frequency, but her urine routine reveals ≥ 10⁵ CFU/ml E. coli. Her urine culture was done again and showed the same organism. What is the most common complication of this condition?</span></p>",
      "unique_key": "Q7746756",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128608,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans B) Preterm labour</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient has asymptomatic bacteriuria (ASB) in pregnancy — defined as ≥10⁵ CFU/mL of a single uropathogen (commonly E. coli) in two consecutive clean-catch specimens without urinary symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pathophysiology</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>During pregnancy:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Progesterone causes smooth muscle relaxation → urinary stasis.</span></li><li><span style=\"font-size:14.0pt;\">Ureteral dilatation + increased bladder volume → predispose to ascending infection.</span></li><li><span style=\"font-size:14.0pt;\">If untreated, ASB can progress to acute pyelonephritis in 20–40% of women.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Major Complications:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_P0Tt973.png\" width=\"614\" height=\"149\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Why Preterm Labour is the Most Common Complication</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The infection induces release of inflammatory cytokines and prostaglandins → leads to uterine contractions and cervical ripening.</span></li><li><span style=\"font-size:14.0pt;\">Hence, preterm labour and low birth weight are the most frequent fetal outcomes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Miscarriage:&nbsp;</strong>Usually not associated; ASB affects mid-to-late pregnancy rather than early loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Fetal hypoxia:&nbsp;</strong>Not directly caused; only secondary if severe sepsis occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Chorioamnionitis:&nbsp;</strong>Occurs with intra-amniotic infection, usually after rupture of membranes — not with isolated bacteriuria.</span></p>",
      "correct_choice_id": 378337,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84508,
      "choices": [
        {
          "id": 336604,
          "text": "<p><span style=\"font-size:14.0pt;\">Adrenal atrophy</span></p>"
        },
        {
          "id": 336605,
          "text": "<p><span style=\"font-size:14.0pt;\">Cushing syndrome</span></p>"
        },
        {
          "id": 336606,
          "text": "<p><span style=\"font-size:14.0pt;\">Ovarian carcinoma</span></p>"
        },
        {
          "id": 336607,
          "text": "<p><span style=\"font-size:14.0pt;\">Endometrial carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old nulliparous woman comes to the OPD for evaluation of infertility. The patient has been attempting to conceive for the past 2 years. Menarche was at age 11, and her menstrual cycles occur 2-3 times per year and last 7-10 days. BMI is 35 kg/m². Physical examination shows mild acne and hair growth on the upper lip and chin. This patient is at greatest risk for which of the following complications?</span></p>",
      "unique_key": "Q9309338",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128609,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Endometrial carcinoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient’s presentation is classic for Polycystic Ovary Syndrome (PCOS).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key diagnostic clues:</span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Oligomenorrhea / anovulation: Menstrual cycles only 2–3 times per year</span></li><li><span style=\"font-size:14.0pt;\">Hyperandrogenism: Acne, hirsutism (upper lip, chin)</span></li><li><span style=\"font-size:14.0pt;\">Obesity: BMI 35 kg/m²</span></li><li><span style=\"font-size:14.0pt;\">Infertility: Due to chronic anovulation</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathophysiology Link to Endometrial Carcinoma</strong></span></p><p><span style=\"font-size:14.0pt;\"><strong>In PCOS:</strong></span><br>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Anovulation → lack of progesterone from corpus luteum</span></li><li><span style=\"font-size:14.0pt;\">Unopposed estrogen exposure → continuous stimulation of endometrial proliferation</span></li><li><span style=\"font-size:14.0pt;\">Leads to endometrial hyperplasia → can progress to endometrial carcinoma (type I, estrogen-dependent).</span></li><li><span style=\"font-size:14.0pt;\">Hence, the greatest long-term risk = Endometrial carcinoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Adrenal atrophy:&nbsp;</strong>Occurs with exogenous corticosteroid use → not in PCOS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cushing syndrome:&nbsp;</strong>Can mimic PCOS (hirsutism, obesity), but PCOS itself does not cause Cushing; cortisol levels are normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ovarian carcinoma:&nbsp;</strong>Ovaries are enlarged with multiple cysts in PCOS, but the risk of ovarian cancer is not significantly increased; main malignancy risk is endometrial.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Summary Table:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_n0NO6sg.png\" width=\"735\" height=\"206\"></strong></span></p>",
      "correct_choice_id": 336607,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 69953,
      "choices": [
        {
          "id": 278885,
          "text": "<p><span style=\"font-size:14.0pt;\">Measure CA-125</span></p>"
        },
        {
          "id": 278886,
          "text": "<p><span style=\"font-size:14.0pt;\">Repeat USG after 6-12 weeks</span></p>"
        },
        {
          "id": 278887,
          "text": "<p><span style=\"font-size:14.0pt;\">Surgical intervention</span></p>"
        },
        {
          "id": 278888,
          "text": "<p><span style=\"font-size:14.0pt;\">MRI pelvis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old P1L1 presents with acute abdominal pain. She has a past history of rheumatic heart disease for which she has undergone mitral valve replacement surgery and is on oral Warfarin. On examination, 14 weeks’ abdominal mass was felt. On USG, 8 x 6 cm unilocular cyst with reticular pattern was observed in left ovary. What is the next line of management?</span></p>",
      "unique_key": "Q8883433",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128730,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Repeat USG after 6-12 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Likely diagnosis - Functional (Hemorrhagic) Ovarian Cyst — Conservative Management</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Unilocular cyst with reticular (“lace-like” or “fishnet”) pattern on USG → suggests a hemorrhagic (functional) cyst.</span></li><li><span style=\"font-size:14.0pt;\">Functional cysts are benign, hormone-related, and usually regress spontaneously within 6–12 weeks. As the patient is on Warfarin (anticoagulant), hemorrhagic cyst formation is common due to bleeding into a functional follicle.</span></li><li><span style=\"font-size:14.0pt;\">Hence, expectant management with repeat USG after 6–12 weeks is the safest approach.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Measure CA-125:</strong> CA-125 is useful for postmenopausal or suspicious adnexal masses, not for young women with classic benign cystic pattern. In premenopausal women, CA-125 may be falsely elevated due to menstruation, endometriosis, or inflammation. Hence, not the next step here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Surgical intervention:</strong> Indicated only if: Persistent or enlarging cyst, Complex/solid mass, Torsion or rupture, Malignancy suspected</span></p><p><span style=\"font-size:14.0pt;\">Here, benign pattern + young age + on Warfarin → conservative approach preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>MRI pelvis:</strong> Used for indeterminate USG findings or complex adnexal lesions when diagnosis is unclear. Here, ultrasound appearance is typical of hemorrhagic cyst, so MRI not required.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Summary of Ovarian cyst management:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_FmqvYmB.png\" width=\"469\" height=\"600\"></strong></span></p>",
      "correct_choice_id": 278886,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 69944,
      "choices": [
        {
          "id": 278853,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 278854,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 278855,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3</span></p>"
        },
        {
          "id": 278856,
          "text": "<p><span style=\"font-size:14.0pt;\">3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the correct statements:</span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\">Only one sacral ala is present in Naegele’s pelvis&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hand prolapse must be managed by LSCS</span></li><li><span style=\"font-size:14.0pt;\">False labour is rhythmic pain that radiates to thigh and back</span></li><li><span style=\"font-size:14.0pt;\">Constriction ring is due to injudicious use of oxytocin&nbsp;</span></li></ol>",
      "unique_key": "Q3417652",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128731,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 2, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Only one sacral ala is present in Naegele’s pelvis: </strong>Correct. Naegele’s pelvis = <i>unilateral obliquely contracted pelvis.</i> Caused by arrest of development of one sacral ala (hemisacrum). Results in asymmetrical pelvic inlet — oblique diameter shortened on affected side. Commonly associated with scoliosis and pelvic tilt.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. Hand prolapse must be managed by LSCS:</strong> Correct.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hand prolapse: descent of hand alongside the presenting part (usually head). Indicates malpresentation or cephalopelvic disproportion. Vaginal delivery risks cord compression or trauma, hence Caesarean section (LSCS) is the management of choice.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement</strong> <strong>3.</strong> <strong>False labour is rhythmic pain that radiates to thigh and back: </strong>Incorrect.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">False labour (Braxton Hicks contractions): Irregular, non-progressive uterine contractions. Do not radiate to back or thighs. No cervical dilatation or effacement.</span></li><li><span style=\"font-size:14.0pt;\">True labour pain is the one that is rhythmic, increases in intensity, and radiates to the back and thighs → causes cervical changes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4. Constriction ring is due to injudicious use of oxytocin: </strong>Correct.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Constriction ring (Schröder’s ring): Localized uterine contraction around a fetal part, usually due to hyperstimulation by oxytocics.</span></li></ul>",
      "correct_choice_id": 278854,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 70457,
      "choices": [
        {
          "id": 280873,
          "text": "<p><span style=\"font-size:14.0pt;\">Secondary follicle</span></p>"
        },
        {
          "id": 280874,
          "text": "<p><span style=\"font-size:14.0pt;\">Theca interna</span></p>"
        },
        {
          "id": 280875,
          "text": "<p><span style=\"font-size:14.0pt;\">Granulosa cell</span></p>"
        },
        {
          "id": 280876,
          "text": "<p><span style=\"font-size:14.0pt;\">Corpus luteum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which ovarian structure is responsible for the following finding?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_NAzwJOI.png\" width=\"349\" height=\"233\"></span></p>",
      "unique_key": "Q7337832",
      "question_audio": null,
      "question_video": null,
      "map_id": 35128732,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Corpus luteum</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Corpus luteum — source of progesterone → secretory transformation of endometrium</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">After ovulation, the ruptured Graafian follicle transforms into the corpus luteum under the influence of LH. The granulosa lutein cells and theca lutein cells secrete progesterone (and some estrogen). Progesterone acts on the proliferative endometrium (previously estrogen-primed) and converts it into secretory endometrium.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Histologic features (as seen in image):</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Tortuous, coiled glands with subnuclear vacuolation (early secretory phase). Edematous stroma rich in glycogen and spiral arterioles. Indicates progesterone activity → hence, corpus luteum is responsible.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Secondary follicle:</strong> Secretes mainly estrogen, responsible for proliferative phase endometrium (straight glands, dense stroma). Not responsible for secretory changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Theca interna:</strong> Produces androgens, which are later aromatized to estrogens by granulosa cells. Indirect role in follicular estrogen synthesis, not secretory transformation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Granulosa cell:</strong> In preovulatory follicle, secretes estrogen, leading to proliferation of endometrium. After ovulation, these become granulosa lutein cells, secreting progesterone as part of corpus luteum. So, granulosa cells alone (pre-ovulation) do not cause secretory endometrium.</span></p>",
      "correct_choice_id": 280876,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95038,
      "choices": [
        {
          "id": 378340,
          "text": "<p><span style=\"font-size:14.0pt;\">USG to see cervical length</span></p>"
        },
        {
          "id": 378341,
          "text": "<p><span style=\"font-size:14.0pt;\">Cervical Cerclage</span></p>"
        },
        {
          "id": 378342,
          "text": "<p><span style=\"font-size:14.0pt;\">Complete Bed rest</span></p>"
        },
        {
          "id": 378343,
          "text": "<p><span style=\"font-size:14.0pt;\">Abdominal cerclage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A G3P2L0 presents with 9 weeks of amenorrhea. She has a history of conization being done one year ago and is currently on follow-up, with no recurrence on PAP smear. What is the appropriate management?</span></p>",
      "unique_key": "Q6816442",
      "question_audio": null,
      "question_video": null,
      "map_id": 35129093,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) USG to see cervical length</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clinical reasoning: History of cervical conization (removal of part of cervix) can predispose to cervical incompetence (incompetent cervix) → risk of second-trimester pregnancy loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">However, not every woman with a history of conization requires prophylactic cerclage. The first step is assessment of cervical length using transvaginal ultrasound (TVS) at 11–14 weeks.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">If cervical length &lt;25 mm → consider cerclage.</span><br><span style=\"font-size:14.0pt;\">If normal → continue surveillance; no immediate intervention needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cervical cerclage: Not yet indicated.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Prophylactic cerclage is done only if: ≥2 second-trimester losses due to cervical incompetence. Short cervix (&lt;25 mm) on TVS before 24 weeks</span></li><li><span style=\"font-size:14.0pt;\">At 9 weeks, evaluation first is required before intervention.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Complete bed rest:</strong> Bed rest does not prevent preterm birth or cervical insufficiency. Only supportive in selected cases after intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Abdominal cerclage:</strong> Not first-line. Reserved for cases where vaginal cerclage fails or cervix too short/scarred to hold a stitch (usually after failed prior cerclages). Not appropriate as first management step here.</span></p>",
      "correct_choice_id": 378340,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95039,
      "choices": [
        {
          "id": 378344,
          "text": "<p><span style=\"font-size:14.0pt;\">At puberty</span></p>"
        },
        {
          "id": 378345,
          "text": "<p><span style=\"font-size:14.0pt;\">Reproductive age</span></p>"
        },
        {
          "id": 378346,
          "text": "<p><span style=\"font-size:14.0pt;\">During Pregnancy</span></p>"
        },
        {
          "id": 378347,
          "text": "<p><span style=\"font-size:14.0pt;\">Postmenopause</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">At which stage of a woman's life, is the vaginal pH at its maximum?</span></p>",
      "unique_key": "Q5453219",
      "question_audio": null,
      "question_video": null,
      "map_id": 35129094,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Postmenopause</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Normal physiology of vaginal pH:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_iZms838.png\" width=\"617\" height=\"285\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Concept:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Estrogen stimulates vaginal epithelium to produce glycogen, which is metabolized by Lactobacillus (Döderlein’s bacillus) into lactic acid, maintaining a low pH (acidic) environment. In postmenopausal women, estrogen deficiency → loss of glycogen, loss of lactobacilli, and rise in pH → most alkaline vaginal environment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. At puberty:</strong> Estrogen starts to rise, but lactobacilli colonization and glycogen deposition are just beginning → pH starts decreasing, not maximum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Reproductive age:</strong> High estrogen → high glycogen → lactobacilli thrive → acidic pH (lowest) to protect against infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. During pregnancy:</strong> Estrogen and progesterone very high → increased glycogen → more lactic acid → very acidic pH, protective against pathogens.</span></p>",
      "correct_choice_id": 378347,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95041,
      "choices": [
        {
          "id": 378352,
          "text": "<p><span style=\"font-size:14.0pt;\">Nulliparous, singleton, cephalic, induced labour</span></p>"
        },
        {
          "id": 378353,
          "text": "<p><span style=\"font-size:14.0pt;\">Nulliparous, singleton, cephalic, spontaneous labour</span></p>"
        },
        {
          "id": 378354,
          "text": "<p><span style=\"font-size:14.0pt;\">Multiparous without previous CS, spontaneous labour</span></p>"
        },
        {
          "id": 378355,
          "text": "<p><span style=\"font-size:14.0pt;\">Multiparous without previous CS, induced/CS before labour</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Modified Robson's classification class 2 includes:</span></p>",
      "unique_key": "Q7292261",
      "question_audio": null,
      "question_video": null,
      "map_id": 35160345,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Nulliparous, singleton, cephalic, induced labour</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Modified Robson’s Classification (10-group system) is used by WHO to analyze and compare cesarean section (CS) rates across different obstetric populations.</span></p><p><br><span style=\"font-size:14.0pt;\">Each woman admitted for delivery is assigned to one of 10 groups based on 5 obstetric parameters: Parity, Previous CS, Onset of labour, Fetal presentation, and Number of fetuses.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Group 1 – 10 (Modified Robson’s Classification):</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_FySZLDj.png\" width=\"612\" height=\"308\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Therefore:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Class 1: Nulliparous + Cephalic + Spontaneous</span></li><li><span style=\"font-size:14.0pt;\">Class 2: Nulliparous + Cephalic + Induced / CS before labour</span></li></ul>",
      "correct_choice_id": 378352,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95042,
      "choices": [
        {
          "id": 378356,
          "text": "<p><span style=\"font-size:14.0pt;\">Blood transfusion</span></p>"
        },
        {
          "id": 378357,
          "text": "<p><span style=\"font-size:14.0pt;\">IV iron sucrose</span></p>"
        },
        {
          "id": 378358,
          "text": "<p><span style=\"font-size:14.0pt;\">45mg elemental iron and 400 mcg folic acid twice daily</span></p>"
        },
        {
          "id": 378359,
          "text": "<p><span style=\"font-size:14.0pt;\">60 mg elemental iron and 500 mcg folic acid twice daily</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A G2P1 woman at 29 weeks POG presents with a Hb of 6.8 g/dl. What is the appropriate treatment?</span></p>",
      "unique_key": "Q1911206",
      "question_audio": null,
      "question_video": null,
      "map_id": 35160366,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) IV iron sucrose</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Stepwise approach – Management of anemia in pregnancy:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_T15o2ML.png\" width=\"613\" height=\"173\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reasoning for This Case:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Patient is 29 weeks (third trimester) → need for rapid correction of anemia before delivery.</span></li><li><span style=\"font-size:14.0pt;\">Hb = 6.8 g/dL → falls into moderate anemia, but not severely symptomatic (no mention of heart failure or hypoxia).</span></li><li><span style=\"font-size:14.0pt;\">IV iron sucrose is preferred because: Safe and effective in 2nd &amp; 3rd trimesters. Rapid rise in Hb and replenishes iron stores. Avoids transfusion risks (reactions, infections, alloimmunization).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Therefore → IV Iron Sucrose (Option B. is most appropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Iron Sucrose Regimen: Dose calculation:</strong></span><br><span style=\"font-size:14.0pt;\"><strong>Required iron (mg) = 2.4 × (Target Hb – Actual Hb) × Pre-pregnancy weight (kg) + 500 mg (for stores)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Usually given as 200 mg IV iron sucrose diluted in 100 mL NS, infused over 30 minutes, 2–3 times/week until total dose reached.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Blood transfusion:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Indicated when: Hb &lt;6 g/dL, or Severe anemia with cardiac decompensation, or Need for urgent correction (near term / imminent delivery).</span></li><li><span style=\"font-size:14.0pt;\">Here, Hb is 6.8 g/dL → borderline; IV iron preferred first if stable.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. 45 mg elemental iron + folic acid:</strong> Too low a dose for therapeutic correction; meant for prophylaxis, not treatment. Used in early antenatal supplementation (for mild anemia or prevention).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. 60 mg elemental iron + folic acid:</strong> Oral therapy is too slow and poorly absorbed in late pregnancy. Also, may cause GI side effects and poor compliance.</span></p>",
      "correct_choice_id": 378357,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95043,
      "choices": [
        {
          "id": 378360,
          "text": "<p><span style=\"font-size:14.0pt;\">Category C</span></p>"
        },
        {
          "id": 378361,
          "text": "<p><span style=\"font-size:14.0pt;\">Category B</span></p>"
        },
        {
          "id": 378362,
          "text": "<p><span style=\"font-size:14.0pt;\">Category X</span></p>"
        },
        {
          "id": 378363,
          "text": "<p><span style=\"font-size:14.0pt;\">Category D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">For a given drug, animal reproduction studies have shown an adverse effect on the fetus, but there are no adequate and well-controlled studies on humans. However, potential benefits may warrant the use of the drug in pregnant women despite potential risks. Such a drug would be classified as:</span></p>",
      "unique_key": "Q1834989",
      "question_audio": null,
      "question_video": null,
      "map_id": 35160417,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Category C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">FDA Pregnancy Risk Categories&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cHcJVV2.png\" width=\"613\" height=\"267\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>The question clearly states:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Animal studies → adverse effects</span></li><li><span style=\"font-size:14.0pt;\">Human studies → inadequate</span></li><li><span style=\"font-size:14.0pt;\">Possible benefit → may justify use</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This exactly matches Category C definition. Hence, the correct answer is Category C&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Category B: Incorrect.</strong> Animal studies show no harm to fetus, or animal harm not confirmed in humans.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Category X: Incorrect.</strong> Absolute contraindication. Risks outweigh any benefit<i>.</i> In the question, it says “may warrant use despite risk” → not X.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Category D: Incorrect.</strong> Confirmed human fetal risk, but may be used in life-threatening conditions (e.g., anticonvulsants). Here, human data not available.</span></p>",
      "correct_choice_id": 378360,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95044,
      "choices": [
        {
          "id": 378364,
          "text": "<p><span style=\"font-size:14.0pt;\">Oral fluconazole 150 mg single dose</span></p>"
        },
        {
          "id": 378365,
          "text": "<p><span style=\"font-size:14.0pt;\">Oral fluconazole 150 mg two doses 1 week apart</span></p>"
        },
        {
          "id": 378366,
          "text": "<p><span style=\"font-size:14.0pt;\">Metronidazole 200 mg oral TDS for 7 days</span></p>"
        },
        {
          "id": 378367,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravaginal topical azole for 7 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A pregnant woman at 8 weeks gestation, presents to the outpatient department with complaints of curdy white vaginal discharge, dysuria, and intense itching. Candidal vaginitis is suspected. What will be the best management in this scenario?</span></p>",
      "unique_key": "Q7745717",
      "question_audio": null,
      "question_video": null,
      "map_id": 35160418,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Intravaginal topical azole for 7 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Diagnosis: Candidal vaginitis (Vulvovaginal candidiasis)</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Common in pregnancy due to high estrogen levels, increased glycogen deposition, and Candida overgrowth.</span></li><li><span style=\"font-size:14.0pt;\">Typical features: Thick, curdy white discharge. Intense itching and burning. Dysuria and vulval erythema</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Rationale for Management:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Systemic azoles (like oral fluconazole) are contraindicated in pregnancy, especially in the first trimester, because: Fluconazole is teratogenic — associated with congenital anomalies (craniofacial, skeletal defects, cardiac malformations).&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hence, local (intravaginal) antifungal therapy is the treatment of choice.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Recommended regimen: Clotrimazole 2% vaginal cream for 7 days or Miconazole / Econazole / Terconazole intravaginally for 7 days</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These are safe and effective during pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Oral fluconazole 150 mg single dose:</strong> Effective in non-pregnant women but contraindicated in pregnancy (teratogenic).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Oral fluconazole 150 mg two doses:</strong> Increases exposure → higher teratogenic risk. Absolutely contraindicated in the first trimester.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Metronidazole 200 mg TDS for 7 days:</strong> Used for bacterial vaginosis or trichomoniasis, not for Candida infections. Ineffective against fungal pathogens.</span></p>",
      "correct_choice_id": 378367,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95045,
      "choices": [
        {
          "id": 378368,
          "text": "<p><span style=\"font-size:14.0pt;\">Perineum, perineal muscles, and &gt;50% of external anal sphincter</span></p>"
        },
        {
          "id": 378369,
          "text": "<p><span style=\"font-size:14.0pt;\">Perineum, perineal muscles, and &lt;50% of external anal sphincter</span></p>"
        },
        {
          "id": 378370,
          "text": "<p><span style=\"font-size:14.0pt;\">Perineum, perineal muscles, external and internal anal sphincter</span></p>"
        },
        {
          "id": 378371,
          "text": "<p><span style=\"font-size:14.0pt;\">Perineum, perineal muscles, anal sphincter complex and anorectal mucosa</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">After the successful delivery of a baby, a grade 3b perineal tear is noticed. Which are the structures injured in this case?</span></p>",
      "unique_key": "Q1395767",
      "question_audio": null,
      "question_video": null,
      "map_id": 35160469,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Perineum, perineal muscles, and &gt;50% of external anal sphincter</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Perineal tears are classified based on the extent of injury to the perineum and anal sphincter complex (as per RCOG classification):</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Classification of Perineal Tears:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_QHgWmXs.png\" width=\"611\" height=\"215\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Subclassification of 3rd Degree Tears:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_16U4xVd.png\" width=\"611\" height=\"171\"></strong></span></p>",
      "correct_choice_id": 378368,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95046,
      "choices": [
        {
          "id": 378372,
          "text": "<p><span style=\"font-size:14.0pt;\">Fetal nuchal cord</span></p>"
        },
        {
          "id": 378373,
          "text": "<p><span style=\"font-size:14.0pt;\">Normal labor</span></p>"
        },
        {
          "id": 378374,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine rupture</span></p>"
        },
        {
          "id": 378375,
          "text": "<p><span style=\"font-size:14.0pt;\">Vasa previa</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old woman, gravida 3 para 2, at 38 weeks gestation comes to the hospital due to contractions. She had a cesarean delivery for breech presentation at 39 weeks gestation in her second pregnancy. Blood pressure is 100/60 mm Hg, pulse is 100/min, and respirations are 22/min. Fetal heart rate tracing shows moderate variability, multiple accelerations, and no decelerations. Uterine contractions are regular and occur every 4 minutes. The cervix is 6 cm dilated and 60% effaced, and the fetal vertex is at 0 station. After 2 hours, the patient is suddenly restless and has intense lower abdominal pain. Fetal heart monitoring shows recurrent late decelerations. On pelvic examination, there is moderate vaginal bleeding, the cervix is 6 cm dilated and 60% effaced, and the fetal vertex is at -3 station. Which of the following is the most likely diagnosis in this patient?</span></p>",
      "unique_key": "Q6124410",
      "question_audio": null,
      "question_video": null,
      "map_id": 35160520,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Uterine rupture</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient has a history of a previous cesarean delivery, sudden severe abdominal pain during labor, fetal distress with late decelerations, vaginal bleeding, and loss of fetal station. These are classic signs of uterine rupture, most commonly occurring at the site of a previous cesarean scar.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key features supporting uterine rupture:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">History of prior cesarean scar</span></li><li><span style=\"font-size:14.0pt;\">Sudden, severe abdominal pain during labor</span></li><li><span style=\"font-size:14.0pt;\">Fetal distress (late decelerations)</span></li><li><span style=\"font-size:14.0pt;\">Vaginal bleeding</span></li><li><span style=\"font-size:14.0pt;\">Loss of fetal station (head moves upward)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option A. Fetal nuchal cord:</strong> causes variable decelerations, not severe pain or loss of station.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option B. Normal labor:</strong> pain is regular and tolerable, without sudden distress or fetal heart abnormalities.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option D. Vasa previa:</strong> presents with painless vaginal bleeding and fetal bradycardia after membrane rupture, no maternal pain or loss of station.</span></p>",
      "correct_choice_id": 378374,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95047,
      "choices": [
        {
          "id": 378376,
          "text": "<p><span style=\"font-size:14.0pt;\">Declare as complete abortion and follow-up in 15 days</span></p>"
        },
        {
          "id": 378377,
          "text": "<p><span style=\"font-size:14.0pt;\">Methotrexate injection</span></p>"
        },
        {
          "id": 378378,
          "text": "<p><span style=\"font-size:14.0pt;\">Diagnostic laparoscopy</span></p>"
        },
        {
          "id": 378379,
          "text": "<p><span style=\"font-size:14.0pt;\">Follow-up with beta-HCG</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient with 6 weeks amenorrhea and a positive pregnancy test came with complaints of lower abdominal pain, moderate bleeding PV. She was hemodynamically stable. On ultrasound, there was no gestational sac in the uterus. Ovaries were normal and no free fluid in the pouch of Douglas. What is the next line of management?</span></p>",
      "unique_key": "Q5002423",
      "question_audio": null,
      "question_video": null,
      "map_id": 35160711,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Follow-up with beta-HCG</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This scenario describes a pregnancy of unknown location (PUL) — when a woman has a positive pregnancy test but no evidence of intrauterine or ectopic gestation on transvaginal ultrasound.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">At this early stage, the situation can evolve into:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">An early intrauterine pregnancy (too small to be seen yet),</span></li><li><span style=\"font-size:14.0pt;\">A completed miscarriage, or</span></li><li><span style=\"font-size:14.0pt;\">A developing ectopic pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Because of these possibilities, immediate intervention is avoided if the patient is stable. The best next step is to repeat serum beta-hCG testing after 48 hours, along with follow-up ultrasound.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">How to interpret serial beta-hCG values:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Normal intrauterine pregnancy: hCG rises by ≥66% in 48 hours.</span></li><li><span style=\"font-size:14.0pt;\">Ectopic pregnancy: hCG rises slower than normal or plateaus.</span></li><li><span style=\"font-size:14.0pt;\">Abortion (failing pregnancy): hCG decreases steadily.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, serial hCG helps to safely differentiate between these conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Declare as complete abortion and follow-up in 15 days:</strong> In a complete abortion, the hCG levels should already be falling, and ultrasound should show an empty uterus after previously documented intrauterine pregnancy. Here, no previous intrauterine pregnancy was documented, so it could still be an early ectopic pregnancy, which can rupture later if missed. Hence, declaring complete abortion without serial monitoring is unsafe.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Methotrexate injection:</strong> Methotrexate is used for confirmed ectopic pregnancy, not for PUL without confirmation. Giving methotrexate now risks terminating a viable intrauterine pregnancy if the pregnancy is simply too early to visualize. It should be considered only when ectopic is proven or strongly suspected (e.g., rising hCG without intrauterine sac once hCG &gt;1500 mIU/mL).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Diagnostic laparoscopy:</strong> Indicated only when the patient is unstable (e.g., hypotension, severe pain, internal bleeding) or when imaging and hCG trends are highly suggestive of ruptured or complicated ectopic pregnancy. This patient is hemodynamically stable, with no free fluid in the pouch of Douglas — hence no immediate indication for surgery.</span></p>",
      "correct_choice_id": 378379,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95048,
      "choices": [
        {
          "id": 378380,
          "text": "<p><span style=\"color:black;font-size:14.0pt;\">Medroxyprogesterone acetate</span></p>"
        },
        {
          "id": 378381,
          "text": "<p><span style=\"color:black;font-size:14.0pt;\">Cabergoline</span></p>"
        },
        {
          "id": 378382,
          "text": "<p><span style=\"color:black;font-size:14.0pt;\">Estradiol</span></p>"
        },
        {
          "id": 378383,
          "text": "<p><span style=\"color:black;font-size:14.0pt;\">Letrozole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old woman presents to the gynecology clinic with complaints of severe pelvic pain, particularly during her menstrual periods, and pain during intercourse for the past several years. On pelvic examination, the gynecologist notes tenderness upon palpation of the posterior vaginal fornix and palpable nodules in the uterosacral ligaments. An ultrasound was performed as shown here. All&nbsp;of the following drugs may be useful except:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_9CO4ZzE.png\" width=\"536\" height=\"282\"></span></p>",
      "unique_key": "Q8570298",
      "question_audio": null,
      "question_video": null,
      "map_id": 35160842,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"color:black;font-size:14.0pt;\"><strong>Ans. C) Estradiol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The clinical and imaging findings are typical of endometriosis with bilateral endometriomas (chocolate cysts).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key diagnostic clues:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Chronic pelvic pain and dysmenorrhea</span></li><li><span style=\"font-size:14.0pt;\">Dyspareunia (pain during intercourse)</span></li><li><span style=\"font-size:14.0pt;\">Nodularity of uterosacral ligaments</span></li><li><span style=\"font-size:14.0pt;\">“Ground-glass” cysts on transvaginal ultrasound → endometriomas</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pathophysiology:</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Endometriosis is an estrogen-dependent disorder in which endometrial tissue grows outside the uterus, causing cyclic bleeding, inflammation, and fibrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Estradiol – Exogenous estrogen stimulates growth and proliferation of endometriotic implants. Worsens symptoms and lesion size. Since endometriosis is estrogen-dependent, giving estradiol exacerbates the disease rather than treating it.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Medroxyprogesterone acetate: Useful.</strong> A progestin that causes decidualization and atrophy of ectopic endometrial tissue. Suppresses LH surge → reduces ovarian steroidogenesis → decreases pain and lesion size. Commonly used for pain relief and hormonal suppression in endometriosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cabergoline: Useful.</strong> A dopamine agonist that reduces angiogenesis in endometriotic tissue. Also lowers VEGF (vascular endothelial growth factor) levels. Shown to reduce endometrioma size and pain in some cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Letrozole: Useful.</strong> An aromatase inhibitor that suppresses estrogen synthesis in both ovaries and endometriotic tissue. Reduces estrogen-driven proliferation and inflammation. Used in refractory endometriosis cases or when combined with progestins.</span></p>",
      "correct_choice_id": 378382,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25099,
      "choices": [
        {
          "id": 100350,
          "text": "<p><span style=\"font-size:18px;\">Stop antibiotics and start heparin</span></p>"
        },
        {
          "id": 100351,
          "text": "<p><span style=\"font-size:18px;\">Antibiotics + Heparin</span></p>"
        },
        {
          "id": 100352,
          "text": "<p><span style=\"font-size:18px;\">Surgical embolectomy</span></p>"
        },
        {
          "id": 100353,
          "text": "<p><span style=\"font-size:18px;\">Hysterectomy</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 34-year-old woman who recently delivered a full-term baby presents to the emergency department with complaints of persistent fever, lower abdominal pain, and increasing tenderness over the past few days. She delivered her baby via an uncomplicated vaginal delivery two weeks ago. She has been feeling generally unwell since the delivery, with fatigue and malaise. On examination, the patient appears pale and febrile. Lower abdominal tenderness is noted, particularly on palpation of the uterine fundus. There is also localized redness and warmth over the lower abdomen. Her vital signs reveal an elevated heart rate and temperature. Laboratory tests show an elevated white blood cell count, and imaging studies such as ultrasound and computed tomography (CT) scan reveal thrombosis in the pelvic veins. Which among the following is the next course of treatment for her?</span></p>",
      "unique_key": "Q6076075",
      "question_audio": null,
      "question_video": null,
      "map_id": 35160843,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Antibiotics + Heparin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This is a case of septic pelvic thrombophlebitis (SPT) — a rare but serious postpartum complication. It typically occurs after delivery (especially within 1–3 weeks) and results from infection and thrombosis of the pelvic veins (usually the ovarian or uterine veins).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pathophysiology:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During or after delivery, endometrial infection (endometritis) may spread to nearby pelvic veins. The combination of endothelial injury, venous stasis, and hypercoagulability (Virchow’s triad) leads to infected thrombus formation. These septic thrombi may cause persistent fever despite broad-spectrum antibiotics.</span></li><li><span style=\"font-size:14.0pt;\">Commonly involves right ovarian vein, as it’s longer and drains directly into the IVC.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clinical Features:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Persistent spiking fever despite appropriate antibiotic therapy for postpartum endometritis. Lower abdominal or flank pain radiating to groin or upper abdomen. Uterine tenderness or pelvic pain disproportionate to findings. Leukocytosis on labs. CT or MRI shows thrombosis in ovarian or pelvic veins.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Management:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Mainstay of treatment:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Broad-spectrum antibiotics – to cover polymicrobial infection (common organisms: <i>E. coli, Streptococci, anaerobes</i>). Typically Clindamycin + Gentamicin ± Metronidazole, or a single broad-spectrum agent like Piperacillin–Tazobactam.</span></li><li><span style=\"font-size:14.0pt;\">Anticoagulation with Heparin – to prevent thrombus propagation and promote resolution. Unfractionated or low-molecular-weight heparin is used.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Combination of Antibiotics + Heparin leads to dramatic defervescence (drop in fever within 48–72 hours), confirming the diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Stop antibiotics and start heparin:</strong> Incorrect. Infection is a major component of this condition. Heparin alone will not treat the septic focus. Both infection and thrombosis must be addressed simultaneously.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Surgical embolectomy:</strong> Reserved only for life-threatening pulmonary embolism not responding to medical management. Rarely indicated in septic pelvic thrombophlebitis, as antibiotics and heparin are usually effective.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hysterectomy:</strong> Not indicated unless there is uncontrolled uterine sepsis or necrosis. SPT is a vascular complication, not confined to the uterus, so hysterectomy does not solve the problem.</span></p>",
      "correct_choice_id": 100351,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 69891,
      "choices": [
        {
          "id": 278641,
          "text": "<p><span style=\"font-size:14.0pt;\">Ospemifene</span></p>"
        },
        {
          "id": 278642,
          "text": "<p><span style=\"font-size:14.0pt;\">Clomiphene&nbsp;</span></p>"
        },
        {
          "id": 278643,
          "text": "<p><span style=\"font-size:14.0pt;\">Tamoxifen&nbsp;</span></p>"
        },
        {
          "id": 278644,
          "text": "<p><span style=\"font-size:14.0pt;\">Raloxifene</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following SERMs is approved in senile vaginitis?&nbsp;</span></p>",
      "unique_key": "Q8576061",
      "question_audio": null,
      "question_video": null,
      "map_id": 35160944,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Ospemifene</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Senile (Atrophic) Vaginitis</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Occurs in postmenopausal women due to estrogen deficiency, leading to: Thinning of the vaginal epithelium. Decreased lubrication. Vaginal dryness, itching, dyspareunia, and recurrent infections</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ospemifene is the only SERM approved specifically for the treatment of moderate to severe dyspareunia and vaginal atrophy due to menopause.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Mechanism: Acts as a selective estrogen receptor agonist on vaginal and vulvar tissues. Improves vaginal epithelial maturation, increases superficial cell layers, and restores vaginal pH and elasticity. Has anti-estrogenic effects on the breast and neutral effects on the endometrium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Indication: Postmenopausal atrophic vaginitis (senile vaginitis). Administered orally (60 mg once daily)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Clomiphene:</strong> Acts as an anti-estrogen at the hypothalamus, stimulating ovulation in infertility treatment. No role in atrophic vaginitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tamoxifen:</strong> Estrogen antagonist in breast tissue, agonist in endometrium and bone. Used in breast cancer therapy and prevention. Causes endometrial hyperplasia, not suitable for vaginal atrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Raloxifene:</strong> Estrogen agonist in bone and lipid metabolism; antagonist in breast and uterus. Used in osteoporosis prevention and treatment in postmenopausal women. No beneficial effect on vaginal epithelium or lubrication.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Other treatment Options for Vaginal Atrophy:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_elvZj4i.png\" width=\"469\" height=\"393\"></span></p>",
      "correct_choice_id": 278641,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 62521,
      "choices": [
        {
          "id": 249333,
          "text": "<p><span style=\"font-size:14.0pt;\">Estriol</span></p>"
        },
        {
          "id": 249334,
          "text": "<p><span style=\"font-size:14.0pt;\">TSH</span></p>"
        },
        {
          "id": 249335,
          "text": "<p><span style=\"font-size:14.0pt;\">Human chorionic gonadotropin</span></p>"
        },
        {
          "id": 249336,
          "text": "<p><span style=\"font-size:14.0pt;\">Luteinizing hormone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 16-year-old girl comes to the physician because of a 3-week history of nausea, increased urinary frequency, and breast tenderness. She has never had a menstrual period. She is actively involved in her school's volleyball team. She is 173 cm tall and weighs 54 kg; BMI is 18 kg/m2. Her breast and pubic hair development are at Tanner stage 5. Which of the following serum assays is the most appropriate next step in the diagnosis of this patient's condition?</span></p>",
      "unique_key": "Q4802490",
      "question_audio": null,
      "question_video": null,
      "map_id": 35160945,
      "difficulty_level": "difficult",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Human chorionic gonadotropin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient has primary amenorrhea with fully developed secondary sexual characteristics (Tanner stage 5 breasts and pubic hair). She now presents with symptoms of early pregnancy — nausea, urinary frequency, and breast tenderness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key diagnostic clue:</span></p><p><br><span style=\"font-size:14.0pt;\">A sexually active adolescent girl with amenorrhea and pregnancy symptoms → rule out pregnancy first, regardless of menstrual history.</span></p><p><span style=\"font-size:14.0pt;\">Hence, the first and most appropriate test is serum or urine β-hCG to confirm or exclude pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Estriol:</strong> Estriol is an estrogen measured to assess fetal well-being during pregnancy (e.g., in triple test). Not useful in evaluating amenorrhea or confirming pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. TSH:</strong> Thyroid dysfunction (especially hypothyroidism) can cause menstrual irregularities, but only after pregnancy is ruled out. It is a secondary test, not the first step.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Luteinizing hormone (LH):</strong> Measured to evaluate causes of primary amenorrhea like gonadal dysgenesis or hypothalamic dysfunction. However, this patient already shows full sexual maturation and pregnancy-like symptoms, so LH testing is premature until pregnancy is excluded.</span></p>",
      "correct_choice_id": 249335,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61894,
      "choices": [
        {
          "id": 246845,
          "text": "<p><span style=\"font-size:18px;\">Insulin resistance</span></p>"
        },
        {
          "id": 246846,
          "text": "<p><span style=\"font-size:18px;\">Loss of ciliary action</span></p>"
        },
        {
          "id": 246847,
          "text": "<p><span style=\"font-size:18px;\">Ectopic endometrial tissue</span></p>"
        },
        {
          "id": 246848,
          "text": "<p><span style=\"font-size:18px;\">Primary ovarian insufficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 29-year-old nulligravid woman comes to the physician for evaluation of infertility. She has been unable to conceive for 14 months. One year ago, she stopped taking the oral contraceptive pill, which she had been taking since she was 17. Her husband's semen analysis was normal. Four years ago, she had an episode of a pelvic tenderness and vaginal discharge that resolved without treatment. Menses occur at regular 28-day intervals. Before her marriage, she was sexually active with 3 male partners and used condoms inconsistently. She is 169 cm (5 ft 6 in) tall and weighs 86 kg (190 lb); BMI is 31.6 kg/m2. Physical examination shows no abnormalities. Which of the following is the most likely cause of this patient's infertility?</span></p>",
      "unique_key": "Q1961053",
      "question_audio": null,
      "question_video": null,
      "map_id": 35160946,
      "difficulty_level": "difficult",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Loss of ciliary action</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This woman has secondary infertility (previously fertile potential, now unable to conceive) with a normal menstrual cycle, indicating normal ovulation.</span></p><p><br><span style=\"font-size:14.0pt;\">The history strongly suggests tubal factor infertility due to prior pelvic inflammatory disease (PID) caused by sexually transmitted infections such as Chlamydia trachomatis or Neisseria gonorrhoeae. Although her infection resolved clinically, it likely caused subclinical tubal damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathophysiology:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">PID leads to inflammation and scarring of the fallopian tubes. Chronic damage destroys tubal cilia, which are responsible for transporting the ovum toward the uterus.</span></li><li><span style=\"font-size:14.0pt;\">Even if tubal patency remains (no complete blockage), loss of ciliary motility prevents fertilization by disrupting gamete transport. The end result is infertility despite normal ovulation and normal semen parameters.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hence, the cause of infertility here is loss of ciliary action within the fallopian tubes secondary to postinfectious damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Insulin resistance:</strong> Seen in polycystic ovarian syndrome (PCOS), which causes anovulation and irregular menses. This patient has regular cycles, ruling out PCOS as the primary issue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Ectopic endometrial tissue:</strong> Endometriosis can cause infertility but typically presents with pelvic pain, dysmenorrhea, or dyspareunia, none of which are reported here. Moreover, her history of pelvic infection and sexual exposure pattern fits PID more closely.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Primary ovarian insufficiency:</strong> Presents with amenorrhea or oligomenorrhea and elevated FSH and LH levels. This patient has regular cycles, implying normal ovarian function.</span></p>",
      "correct_choice_id": 246846,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22776,
      "choices": [
        {
          "id": 91065,
          "text": "<p><span style=\"font-size:14.0pt;\">20-year-old with amenorrhea and hirsutism&nbsp;</span></p>"
        },
        {
          "id": 91066,
          "text": "<p><span style=\"font-size:14.0pt;\">18-year-old with amenorrhea and an elevated prolactin level&nbsp;</span></p>"
        },
        {
          "id": 91067,
          "text": "<p><span style=\"font-size:14.0pt;\">16-year-old with amenorrhea with normal secondary sexual characters and no mullerian structures on sonography&nbsp;</span></p>"
        },
        {
          "id": 91068,
          "text": "<p><span style=\"font-size:14.0pt;\">16-year-old with amenorrhea with normal secondary sexual characters and uterus seen on imaging</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In which of the following patients is a karyotype most likely needed?</span></p>",
      "unique_key": "Q3867164",
      "question_audio": null,
      "question_video": null,
      "map_id": 35160947,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;16-year-old with amenorrhea with normal secondary sexual characters and no mullerian structures on sonography&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a <strong>16-year-old with primary amenorrhea</strong> and <strong>normal secondary sexual characteristics</strong> but <strong>absence of Mullerian structures (uterus, fallopian tubes, and upper two-thirds of the vagina)</strong>, a karyotype is essential to differentiate between two primary conditions:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Mullerian Agenesis (Mayer-Rokitansky-Küster-Hauser Syndrome - MRKH)</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Karyotype: <strong>46, XX</strong></span></li><li><span style=\"font-size:14.0pt;\">Normal ovarian function (producing estrogen), leading to the development of secondary sexual characteristics.</span></li><li><span style=\"font-size:14.0pt;\">No uterus or upper vaginal structures due to Mullerian agenesis.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Androgen Insensitivity Syndrome (AIS):</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Karyotype: <strong>46, XY</strong></span></li><li><span style=\"font-size:14.0pt;\">Complete androgen insensitivity results in the inability of the body to respond to androgens.</span></li><li><span style=\"font-size:14.0pt;\">Secondary sexual characteristics develop due to peripheral conversion of testosterone to estrogen.</span></li><li><span style=\"font-size:14.0pt;\">Testes are present (may be intra-abdominal), but Mullerian structures regress due to Anti-Mullerian Hormone (AMH) produced by Sertoli cells.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A <strong>karyotype test</strong> helps differentiate between these conditions, making it essential in this clinical scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 20-year-old with amenorrhea and hirsutism:</strong> This is likely <strong>PCOS</strong> or another hyperandrogenic condition, where karyotyping is not necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. 18-year-old with amenorrhea and an elevated prolactin level:</strong> This indicates <strong>hyperprolactinemia</strong> (e.g., due to a prolactinoma or hypothyroidism), where a <strong>prolactin assay</strong> and imaging, not a karyotype, are the key diagnostic tools.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. 16-year-old with amenorrhea, normal secondary sexual characters, and uterus seen on imaging:</strong> A <strong>functional or structural outflow obstruction</strong> (e.g., transverse vaginal septum or imperforate hymen) or <strong>constitutional delay of puberty</strong> is more likely. Karyotyping is not typically required.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A <strong>karyotype</strong> is necessary to differentiate between <strong>Mullerian agenesis (MRKH)</strong> and <strong>Androgen Insensitivity Syndrome (AIS)</strong> in a patient with primary amenorrhea, normal secondary sexual characteristics, and absence of Mullerian structures. These conditions have different genetic backgrounds (46,XX for MRKH and 46,XY for AIS), which guides appropriate management.</span></p>",
      "correct_choice_id": 91067,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 37147,
      "choices": [
        {
          "id": 148367,
          "text": "<p><span style=\"font-size:18px;\">Ceftriaxone</span></p>"
        },
        {
          "id": 148368,
          "text": "<p><span style=\"font-size:18px;\">Ceftriaxone plus azithromycin</span></p>"
        },
        {
          "id": 148369,
          "text": "<p><span style=\"font-size:18px;\">Clindamycin plus gentamicin</span></p>"
        },
        {
          "id": 148370,
          "text": "<p><span style=\"font-size:18px;\">Dicloxacillin</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 31-year-old woman, gravida 1 para 1, is seen in the hospital on postoperative day 2 due to lower abdominal pain, chills, and pain with sitting. She came to the hospital when she had no contractions a day after spontaneous rupture of membranes. After a 26-hour induction of labor, she had a primary cesarean delivery for arrest of descent. The breasts are full but have no erythema or fluctuant masses. The uterine fundus is firm and tender to palpation. There is scant serosanguineous drainage from the lower aspect of the incision. Pelvic examination shows a small amount of blood on the perineal pad with mildly foul-smelling discharge. Which of the following is the best regimen for treating this patient's condition?</span></p>",
      "unique_key": "Q1907623",
      "question_audio": null,
      "question_video": null,
      "map_id": 35160948,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. C) Clindamycin plus gentamicin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient has postpartum endometritis, a polymicrobial uterine infection that commonly occurs after cesarean delivery, especially following prolonged rupture of membranes and labor induction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key Clinical Features of Postpartum Endometritis:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Timing: Usually within 2–10 days after delivery</span></li><li><span style=\"font-size:14.0pt;\">Symptoms: Fever, chills, Lower abdominal or pelvic pain, Uterine tenderness on palpation, Foul-smelling lochia (vaginal discharge)</span></li><li><span style=\"font-size:14.0pt;\">Physical findings: Uterus firm (not boggy, ruling out atony) and tender; incision may show mild drainage but main source is uterine infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Causative Organisms:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Polymicrobial infection including:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Ureaplasma, Mycoplasma&nbsp;hominis</span></li><li><span style=\"font-size:14.0pt;\">Gardnerellavaginalis</span></li><li><span style=\"font-size:14.0pt;\">Peptostreptococcus, Bacteroides</span></li><li><span style=\"font-size:14.0pt;\">E. coli, Group B Streptococcus</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Because of this mixed aerobic and anaerobic flora, broad-spectrum coverage is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Treatment:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Empiric antibiotic regimen: Clindamycin + Gentamicin</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Rationale:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Clindamycin: Excellent coverage for anaerobes and gram-positive cocci.</span></li><li><span style=\"font-size:14.0pt;\">Gentamicin: Covers gram-negative organisms. This combination provides broad-spectrum coverage against nearly all common postpartum pathogens.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Continue IV therapy until the patient is afebrile for ≥24 hours and clinically improved.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Ceftriaxone:</strong> Covers mainly gram-negative and some gram-positive bacteria, but not anaerobes. Inadequate for polymicrobial uterine infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ceftriaxone plus azithromycin:</strong> Used for pelvic inflammatory disease (PID) caused by Neisseria gonorrhoeae and Chlamydia trachomatis, not postpartum endometritis. Fails to cover the typical postpartum anaerobic flora.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Dicloxacillin:</strong> Used for mastitis (Staphylococcus aureus), not uterine infection. No role in postpartum endometritis.</span></p>",
      "correct_choice_id": 148369,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 37141,
      "choices": [
        {
          "id": 148343,
          "text": "<p><span style=\"font-size:18px;\">Bartholin duct cyst</span></p>"
        },
        {
          "id": 148344,
          "text": "<p><span style=\"font-size:18px;\">Condylomata acuminata</span></p>"
        },
        {
          "id": 148345,
          "text": "<p><span style=\"font-size:18px;\">Gartner duct cyst</span></p>"
        },
        {
          "id": 148346,
          "text": "<p><span style=\"font-size:18px;\">Hematoma</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 22-year-old woman comes to the clinic for a routine examination. She is a gymnast. Three months ago, she sustained a vulvar contusion during a competition but otherwise she has been healthy. The patient is sexually active with a male partner and uses an intrauterine device for contraception. She does not use tobacco, alcohol, or illicit drugs. Examination shows a mobile, soft, nontender, flesh-coloured, 2-cm cystic mass at the 4 o'clock position at the base of the left labium majus. Which of the following is the most likely diagnosis for this patient?</span></p>",
      "unique_key": "Q3166789",
      "question_audio": null,
      "question_video": null,
      "map_id": 35161049,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) Bartholin duct cyst</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Bartholin duct cyst is the most likely diagnosis based on:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Location: 4 o’clock or 8 o’clock position on the posterior aspect of the vaginal introitus (base of labium majus)</span></li><li><span style=\"font-size:14.0pt;\">Character: Soft, mobile, cystic, and usually non-tender unless infected</span></li><li><span style=\"font-size:14.0pt;\">Size: Often 1–4 cm</span></li><li><span style=\"font-size:14.0pt;\">Cause: Obstruction of the Bartholin gland duct, leading to retention of glandular secretions and cyst formation</span></li><li><span style=\"font-size:14.0pt;\">Predisposing factors: Trauma or inflammation (in this case, vulvar contusion could have blocked the duct)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pathophysiology: Bartholin glands (paired glands) are located at 4 and 8 o’clock positions of the vaginal opening. Their ducts open into the vestibule and provide lubrication during sexual activity. Trauma, inflammation, or infection can block the duct → accumulation of mucus → Bartholin duct cyst. If infected, it can form a Bartholin abscess (tender, erythematous, fluctuant swelling).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_0vnzJEN.png\" width=\"469\" height=\"319\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Condylomata acuminata:</strong> Caused by Human Papillomavirus (HPV 6, 11). Appear as multiple, firm, cauliflower-like or verrucous growths, not cystic or fluid-filled. Usually on the vulva, perineum, or anus, not localized to a single cystic lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Gartner duct cyst:</strong> Remnant of the Wolffian (mesonephric) duct. Located on the lateral wall of the vagina, not at the labial base. Typically felt as a cyst along the anterolateral vaginal wall, superior to the Bartholin glands.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hematoma:</strong> Occurs acutely after trauma with painful, tender, and often discolored swelling. This patient’s mass is nontender and chronic (3 months), excluding a hematoma.</span></p>",
      "correct_choice_id": 148343,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95049,
      "choices": [
        {
          "id": 378384,
          "text": "<p><span style=\"font-size:14.0pt;\">Fractional curettage of the endometrium and endocervix</span></p>"
        },
        {
          "id": 378385,
          "text": "<p><span style=\"font-size:14.0pt;\">Dilatation and curettage of the endometrium</span></p>"
        },
        {
          "id": 378386,
          "text": "<p><span style=\"font-size:14.0pt;\">Hysterectomy</span></p>"
        },
        {
          "id": 378387,
          "text": "<p><span style=\"font-size:14.0pt;\">Hysteroscopic inspection and selective biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 56 year old post-menopausal woman presents with irregular vaginal bleeding for the past 4 months. On transvaginal ultrasound, the endometrial thickness is 2 mm but a focal area shows 6 mm of endometrial thickness. Which of the following is the next best step to diagnose the cause of bleeding in this patient?</span></p>",
      "unique_key": "Q7955047",
      "question_audio": null,
      "question_video": null,
      "map_id": 35161090,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Hysteroscopic inspection and selective biopsy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a postmenopausal woman with vaginal bleeding, evaluation aims to rule out endometrial carcinoma or focal intrauterine pathology (like a polyp or submucosal fibroid).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">On TVS, a uniform endometrial thickness ≤4 mm generally excludes malignancy. However, when there is a focal area of thickening (e.g., localized 6 mm region), it indicates asymmetric pathology, which requires targeted evaluation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hence, the best diagnostic approach is hysteroscopic inspection with selective biopsy, allowing:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Direct visualization of the uterine cavity.</span></li><li><span style=\"font-size:14.0pt;\">Precise biopsy of the suspicious area (unlike blind sampling).</span></li><li><span style=\"font-size:14.0pt;\">Diagnosis of focal lesions (e.g., polyps, carcinoma in situ).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fractional curettage:</strong> It is a blind procedure; the curette may miss a small focal lesion. Suitable for diffuse endometrial thickening, not focal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Dilatation and curettage:</strong> Also, a blind method and often misses focal pathologies such as polyps or focal hyperplasia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hysterectomy:</strong> Therapeutic, not diagnostic. Performed only after histological confirmation of malignancy or atypical hyperplasia.</span></p>",
      "correct_choice_id": 378387,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6042,
      "choices": [
        {
          "id": 24138,
          "text": "<p><span style=\"font-size:18px;\">4 contractions in 20 min and 8 contractions in 60 min with changes in cervix</span></p>"
        },
        {
          "id": 24139,
          "text": "<p><span style=\"font-size:18px;\">Cervical dilatation &gt; 2 cm</span></p>"
        },
        {
          "id": 24140,
          "text": "<p><span style=\"font-size:18px;\">More than 80 percent effaced cervix</span></p>"
        },
        {
          "id": 24141,
          "text": "<p><span style=\"font-size:18px;\">Cervix posterior in position</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">All of the following are the diagnostic criteria for preterm labor except?</span></p>",
      "unique_key": "Q2472082",
      "question_audio": null,
      "question_video": null,
      "map_id": 35161091,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Cervix posterior in position</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Preterm labor (PTL) is labor that occurs before the 37th week of gestation. Accurate diagnosis involves evaluating several key criteria:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Contractions:</strong> At least one regular contraction every 10 minutes, or 4 contractions in 20 minutes, or 8 contractions in 60 minutes, with or without pain.</span></li><li><span style=\"font-size:18px;\"><strong>Cervical Changes:</strong> Cervical dilation greater than 2 cm and more than 80% effacement are significant indicators of preterm labor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">The incorrect statement is <strong>Option D</strong>. A cervix that is posterior in position is not a diagnostic criterion for preterm labor. Instead, the cervix's position may be less relevant than its dilation and effacement in the diagnosis of preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. 4 contractions in 20 min and 8 contractions in 60 min with changes in cervix:</strong> Correct. Regular contractions that meet the criteria of 4 in 20 minutes or 8 in 60 minutes, along with changes in the cervix, are used to diagnose preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Cervical dilatation &gt; 2 cm:</strong> Correct. Cervical dilation greater than 2 cm is a diagnostic criterion for preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. More than 80 percent effaced cervix:</strong> Correct. Cervical effacement greater than 80% is another diagnostic criterion for preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The cervix being in a posterior position is not a diagnostic criterion for preterm labor. The diagnosis involves assessing contraction patterns and cervical changes such as dilation and effacement.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Ref: Page no 366, DC Dutta’s Textbook of Obstetrics, 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95050,
      "choices": [
        {
          "id": 378388,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 378389,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2</span></p>"
        },
        {
          "id": 378390,
          "text": "<p><span style=\"font-size:14.0pt;\">3, 4</span></p>"
        },
        {
          "id": 378391,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">Identify the correct statements:</span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:18px;\">During the 1st stage of labor, pain is mediated by spinal segments T10 to L1.</span></li><li><span style=\"font-size:18px;\">The WHO recommends a minimum of 8 antenatal visits to improve pregnancy outcomes.&nbsp;</span></li><li><span style=\"font-size:18px;\">Gestational age is calculated from the last day of the last menstrual period (LMP).</span></li><li><span style=\"font-size:18px;\">Bleeding diathesis is the most common cause of menorrhagia in puberty.</span></li></ol>",
      "unique_key": "Q8458147",
      "question_audio": null,
      "question_video": null,
      "map_id": 35161512,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1: During the 1st stage of labor, pain is mediated by spinal segments T10 to L1.:</strong> In the first stage of labor, pain arises due to uterine contractions and cervical dilatation. The pain is visceral in nature and transmitted via afferent fibers accompanying sympathetic nerves from T10 to L1 spinal segments. In the second stage, pain is somatic, transmitted via pudendal nerve (S2–S4) due to distension of the vagina, pelvic floor, and perineum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2: The WHO recommends a minimum of 8 antenatal visits to improve pregnancy outcomes.:&nbsp;</strong>According to the 2016 WHO Antenatal Care Model, a minimum of 8 antenatal contacts is recommended. This replaced the earlier recommendation of 4 visits under the Focused Antenatal Care (FANC) model. The new model aims to improve maternal and fetal outcomes through more frequent monitoring and counseling.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3: Gestational age is calculated from the last day of the last menstrual period (LMP).:&nbsp;</strong>Gestational age is calculated from the first day of the last menstrual period (LMP), not the last day. Ovulation and fertilization typically occur about 14 days after the first day of LMP. Therefore, gestational age includes roughly two extra weeks before conception.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4: Bleeding diathesis is the most common cause of menorrhagia in puberty.:&nbsp;</strong>The most common cause of menorrhagia in puberty is anovulatory cycles due to immature hypothalamic-pituitary-ovarian axis. Bleeding diathesis (e.g., von Willebrand disease) can cause menorrhagia but is not the most common cause — it accounts for around 10–20% of cases in adolescents.</span></p>",
      "correct_choice_id": 378389,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95051,
      "choices": [
        {
          "id": 378392,
          "text": "<p><span style=\"font-size:14.0pt;\">Debulking followed by radiotherapy</span></p>"
        },
        {
          "id": 378393,
          "text": "<p><span style=\"font-size:14.0pt;\">Debulking followed by chemotherapy</span></p>"
        },
        {
          "id": 378394,
          "text": "<p><span style=\"font-size:14.0pt;\">Chemotherapy followed by debulking</span></p>"
        },
        {
          "id": 378395,
          "text": "<p><span style=\"font-size:14.0pt;\">Staging laparotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old woman with epithelial ovarian cancer with raised CA-125 and abdominal distension presents with the following CECT. What is the management?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img class=\"image_resized\" style=\"aspect-ratio:604/609;width:62.68%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ehAjVqP.png\" width=\"604\" height=\"609\"></span></p>",
      "unique_key": "Q4119730",
      "question_audio": null,
      "question_video": null,
      "map_id": 35161513,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Chemotherapy followed by debulking</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Interpretation of the CT: The scan shows diffuse peritoneal deposits and omental caking — characteristic of advanced epithelial ovarian carcinoma. There is also ascites, suggesting peritoneal dissemination.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Management principle:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For advanced ovarian cancer, the two accepted approaches are:</span></li></ul><ol><li><span style=\"font-size:14.0pt;\">Primary cytoreductive (debulking) surgery followed by adjuvant chemotherapy</span></li><li><span style=\"font-size:14.0pt;\">Neoadjuvant chemotherapy (NACT) followed by interval debulking surgery</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">However, when extensive disease is seen on imaging (as here), and optimal debulking (&lt;1 cm residual disease) is unlikely due to diffuse peritoneal spread, neoadjuvant chemotherapy is preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus:&nbsp; Initial chemotherapy (usually platinum + taxane-based).&nbsp;Followed by interval debulking surgery after 3 cycles if disease becomes operable.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Debulking followed by radiotherapy:</strong> Radiotherapy is not part of standard ovarian cancer treatment. Ovarian carcinoma primarily spreads transcoelomically; radiotherapy has a limited role.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Debulking followed by chemotherapy:</strong> Primary debulking is done only if disease is resectable. Here, diffuse omental/peritoneal spread indicates unresectable disease initially.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Staging laparotomy:</strong> Used for early-stage ovarian cancer to determine extent of spread. Not appropriate in advanced disseminated disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Management Algorithm:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_h8u2GLb.png\" width=\"469\" height=\"568\"></span></p>",
      "correct_choice_id": 378394,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95052,
      "choices": [
        {
          "id": 378396,
          "text": "<p><span style=\"font-size:14.0pt;\">Labetalol + MgSO4 + Expedite delivery</span></p>"
        },
        {
          "id": 378397,
          "text": "<p><span style=\"font-size:14.0pt;\">Labetalol + MgSO4 + Wait till 37 weeks</span></p>"
        },
        {
          "id": 378398,
          "text": "<p><span style=\"font-size:14.0pt;\">Labetalol + Corticosteroids + wait till 37 weeks</span></p>"
        },
        {
          "id": 378399,
          "text": "<p><span style=\"font-size:14.0pt;\">Labetalol + Corticosteroids + Expedite delivery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient presents at 36 weeks with chronic HTN and 3+ proteinuria. Her BP is 170/100 mmHg and she complains of headache and blurring of vision. What is the best management option?</span></p>",
      "unique_key": "Q9336211",
      "question_audio": null,
      "question_video": null,
      "map_id": 35161564,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Labetalol + MgSO4 + Expedite delivery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Diagnosis: Chronic hypertension with superimposed preeclampsia — indicated by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Known hypertension</span></li><li><span style=\"font-size:14.0pt;\">New onset proteinuria (3+)</span></li><li><span style=\"font-size:14.0pt;\">Severe features: BP ≥160/110 mmHg, headache, visual symptoms.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Management Principle:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In preeclampsia with severe features, the only definitive treatment is delivery, regardless of gestational age (≥34 weeks).</span></p><p><br><span style=\"font-size:14.0pt;\">At 36 weeks, fetal maturity is adequate, so delivery must be expedited.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Stepwise Management:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Control BP: Labetalol (IV or oral) is first-line antihypertensive in pregnancy. Target: &lt;160/110 mmHg, but maintain uteroplacental perfusion.</span></li><li><span style=\"font-size:14.0pt;\">Prevent eclampsia: Magnesium sulfate (MgSO₄) is given for seizure prophylaxis. Regimen: Pritchard or Zuspan regimen.</span></li><li><span style=\"font-size:14.0pt;\">Delivery: Immediate delivery is indicated (either induction or cesarean) after stabilization. No need to delay since fetus is near term (36 weeks).</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Labetalol + MgSO₄ + Wait till 37 weeks:</strong> Delay in delivery increases risk of eclampsia, placental abruption, and maternal complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Labetalol + Corticosteroids + Wait till 37 weeks:</strong> Corticosteroids for lung maturity are indicated before 34 weeks, not at 36 weeks. Waiting is unsafe in severe preeclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Labetalol + Corticosteroids + Expedite delivery:</strong> Corticosteroids unnecessary at this gestation; MgSO₄ is required for seizure prophylaxis.</span></p>",
      "correct_choice_id": 378396,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61525,
      "choices": [
        {
          "id": 245377,
          "text": "<p><span style=\"font-size:18px;\">Bladder outlet obstruction</span></p>"
        },
        {
          "id": 245378,
          "text": "<p><span style=\"font-size:18px;\">Detrusor overactivity</span></p>"
        },
        {
          "id": 245379,
          "text": "<p><span style=\"font-size:18px;\">Urethral hypermobility</span></p>"
        },
        {
          "id": 245380,
          "text": "<p><span style=\"font-size:18px;\">Vesicovaginal fistula</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 49-year-old woman, gravida 5 para 5, comes to the OPD due to involuntary, intermittent loss of urine over the past 5 months. The patient loses a small amount of urine when asked to cough. She has no dysuria, urgency, or hematuria and usually awakens once a night to void.&nbsp; Postvoid residual urine volume is 40 mL. Which of the following is the most likely cause of this patient's symptoms?</span></p>",
      "unique_key": "Q4077191",
      "question_audio": null,
      "question_video": null,
      "map_id": 35161565,
      "difficulty_level": "beginner",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. C) Urethral hypermobility</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Diagnosis: Stress urinary incontinence (SUI) due to urethral hypermobility.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Seen in multiparous women with weakened pelvic floor and loss of urethral support.</span></li><li><span style=\"font-size:14.0pt;\">Mechanism: The pelvic floor and endopelvic fascia normally stabilize the proximal urethra. When these supports are weakened, increased intra-abdominal pressure (cough, sneeze, laugh) transiently exceeds urethral closing pressure → leakage of urine.</span></li><li><span style=\"font-size:14.0pt;\">Clinical features: Leakage only with exertion, coughing, or laughing. No urgency or nocturia. Normal postvoid residual volume</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Bladder outlet obstruction:</strong> Causes hesitancy, weak stream, incomplete emptying, and high residual volume, not intermittent leakage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Detrusor overactivity:</strong> Causes urge incontinence (sudden urge, cannot hold urine). Associated with frequency and nocturia, not stress triggers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Vesicovaginal fistula:</strong> Causes continuous, painless leakage of urine unrelated to activity. Common after pelvic surgery or prolonged labor, not intermittent or exertion-related.</span></p>",
      "correct_choice_id": 245379,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95053,
      "choices": [
        {
          "id": 378400,
          "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman who has undergone TAH+BSO</span></p>"
        },
        {
          "id": 378401,
          "text": "<p><span style=\"font-size:14.0pt;\">A 9-year-old girl who has Turner syndrome</span></p>"
        },
        {
          "id": 378402,
          "text": "<p><span style=\"font-size:14.0pt;\">A 47-year-old woman with hot flushes and history of breast cancer</span></p>"
        },
        {
          "id": 378403,
          "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old woman with a history of ischemic heart disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">HRT should be prescribed to which of the following patients?</span></p>",
      "unique_key": "Q5408798",
      "question_audio": null,
      "question_video": null,
      "map_id": 35161666,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) A 35-year-old woman who has undergone TAH+BSO</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Rationale: TAH + BSO (Total abdominal hysterectomy with bilateral salpingo-oophorectomy) at age 35 causes surgical menopause with abrupt estrogen withdrawal. This predisposes to severe vasomotor symptoms, osteoporosis, and cardiovascular risks if untreated. Hence, Hormone Replacement Therapy (HRT) with estrogen alone (since uterus is absent) is indicated until the natural menopausal age (~50 years).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Benefits: Relieves hot flushes, night sweats, vaginal dryness. Prevents osteoporosis and premature cardiovascular disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Turner syndrome:</strong> Requires pubertal induction with low-dose estrogen, not menopausal HRT. Managed under pediatric endocrinology protocols.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. History of breast cancer:</strong> Absolute contraindication to systemic estrogen therapy due to risk of recurrence. Use non-hormonal alternatives for symptom control.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Age 60 with ischemic heart disease:</strong> HRT should not be initiated after 60 years or in established cardiovascular disease due to increased thromboembolic and cardiac risk.</span></p>",
      "correct_choice_id": 378400,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95054,
      "choices": [
        {
          "id": 378404,
          "text": "<p><span style=\"font-size:14.0pt;\">B</span></p>"
        },
        {
          "id": 378405,
          "text": "<p><span style=\"font-size:14.0pt;\">D</span></p>"
        },
        {
          "id": 378406,
          "text": "<p><span style=\"font-size:14.0pt;\">E</span></p>"
        },
        {
          "id": 378407,
          "text": "<p><span style=\"font-size:14.0pt;\">F</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An investigator is studying the menstrual cycle in premenopausal female volunteers with normal ovarian function. Pap smear&nbsp;specimens are taken from each volunteer every 6 days for a month. Microscopic examination of one such specimen shows vaginal epithelial cells with deeply eosinophilic cytoplasm. These types of cells are most likely to be seen in which of the following points in the menstrual cycle?</span></p><p>&nbsp;</p><p><img class=\"image_resized\" style=\"aspect-ratio:656/439;width:69.02%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_2P94NsV.png\" width=\"656\" height=\"439\"></p>",
      "unique_key": "Q3289696",
      "question_audio": null,
      "question_video": null,
      "map_id": 35161728,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Graph interpretation: The graph shows hormonal fluctuations across the menstrual cycle. Point B corresponds to the late follicular (pre-ovulatory) phase — just before the LH surge and ovulation (around day 12–14). During this phase, estrogen levels are at their peak.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cellular Basis:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Estrogen dominance during the follicular phase stimulates proliferation and maturation of vaginal squamous epithelial cells.</span></li><li><span style=\"font-size:14.0pt;\">The superficial epithelial cells become large, polygonal, and have small pyknotic nuclei with abundant eosinophilic (acidophilic) cytoplasm — indicating high estrogen exposure.</span></li><li><span style=\"font-size:14.0pt;\">These are referred to as cornified or superficial cells, and they appear most prominently around ovulation (point B).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Phase-wise Cytologic Changes:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_julvhWr.png\" width=\"612\" height=\"290\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. D: </strong>Incorrect. Corresponds to the early luteal phase, dominated by progesterone. Vaginal cytology shows intermediate cells with basophilic cytoplasm — not eosinophilic.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. E: </strong>Incorrect. Mid-luteal phase; progesterone peak. Secretory endometrium, intermediate-type cells predominate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. F: </strong>Incorrect. End of the cycle, hormonal withdrawal; mixed cell population, not estrogenic pattern.</span></p>",
      "correct_choice_id": 378404,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84477,
      "choices": [
        {
          "id": 336480,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine artery → Arcuate artery → Radial artery → Basilar artery → Spiral artery</span></p>"
        },
        {
          "id": 336481,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine artery → Radial artery → Arcuate artery → Basilar artery → Spiral artery</span></p>"
        },
        {
          "id": 336482,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine artery → Arcuate artery → Basilar artery → Radial artery → Spiral artery</span></p>"
        },
        {
          "id": 336483,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine artery → Basilar artery → Arcuate artery → Radial artery → Spiral artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Arrange the following branches of the uterine artery in the correct sequence as they proceed towards the endometrium:</span></p>",
      "unique_key": "Q4591159",
      "question_audio": null,
      "question_video": null,
      "map_id": 35161779,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Uterine artery → Arcuate artery → Radial artery → Basilar artery → Spiral artery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The uterine artery is the main arterial supply to the uterus, arising from the internal iliac artery (anterior division). It traverses through the broad ligament and gives off a series of branches that penetrate the myometrium and supply the endometrium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Sequential branching pattern:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Uterine artery → runs along the lateral uterine wall within the broad ligament.</span></li><li><span style=\"font-size:14.0pt;\">Arcuate arteries → run circumferentially within the myometrium.</span></li><li><span style=\"font-size:14.0pt;\">Radial arteries → branch from arcuate arteries and penetrate the myometrium toward the endometrium.</span></li><li><span style=\"font-size:14.0pt;\">Basilar arteries → supply the stratum basale (basal layer) of the endometrium.</span></li><li><span style=\"font-size:14.0pt;\">Spiral arteries → extend into the stratum functionale, the superficial layer that proliferates and sheds during menstruation.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xsYAgWo.png\" width=\"469\" height=\"506\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Physiological importance: Spiral arteries are progesterone-sensitive and play a critical role in endometrial perfusion and implantation. During menstruation, these arteries undergo spasm and breakdown, leading to endometrial shedding. In pregnancy, they undergo trophoblastic remodeling to ensure low-resistance uteroplacental blood flow.</span></p>",
      "correct_choice_id": 336480,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 37134,
      "choices": [
        {
          "id": 148315,
          "text": "<p><span style=\"font-size:18px;\">Maternal beta blocker therapy</span></p>"
        },
        {
          "id": 148316,
          "text": "<p><span style=\"font-size:18px;\">Hypothermia</span></p>"
        },
        {
          "id": 148317,
          "text": "<p><span style=\"font-size:18px;\">Hypoglycemia</span></p>"
        },
        {
          "id": 148318,
          "text": "<p><span style=\"font-size:18px;\">Maternal fever</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 24-year-old primi is in labor. The baseline FHR is 110 bpm. All are possible causes for fetal bradycardia except:</span></p>",
      "unique_key": "Q9623393",
      "question_audio": null,
      "question_video": null,
      "map_id": 35161830,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Maternal fever</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Normal FHR: 110–160 beats per minute.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">FHR &lt;110 bpm for &gt;10 minutes = fetal bradycardia.</span></li><li><span style=\"font-size:14.0pt;\">Bradycardia may be due to maternal, fetal, or drug-related causes that decrease fetal oxygenation or vagal stimulation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Causes of Fetal Bradycardia:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">1. Maternal causes:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hypotension (e.g., after epidural or hemorrhage) → reduced uteroplacental flow</span></li><li><span style=\"font-size:14.0pt;\">Hypothermia → reduced fetal metabolism and heart rate</span></li><li><span style=\"font-size:14.0pt;\">Hypoglycemia → decreased fetal metabolic activity</span></li><li><span style=\"font-size:14.0pt;\">Drugs: Beta-blockers (e.g., labetalol, propranolol) → transplacental effect on fetal heart</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">2. Fetal causes:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hypoxia or acidosis (most common cause in labor)</span></li><li><span style=\"font-size:14.0pt;\">Umbilical cord compression or cord prolapse → vagal stimulation</span></li><li><span style=\"font-size:14.0pt;\">Congenital heart block (especially with maternal lupus or Sjögren’s syndrome — anti-Ro/SSA antibodies)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Option D (Maternal fever) is Incorrect: Maternal fever causes fetal tachycardia, not bradycardia. The mechanism: increased maternal and fetal metabolism → increased FHR (&gt;160 bpm). Commonly seen with chorioamnionitis or maternal infection.</span></p>",
      "correct_choice_id": 148318,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 37132,
      "choices": [
        {
          "id": 148307,
          "text": "<p><span style=\"font-size:18px;\">Anemia</span></p>"
        },
        {
          "id": 148308,
          "text": "<p><span style=\"font-size:18px;\">Hyperemesis gravidarum</span></p>"
        },
        {
          "id": 148309,
          "text": "<p><span style=\"font-size:18px;\">Normal pregnancy</span></p>"
        },
        {
          "id": 148310,
          "text": "<p><span style=\"font-size:18px;\">Preeclampsia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 32-year-old woman is evaluated at her 32nd week of pregnancy. Laboratory results are as follows:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Arterial pH: 7.45</span></p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">PaO2: 110 mm Hg</span></p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">PaCO2: 30 mm Hg</span></p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Bicarbonate: 20 mEq/L</span></p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Hemoglobin: 11 g/dL</span></p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Blood urea nitrogen:5 mg/dL</span></p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Creatinine: 0.6 mg/dL</span></p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Which of the following best explains this patient's status?</span></p>",
      "unique_key": "Q8744051",
      "question_audio": null,
      "question_video": null,
      "map_id": 35161881,
      "difficulty_level": "beginner",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. C) Normal pregnancy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These lab findings represent normal physiological changes in pregnancy.</span><br><span style=\"font-size:14.0pt;\">Let’s interpret each finding:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">1. Arterial blood gas (ABG) values:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">pH: 7.45 → slightly alkalotic but within normal range</span></li><li><span style=\"font-size:14.0pt;\">PaCO₂: 30 mmHg → low (normal 35–45 mmHg)</span></li><li><span style=\"font-size:14.0pt;\">HCO₃⁻: 20 mEq/L → compensatory decrease</span></li><li><span style=\"font-size:14.0pt;\">Interpretation: Chronic respiratory alkalosis with renal compensation</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Mechanism: In pregnancy, progesterone stimulates the respiratory center → mild hyperventilation → ↓ PaCO₂ → mild respiratory alkalosis. The kidneys compensate by excreting bicarbonate, maintaining near-normal pH.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">2. Hemoglobin (11 g/dL): Physiologic hemodilution (physiologic anemia of pregnancy) due to plasma volume expansion &gt; RBC mass increase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">3. PaO₂ (110 mmHg): Slightly higher than nonpregnant range (due to hyperventilation and increased alveolar ventilation).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">4. BUN (5 mg/dL) and Creatinine (0.6 mg/dL): Lowered due to increased renal plasma flow and GFR in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Anemia:</strong> Hb is 11 g/dL, which is normal for pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hyperemesis gravidarum:</strong> Causes metabolic alkalosis due to vomiting (↑ HCO₃⁻, not ↓).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Preeclampsia:</strong> Would show elevated BP, proteinuria, and often elevated creatinine, not low.</span></p>",
      "correct_choice_id": 148309,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95055,
      "choices": [
        {
          "id": 378408,
          "text": "<p><span style=\"font-size:14.0pt;\">Patient with Postpartum hemorrhage</span></p>"
        },
        {
          "id": 378409,
          "text": "<p><span style=\"font-size:14.0pt;\">Prior to the removal of Placenta accreta in Multiparous woman</span></p>"
        },
        {
          "id": 378410,
          "text": "<p><span style=\"font-size:14.0pt;\">Patient diagnosed with pedunculated submucous fibroids</span></p>"
        },
        {
          "id": 378411,
          "text": "<p><span style=\"font-size:14.0pt;\">Multiparous woman with menorrhagia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">You would consider uterine artery embolization as a treatment option in all of the following cases except:</span></p>",
      "unique_key": "Q3140187",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162072,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Patient diagnosed with pedunculated submucous fibroids</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Uterine artery embolization (UAE) is a minimally invasive interventional radiology procedure that involves occlusion of uterine arteries using embolic agents to reduce blood flow to the uterus or fibroid.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Indications:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Postpartum hemorrhage (PPH): Life-saving when medical management (uterotonics) fails. Controls bleeding while preserving the uterus.</span></li><li><span style=\"font-size:14.0pt;\">Placenta accreta: UAE may be done prophylactically before surgical removal to minimize intraoperative bleeding.</span></li><li><span style=\"font-size:14.0pt;\">Symptomatic uterine fibroids: For women with menorrhagia, bulk symptoms, or anemia who want to avoid surgery and are not seeking future fertility.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Contraindications:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pedunculated submucous fibroids (Option C.:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">These fibroids are attached by a stalk and lie partly within the uterine cavity.</span></li><li><span style=\"font-size:14.0pt;\">UAE is contraindicated because: The stalk’s vascular supply may thrombose and lead to fibroid detachment or expulsion, causing infection or sepsis. Poor response to embolization.</span></li><li><span style=\"font-size:14.0pt;\">Surgical removal (hysteroscopic myomectomy) is the treatment of choice.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Notes:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_1WPrHvc.png\" width=\"566\" height=\"126\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Conclusion:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">UAE is effective for diffuse uterine bleeding or intramural fibroids, but contraindicated in pedunculated submucous fibroids due to risk of infection and expulsion.</span></p>",
      "correct_choice_id": 378410,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 37109,
      "choices": [
        {
          "id": 148215,
          "text": "<p><span style=\"background-color:white;color:black;font-size:18px;\">Polyps</span></p>"
        },
        {
          "id": 148216,
          "text": "<p><span style=\"background-color:white;color:black;font-size:18px;\">Leiomyoma</span></p>"
        },
        {
          "id": 148217,
          "text": "<p><span style=\"background-color:white;color:black;font-size:18px;\">Adenomyosis</span></p>"
        },
        {
          "id": 148218,
          "text": "<p><span style=\"background-color:white;color:black;font-size:18px;\">Endometrial hyperplasia</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A woman presented to the clinic with heavy, painful menses that have worsened over the past year. On pelvic examination the uterus is enlarged and tender. USG is shown below. What is the most likely diagnosis?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/02/picture18_BEzpmKk.jpg\" alt=\"\" width=\"300\" height=\"243\"></span></p>",
      "unique_key": "Q7786908",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162073,
      "difficulty_level": "beginner",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"background-color:white;color:black;font-size:18px;\"><strong>Ans. C) Adenomyosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Adenomyosis is characterized by the presence of endometrial glands and stroma within the myometrium.</span></p><p><br><span style=\"font-size:14.0pt;\">This leads to diffuse uterine enlargement, dysmenorrhea, and menorrhagia due to cyclical bleeding within the myometrium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key Diagnostic Features:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clinical Findings:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Age group: Typically multiparous women aged 35–50 years.</span></li><li><span style=\"font-size:14.0pt;\">Symptoms:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Heavy, prolonged menstrual bleeding (menorrhagia)</span></li><li><span style=\"font-size:14.0pt;\">Painful menstruation (secondary dysmenorrhea)</span></li><li><span style=\"font-size:14.0pt;\">Diffuse uterine tenderness and enlargement (“boggy uterus”)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ultrasound Findings (as in the image):</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Diffuse thickening of the myometrium</span></li><li><span style=\"font-size:14.0pt;\">Heterogeneous echotexture</span></li><li><span style=\"font-size:14.0pt;\">Fan-shaped / “Venetian blind” acoustic shadowing</span></li><li><span style=\"font-size:14.0pt;\">Poorly defined endo-myometrial junction</span></li><li><span style=\"font-size:14.0pt;\">Small myometrial cysts (due to trapped endometrial glands)</span></li><li><span style=\"font-size:14.0pt;\">No well-defined mass, unlike leiomyoma</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pathophysiology: Caused by invasion of endometrial tissue into the myometrium through the basal layer of the endometrium. Leads to myometrial hypertrophy and increased uterine size. Estrogen-dependent condition, often coexisting with endometriosis or fibroids.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Polyps:</strong> Focal endometrial overgrowths. Cause intermenstrual spotting or irregular bleeding, not diffuse uterine tenderness or enlargement. USG shows focal echogenic mass within endometrial cavity, not diffuse myometrial heterogeneity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Leiomyoma:</strong> Benign smooth muscle tumor (fibroid). Uterus is firm, irregular, often non-tender. Ultrasound shows well-defined hypoechoic mass with acoustic shadowing, unlike diffuse pattern in adenomyosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Endometrial hyperplasia:</strong> Caused by unopposed estrogen stimulation. Presents with irregular or postmenopausal bleeding, not pain. Uterus is normal in size; USG shows uniformly thickened endometrium.</span></p>",
      "correct_choice_id": 148217,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 37101,
      "choices": [
        {
          "id": 148183,
          "text": "<p><span style=\"font-size:18px;\">Fetal congenital infection</span></p>"
        },
        {
          "id": 148184,
          "text": "<p><span style=\"font-size:18px;\">Maternal dehydration</span></p>"
        },
        {
          "id": 148185,
          "text": "<p><span style=\"font-size:18px;\">Normal gestational age variant</span></p>"
        },
        {
          "id": 148186,
          "text": "<p><span style=\"font-size:18px;\">Rupture of membranes</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 39-year-old woman, gravida 2 para 1, at 38 weeks gestation, comes to the office for a routine prenatal visit. The patient feels well and reports normal fetal activity. Last week, she had nausea, vomiting, and diarrhea for 24 hours, but she has been able to eat and drink normally for the past several days. For the past 2 days, the patient has had increased clear vaginal discharge with irregular, painful contractions but no vaginal bleeding. Temperature is 99.6°F (37.6°C), blood pressure is 132/86 mm Hg, and pulse is 96/ min. The uterus is nontender and the fundal height is 34 cm. Fetal heart tones are 135/ min. Fetal ultrasound shows a cephalic fetus, measuring at the 50th percentile for gestational age, and an amniotic fluid index of 2 cm (normal: &gt;5 cm). Which of the following is the most likely cause of this patient's amniotic fluid level?</span></p>",
      "unique_key": "Q2365238",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162094,
      "difficulty_level": "beginner",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Rupture of membranes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Diagnosis:&nbsp; Rupture of membranes (ROM) resulting in oligohydramnios.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key Reasoning:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">History of clear vaginal fluid leakage → strongly suggests amniotic fluid loss.</span></li><li><span style=\"font-size:14.0pt;\">AFI of 2 cm → diagnostic of oligohydramnios.</span></li><li><span style=\"font-size:14.0pt;\">Uterus smaller than expected (fundal height 34 cm at 38 weeks) → due to loss of amniotic fluid volume.</span></li><li><span style=\"font-size:14.0pt;\">Fetus with normal growth and heart rate → no placental insufficiency or infection.</span></li><li><span style=\"font-size:14.0pt;\">Nontender uterus, afebrile → no chorioamnionitis or abruption.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, prelabor rupture of membranes (PROM) is the most likely cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pathophysiology: Amniotic fluid is produced mainly by fetal urine and resorbed by fetal swallowing. When membranes rupture, fluid leaks through the cervix and vagina. Leads to decreased AFI (&lt;5 cm) and risk of cord compression or infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Supporting Clinical Features:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_MmgJ9tJ.png\" width=\"525\" height=\"168\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fetal congenital infection:</strong> Causes hydrops fetalis, hepatosplenomegaly, or polyhydramnios, not isolated oligohydramnios.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Maternal dehydration:</strong> May cause mild, transient oligohydramnios, but would resolve after rehydration. The patient is currently well hydrated and has persistent low AFI with fluid leakage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Normal gestational age variant:</strong> AFI normally decreases slightly late in pregnancy but never to 2 cm. AFI &lt;5 cm is pathologic and requires evaluation for ROM or placental insufficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Confirmatory Tests for Rupture of Membranes:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Speculum examination: Pooling of clear fluid in posterior fornix.</span></li><li><span style=\"font-size:14.0pt;\">Nitrazine test: Turns blue (alkaline) due to amniotic fluid pH (~7.0–7.5).</span></li><li><span style=\"font-size:14.0pt;\">Fern test: Microscopic “fern-like” pattern due to crystallized amniotic fluid.</span></li><li><span style=\"font-size:14.0pt;\">Ultrasound: Confirms low AFI consistent with fluid loss.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Management:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">At term (≥37 weeks): Induce labor to prevent infection.</span></li><li><span style=\"font-size:14.0pt;\">At 34–36 weeks: Consider delivery after assessing fetal lung maturity.</span></li><li><span style=\"font-size:14.0pt;\">At &lt;34 weeks: Conservative management with corticosteroids and antibiotics if no infection.</span></li></ul>",
      "correct_choice_id": 148186,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 69912,
      "choices": [
        {
          "id": 278725,
          "text": "<p><span style=\"font-size:14.0pt;\">GnRH high, FSH low, Estrogen low</span></p>"
        },
        {
          "id": 278726,
          "text": "<p><span style=\"font-size:14.0pt;\">GnRH low, FSH low, Estrogen low</span></p>"
        },
        {
          "id": 278727,
          "text": "<p><span style=\"font-size:14.0pt;\">GnRH high, FSH high, Estrogen high</span></p>"
        },
        {
          "id": 278728,
          "text": "<p><span style=\"font-size:14.0pt;\">GnRH high, FSH high, Estrogen low</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old woman comes to the emergency department due to an acute episode of heavy menstrual bleeding. The patient has a history of menorrhagia, with monthly cycles lasting 7-10 days and brisk blood flow with the passage of large clots. Pelvic examination reveals an enlarged fibroid uterus, and she is found to have significant anemia due to blood loss. The patient is prescribed continuous leuprolide therapy. After several weeks, which of the following sustained hormonal changes are expected to have occurred as a result of the treatment?</span></p>",
      "unique_key": "Q8671833",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162185,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) GnRH low, FSH low, Estrogen low</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Step 1: Diagnosis — Uterine fibroids (leiomyoma)</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Common cause of menorrhagia with clots and uterine enlargement.</span></li><li><span style=\"font-size:14.0pt;\">Estrogen-dependent tumor — shrinks with hypoestrogenic states (e.g., menopause or GnRH analog therapy).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Step 2: Mechanism of Leuprolide</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Leuprolide is a GnRH agonist (a synthetic analog of gonadotropin-releasing hormone). Its effect depends on administration pattern:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_T5BISxA.png\" width=\"677\" height=\"172\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Step 3: Phases of Action</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Initial phase (“flare”): Short-term increase in LH, FSH, and estrogen due to pituitary stimulation.</span></li><li><span style=\"font-size:14.0pt;\">Sustained phase (after 2–4 weeks): Continuous exposure leads to desensitization and downregulation of GnRH receptors in the anterior pituitary. Result: Suppression of gonadotropins (FSH, LH) → reduced ovarian estrogen production.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Step 4: Hormonal Pattern (after several weeks):</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_DiMm2kd.png\" width=\"677\" height=\"138\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hence: GnRH low, FSH low, Estrogen low</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Step 5: Clinical Utility in This Case- Fibroids (leiomyoma): Estrogen promotes growth → suppressing estrogen shrinks fibroids and reduces bleeding. Short-term use (≤6 months) is effective for preoperative correction of anemia and reducing uterine volume. Long-term use causes menopausal side effects (hot flashes, vaginal dryness, bone loss).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. GnRH high, FSH low, Estrogen low:</strong> GnRH secretion itself is not reduced; rather, its effect is blocked by receptor downregulation. Functionally, pituitary \"perceives\" low GnRH activity → similar to a low GnRH state.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. GnRH high, FSH high, Estrogen high:</strong> Represents the initial flare phase, not the sustained effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. GnRH high, FSH high, Estrogen low:</strong> Impossible combination; persistent FSH elevation would maintain estrogen production.</span></p>",
      "correct_choice_id": 278726,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73713,
      "choices": [
        {
          "id": 293793,
          "text": "<p><span style=\"font-size:14.0pt;\">Pomeroy's technique</span></p>"
        },
        {
          "id": 293794,
          "text": "<p><span style=\"font-size:14.0pt;\">Salpingectomy</span></p>"
        },
        {
          "id": 293795,
          "text": "<p><span style=\"font-size:14.0pt;\">Tubal recanalization</span></p>"
        },
        {
          "id": 293796,
          "text": "<p><span style=\"font-size:14.0pt;\">Parkland procedure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Identify the procedure shown:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_c3jedKp.png\" width=\"794\" height=\"613\"></p>",
      "unique_key": "Q4130378",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162186,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Pomeroy's technique</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Procedure: The Pomeroy’s technique is the most commonly performed method of female tubal sterilization (tubal ligation). It is typically performed postpartum or as an interval procedure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Steps of Pomeroy’s Technique:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">A loop (knuckle) of the fallopian tube is lifted up with a Babcock’s forceps.</span></li><li><span style=\"font-size:14.0pt;\">The base of the loop is ligated using an absorbable suture (usually plain catgut or chromic catgut).</span></li><li><span style=\"font-size:14.0pt;\">The tubal segment above the ligature is then excised.</span></li><li><span style=\"font-size:14.0pt;\">The cut ends retract away from each other as the ligature dissolves, minimizing chances of recanalization.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Type of sterilization: Tubal ligation (female sterilization).</span></li><li><span style=\"font-size:14.0pt;\">Site: Ampullary–isthmic junction of the fallopian tube.</span></li><li><span style=\"font-size:14.0pt;\">Material: Absorbable suture (plain catgut).</span></li><li><span style=\"font-size:14.0pt;\">Failure rate: Approximately 1–2 per 1000 procedures (very low).</span></li><li><span style=\"font-size:14.0pt;\">Reversibility: Difficult, but recanalization is sometimes possible if enough tubal length remains.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Salpingectomy:</strong> Involves complete removal of the fallopian tube, not just ligation and excision of a loop. Done in cases of ectopic pregnancy, hydrosalpinx, or risk reduction for ovarian cancer, not for contraception.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tubal recanalization:</strong> A reconstructive procedure to restore fertility by rejoining previously ligated tubes. Opposite of Pomeroy’s ligation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Parkland procedure:</strong> Also, a tubal ligation method, but differs in technique:&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">The tube is doubly ligated and a segment excised without forming a loop.</span></p><p><span style=\"font-size:14.0pt;\">Two separate ligatures are applied 1–2 cm apart, and the intervening segment is removed. Commonly used during cesarean section.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_WFK0ia8.png\" width=\"471\" height=\"481\"></span></p>",
      "correct_choice_id": 293793,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 37077,
      "choices": [
        {
          "id": 148087,
          "text": "<p><span style=\"font-size:18px;\">Induction of labor</span></p>"
        },
        {
          "id": 148088,
          "text": "<p><span style=\"font-size:18px;\">Corticosteroids followed by induction of labor</span></p>"
        },
        {
          "id": 148089,
          "text": "<p><span style=\"font-size:18px;\">Start Labetalol and immediate LSCS</span></p>"
        },
        {
          "id": 148090,
          "text": "<p><span style=\"font-size:18px;\">Induction of labor at 37 weeks</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 23-year primi came to the emergency department at 35 weeks of pregnancy with pedal edema and BP of 140/90 mmHg. The urine dipstick was 2+. Her investigations are listed below. Hb – 9.2g%, RBS – 123, SGOT – 250, SGPT- 300, Creatinine-0.7, platelet: 50000. What is the next best step?</span></p>",
      "unique_key": "Q9869287",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162277,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) Induction of labor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Diagnosis:&nbsp; Severe preeclampsia with features of HELLP syndrome.</span></p><p><span style=\"font-size:14.0pt;\">Justification:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">BP ≥140/90 mmHg with proteinuria (2+) → Preeclampsia.</span></li><li><span style=\"font-size:14.0pt;\">AST/ALT markedly elevated → Hepatic involvement.</span></li><li><span style=\"font-size:14.0pt;\">Platelet count &lt;100,000/mm³ → Thrombocytopenia.</span></li><li><span style=\"font-size:14.0pt;\">Together, these findings fulfill criteria for HELLP syndrome:</span></li><li><span style=\"font-size:14.0pt;\">Hemolysis</span></li><li><span style=\"font-size:14.0pt;\">Elevated Liver enzymes</span></li><li><span style=\"font-size:14.0pt;\">Low Platelets</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Stepwise Clinical Reasoning:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Gestational age = 35 weeks (near term).</span></li><li><span style=\"font-size:14.0pt;\">HELLP syndrome = life-threatening complication of preeclampsia.</span></li><li><span style=\"font-size:14.0pt;\">The only definitive treatment = delivery, regardless of gestational age.</span></li><li><span style=\"font-size:14.0pt;\">Induction of labor is preferred if: Cervix is favorable. Mother and fetus are stable</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Therefore: Immediate delivery (induction of labor) is indicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Corticosteroids followed by induction of labor:</strong> Steroids for fetal lung maturity are useful &lt;34 weeks. Here, the patient is 35 weeks — lungs are mature enough, and delaying delivery increases maternal risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Start Labetalol and immediate LSCS:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">LSCS (Caesarean section) is indicated only if: There is fetal distress. Unfavorable cervix with urgent need for delivery. Failed induction</span></li><li><span style=\"font-size:14.0pt;\">Here, BP is only mildly elevated, and patient can be induced safely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Induction at 37 weeks:</strong> Waiting is unsafe in HELLP syndrome — it can rapidly progress to DIC, liver rupture, or maternal death. Delivery must be done immediately, not delayed.</span></p>",
      "correct_choice_id": 148087,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33243,
      "choices": [
        {
          "id": 132818,
          "text": "<p><span style=\"font-size:14.0pt;\">Try to slip the cords over the fetal head</span></p>"
        },
        {
          "id": 132819,
          "text": "<p><span style=\"font-size:14.0pt;\">Deliver the anterior shoulder immediately</span></p>"
        },
        {
          "id": 132820,
          "text": "<p><span style=\"font-size:14.0pt;\">Clamp the cord, cut it and unwind it from around the fetal neck</span></p>"
        },
        {
          "id": 132821,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediately call for help</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">You are an intern and are conducting delivery of a 24-year G2P1. The head is delivered and undergoes restitution and external rotation. When you attempt to deliver the anterior shoulder, you notice that there are 2 tight loops of cord around the neck. What is the next best step?</span></p>",
      "unique_key": "Q2367802",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162378,
      "difficulty_level": "difficult",
      "subjects_id": [
        14,
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Clamp the cord, cut it and unwind it from around the fetal neck</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The presence of <strong>tight loops of the umbilical cord around the fetal neck</strong> (nuchal cord) can pose a risk to the fetus during delivery due to compression of the cord and reduced blood flow. In this case, you have already observed <strong>two tight loops</strong> around the fetal neck, which may hinder the delivery of the shoulders and risk fetal blood loss if not addressed promptly.</span></p><p><span style=\"font-size:14.0pt;\">The appropriate and immediate step in this situation is to <strong>clamp the cord</strong> in two places, <strong>cut it</strong>, and then <strong>unwind it from around the neck</strong> to avoid tension on the cord and prevent fetal blood loss. This ensures that the delivery can proceed safely without further complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Try to slip the cords over the fetal head:&nbsp;</strong>This approach can be considered for <strong>loose loops</strong> of cord around the neck, which can often be slipped over the head without much difficulty. However, in this case, the loops are described as tight, and attempting to slip them over could be dangerous or ineffective.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Deliver the anterior shoulder immediately:&nbsp;</strong>Attempting to deliver the anterior shoulder without addressing the tight loops of cord could cause excessive tension on the cord, leading to cord rupture or fetal blood loss. This is not recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Immediately call for help:&nbsp;</strong>While calling for help in a complicated delivery scenario is always a good step, in this situation, the best immediate action is to <strong>clamp, cut, and unwind the cord</strong>, as delaying to wait for help could put the fetus at risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In the presence of <strong>tight loops of the umbilical cord</strong> around the fetal neck during delivery, the correct action is to <strong>clamp, cut, and unwind</strong> the cord to avoid complications such as fetal blood loss or cord snapping. This allows for a safe delivery to proceed.</span></p>",
      "correct_choice_id": 132820,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73779,
      "choices": [
        {
          "id": 294057,
          "text": "<p><span style=\"font-size:14.0pt;\">1</span></p>"
        },
        {
          "id": 294058,
          "text": "<p><span style=\"font-size:14.0pt;\">2</span></p>"
        },
        {
          "id": 294059,
          "text": "<p><span style=\"font-size:14.0pt;\">7</span></p>"
        },
        {
          "id": 294060,
          "text": "<p><span style=\"font-size:14.0pt;\">14</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old P2L2 is taking “Chhaya” for contraception. She has been taking it for 9 months. She reports to you that she has missed taking the pill for the last 2 weeks as she had been traveling and forgot to carry the pill with her. How many tablets has she missed?</span></p>",
      "unique_key": "Q3482175",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162379,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Chhaya: A centchroman (Ormeloxifene) tablet — a non-hormonal, selective estrogen receptor modulator (SERM) used for contraception. It is not a daily pill, unlike combined oral contraceptives.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Dosing Schedule of “Chhaya”:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">1 tablet twice weekly for the first 3 months (every 3 days).</span></li><li><span style=\"font-size:14.0pt;\">Then 1 tablet once weekly thereafter for maintenance.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Interpretation: The woman is in her 9th month of use → she is on maintenance phase (1 tablet per week). She has missed 2 weeks of doses → 1 tablet per week × 2 weeks = 2 tablets missed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 1:</strong> Would be correct if she missed only 1 week.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. 7 &amp; Option D. 14: Incorrect.</strong> because Chhaya is not taken daily; it’s a weekly regimen, not a daily contraceptive pill.</span></p>",
      "correct_choice_id": 294058,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73715,
      "choices": [
        {
          "id": 293801,
          "text": "<p><span style=\"font-size:14.0pt;\">Obtain a trans vaginal ultrasound</span></p>"
        },
        {
          "id": 293802,
          "text": "<p><span style=\"font-size:14.0pt;\">Obtain a KUB radiograph&nbsp;</span></p>"
        },
        {
          "id": 293803,
          "text": "<p><span style=\"font-size:14.0pt;\">Attempt IUD removal by means of an IUD hook or long artery forceps</span></p>"
        },
        {
          "id": 293804,
          "text": "<p><span style=\"font-size:14.0pt;\">Continue the exam by twirling a cytologic brush in her endocervical canal</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Ms. T visits the OPD for a routine check. She has a Copper containing IUD inserted 6 months back and is concerned as she cannot feel the thread. Her LMP was 2 weeks back. On speculum examination you see the picture below. Which of the following is the most appropriate next step?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_c4NFK3z.png\" alt=\"Close-up of a human mouth\r\n\r\nAI-generated content may be incorrect.\" width=\"473\" height=\"372\"></span></p>",
      "unique_key": "Q7560836",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162380,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)&nbsp;Obtain a trans vaginal ultrasound</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical situation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient’s IUD strings are not visible — a missing IUD thread situation.</span></li><li><span style=\"font-size:14.0pt;\">The possible causes include:</span></li></ul><ol><li><span style=\"font-size:14.0pt;\">Strings curled up in the cervical canal.</span></li><li><span style=\"font-size:14.0pt;\">Expulsion of IUD.</span></li><li><span style=\"font-size:14.0pt;\">Pregnancy with IUD in situ.</span></li><li><span style=\"font-size:14.0pt;\">Perforation with IUD migration into the peritoneal cavity.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Stepwise Management Algorithm for Missing IUD Strings:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 1: </strong>Rule out pregnancy</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Obtain urine β-hCG test → if positive, manage as per pregnancy with IUD.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Step 2:</strong> Transvaginal ultrasound (TVS)</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Most appropriate first investigation for locating the IUD.</span></li><li><span style=\"font-size:14.0pt;\">TVS can confirm whether: IUD is in the uterine cavity (proper position or displaced), Expelled, or Perforated through the uterine wall.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Findings and Further Management:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_46thCEi.png\" width=\"615\" height=\"194\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Obtain a KUB radiograph:</strong> Only indicated after TVS fails to visualize the IUD, to locate an extrauterine IUD (e.g., perforation into peritoneal cavity).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Attempt IUD removal with IUD hook or artery forceps:</strong> Should not be done blindly — risk of uterine or cervical trauma. Only appropriate after confirming intrauterine location by imaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cytologic brush to locate threads:</strong> Gentle brushing may be tried if ultrasound confirms intrauterine IUD, but not before confirming its position. Here, TVS is the safest next step.</span></p>",
      "correct_choice_id": 293801,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84529,
      "choices": [
        {
          "id": 336688,
          "text": "<p><span style=\"font-size:14.0pt;\">Cyclooxygenase inhibitor</span></p>"
        },
        {
          "id": 336689,
          "text": "<p><span style=\"font-size:14.0pt;\">PG analogue</span></p>"
        },
        {
          "id": 336690,
          "text": "<p><span style=\"font-size:14.0pt;\">Oxytocin receptor agonist</span></p>"
        },
        {
          "id": 336691,
          "text": "<p><span style=\"font-size:14.0pt;\">Progesterone antagonist</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is the mechanism of action of the first drug used in the regimen of medical MTP in first trimester?</span></p>",
      "unique_key": "Q4672651",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162431,
      "difficulty_level": "beginner",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Progesterone antagonist</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Medical abortion regimen (≤9 weeks gestation):</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Step 1: Mifepristone (RU-486) — Progesterone receptor antagonist</span></li><li><span style=\"font-size:14.0pt;\">Step 2: Misoprostol — Prostaglandin E1 analogue (given 24–48 hours later)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Mechanism of Mifepristone (First Drug):</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mifepristone blocks progesterone receptors in the uterus and decidua.</span></li><li><span style=\"font-size:14.0pt;\">Progesterone is essential for maintaining pregnancy — it keeps the endometrium intact and suppresses uterine contractions.</span></li><li><span style=\"font-size:14.0pt;\">By antagonizing progesterone, mifepristone causes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Decidual necrosis</span></li><li><span style=\"font-size:14.0pt;\">Detachment of the gestational sac</span></li><li><span style=\"font-size:14.0pt;\">Cervical softening</span></li><li><span style=\"font-size:14.0pt;\">Increased uterine sensitivity to prostaglandins</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These effects prepare the uterus for expulsion of products when misoprostol (a prostaglandin analogue) is administered.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cyclooxygenase inhibitor:</strong> NSAIDs inhibit prostaglandin synthesis, which would prevent uterine contractions, not induce abortion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. PG analogue:</strong> Refers to misoprostol, the second drug in the MTP regimen, not the first. Causes uterine contractions and expulsion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Oxytocin receptor agonist:</strong> Oxytocin acts on uterine smooth muscle but is used for induction or augmentation of labor, not first-trimester abortion.</span></p>",
      "correct_choice_id": 336691,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73747,
      "choices": [
        {
          "id": 293929,
          "text": "<p><span style=\"font-size:14.0pt;\">LLETZ</span></p>"
        },
        {
          "id": 293930,
          "text": "<p><span style=\"font-size:14.0pt;\">Acyclovir and review after 6 weeks for a repeat test</span></p>"
        },
        {
          "id": 293931,
          "text": "<p><span style=\"font-size:14.0pt;\">HPV vaccine</span></p>"
        },
        {
          "id": 293932,
          "text": "<p><span style=\"font-size:14.0pt;\">Colposcopy and biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 27-year-old woman approaches the clinic for HPV testing for cervical cancer screening. The HPV is positive for type 18 HPV. What is the next best step?</span></p>",
      "unique_key": "Q8583336",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162453,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D)&nbsp;Colposcopy and biopsy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">HPV types 16 and 18 are high-risk oncogenic subtypes strongly associated with cervical intraepithelial neoplasia (CIN) and cervical carcinoma. When a screening test detects high-risk HPV (especially 16 or 18), the next step is to perform a colposcopic evaluation of the cervix. Colposcopy allows visualization of abnormal epithelium using acetic acid and Lugol’s iodine, followed by directed biopsy to confirm the grade of the lesion (CIN I, II, or III). This diagnostic step determines whether treatment such as excision (LLETZ or conization) is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cDDTIKD.png\" width=\"469\" height=\"375\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>LLETZ:</strong> Loop Electrosurgical Excision of the Transformation Zone is a therapeutic procedure used after confirmation of high-grade CIN (CIN II/III). It is not the first diagnostic step. Performing it without prior biopsy can lead to unnecessary excision and scarring.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Acyclovir and review after 6 weeks:</strong> Acyclovir is an antiviral agent effective against herpes simplex virus, not HPV. Human papillomavirus is a DNA virus that is not responsive to antiviral therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>HPV vaccine:</strong> The vaccine is prophylactic and prevents future infection with HPV types 6, 11, 16, and 18. It has no therapeutic role once infection has already occurred. Therefore, vaccination at this stage will not help in treating the current infection.</span></p>",
      "correct_choice_id": 293932,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33530,
      "choices": [
        {
          "id": 133966,
          "text": "<p><span style=\"color:black;font-size:18px;\">Red degeneration of fibroid</span></p>"
        },
        {
          "id": 133967,
          "text": "<p><span style=\"color:black;font-size:18px;\">Preterm labor</span></p>"
        },
        {
          "id": 133968,
          "text": "<p><span style=\"color:black;font-size:18px;\">Torsion of fibroid</span></p>"
        },
        {
          "id": 133969,
          "text": "<p><span style=\"color:black;font-size:18px;\">PID</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A pregnant woman with a fibroid uterus develops severe acute pain abdomen at 28 weeks of gestation. There is no history of fever. WBC count is 8000 cells/µl. The most likely diagnosis is?</span></p>",
      "unique_key": "Q1514442",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162454,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. C) Torsion of fibroid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Subserosal fibroids can grow on a stalk (pedunculated) and may undergo torsion, particularly during pregnancy when the uterus enlarges and shifts position. Torsion causes sudden, localized, and severe abdominal pain due to ischemia of the fibroid tissue. The absence of fever and normal white blood cell count distinguishes torsion from infective causes. There are no uterine contractions or cervical changes, which rules out preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Red degeneration of fibroid:</strong> Also known as carneous degeneration, it occurs due to venous thrombosis within the fibroid, leading to hemorrhagic infarction. It is common in the second trimester and presents with pain, fever, and leukocytosis. The absence of fever and normal WBC count in this case makes red degeneration unlikely.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Preterm labor:</strong> Presents with regular uterine contractions and cervical dilation, which are not described here. The pain in preterm labor is typically colicky and associated with uterine tightening, not localized tenderness over a fibroid.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>PID:</strong> Pelvic inflammatory disease presents with fever, purulent vaginal discharge, and cervical motion tenderness. It is rare during pregnancy because the cervical mucus plug prevents ascending infection.</span></p>",
      "correct_choice_id": 133968,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33552,
      "choices": [
        {
          "id": 134054,
          "text": "<p><span style=\"font-size:18px;\">Karyotype analysis</span></p>"
        },
        {
          "id": 134055,
          "text": "<p><span style=\"font-size:18px;\">Diagnostic laparoscopy</span></p>"
        },
        {
          "id": 134056,
          "text": "<p><span style=\"font-size:18px;\">Hymenal incision and drainage</span></p>"
        },
        {
          "id": 134057,
          "text": "<p><span style=\"font-size:18px;\">Hysterosalpingogram</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 12-year-old girl is brought to the OPD for evaluation of increasing lower abdominal pain. There is a tender, symmetric suprapubic mass to the level of the umbilicus. There is a blue-tinged bulge between the labia. Rectal examination reveals an anterior tender, central mass. Which of the following is the best next step in management of this patient?</span></p>",
      "unique_key": "Q6666732",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162836,
      "difficulty_level": "beginner",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. C) Hymenal incision and drainage</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This is a classical presentation of imperforate hymen with hematocolpos (accumulation of menstrual blood in the vagina) and possibly hematometra (blood in the uterus). The blue bulge at the introitus represents a distended hymen due to retained menstrual blood. The appropriate management is a cruciate (X-shaped) hymenal incision, which allows drainage of the collected blood and relieves the obstruction. This procedure is curative and prevents future complications such as endometriosis or infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Karyotype analysis:</strong> Not required in this case because the girl has normal secondary sexual characteristics and normal external genitalia. Karyotyping is reserved for cases of primary amenorrhea with absent secondary sexual characteristics or structural anomalies (like MRKH syndrome).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Diagnostic laparoscopy:</strong> Not indicated because the diagnosis is evident clinically. Laparoscopy is used for diagnostic uncertainty or when intra-abdominal causes like ovarian cysts are suspected.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Hysterosalpingogram:</strong> A radiologic procedure used to evaluate the uterine cavity and tubal patency in infertility, not for diagnosing outflow tract obstruction in adolescents.</span></p>",
      "correct_choice_id": 134056,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33487,
      "choices": [
        {
          "id": 133794,
          "text": "<p><span style=\"font-size:18px;\">21-hydroxylase deficiency</span></p>"
        },
        {
          "id": 133795,
          "text": "<p><span style=\"font-size:18px;\">Adrenocortical carcinoma</span></p>"
        },
        {
          "id": 133796,
          "text": "<p><span style=\"font-size:18px;\">Polycystic ovary syndrome</span></p>"
        },
        {
          "id": 133797,
          "text": "<p><span style=\"font-size:18px;\">Sertoli-Leydig cell tumor</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 22-year-old nulligravid woman comes to the OPD for worsening acne on her face and body over the last 6 months. She initially attributed the acne to her diet and has been eating healthier to improve the acne and lose weight. The patient has lost 6.8 kg in the last 3 months, but the acne has not improved. BMI is 42 kg/m2. Coarse hair is noted on the chin and upper lip. Pelvic examination shows an enlarged clitoris but otherwise normal external genitalia. Laboratory results reveal elevated total testosterone and normal dehydroepiandrosterone sulphate. Which of the following is the most likely diagnosis in this patient?</span></p>",
      "unique_key": "Q9630561",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162837,
      "difficulty_level": "difficult",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Sertoli-Leydig cell tumor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Diagnosis: Sertoli-Leydig cell tumor (Androblastoma)</span><br><span style=\"font-size:14.0pt;\">This is a rare ovarian sex cord-stromal tumor that secretes testosterone, leading to rapid-onset virilization.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key Diagnostic Clues:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Rapid onset (within months) of virilizing features → strongly suggests an androgen-secreting tumor rather than PCOS.</span></li><li><span style=\"font-size:14.0pt;\">Virilization signs: clitoromegaly, deepening of voice, male pattern baldness, and marked hirsutism.</span></li><li><span style=\"font-size:14.0pt;\">Hormonal pattern: ↑ Total testosterone (from ovarian source) Normal DHEA-S (rules out adrenal source)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Mechanism:</span></p><p><br><span style=\"font-size:14.0pt;\">Sertoli and Leydig cells in the ovary produce excess androgens (testosterone) → virilization and suppression of gonadotropins → anovulation and menstrual irregularity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Next Step in Management:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pelvic ultrasound or MRI to locate ovarian mass.</span></li><li><span style=\"font-size:14.0pt;\">Surgical removal (unilateral salpingo-oophorectomy) is curative in most cases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>21-hydroxylase deficiency (Congenital adrenal hyperplasia):</strong> Typically presents in childhood or adolescence with ambiguous genitalia, menstrual irregularities, and elevated DHEA-S (adrenal source). Onset is long-standing, not rapid as in this case. Here, DHEA-S is normal, excluding adrenal pathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Adrenocortical carcinoma:</strong> Produces excess DHEA-S and cortisol, leading to Cushingoid features along with virilization. This patient has isolated testosterone elevation with normal DHEA-S — inconsistent with adrenal carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Polycystic Ovary Syndrome (PCOS):</strong> Common cause of hirsutism and acne, but the onset is gradual, and clitoromegaly is rare. Both testosterone and DHEA-S are mildly elevated in PCOS, unlike the isolated, marked elevation of testosterone here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key Concept: Isolated high testosterone + rapid virilization + normal DHEA-S = Ovarian androgen-secreting tumor. Most common = Sertoli-Leydig cell tumor</span></p>",
      "correct_choice_id": 133797,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73734,
      "choices": [
        {
          "id": 293877,
          "text": "<p><span style=\"font-size:14.0pt;\">ARM + Oxytocin</span></p>"
        },
        {
          "id": 293878,
          "text": "<p><span style=\"font-size:14.0pt;\">Steroids followed by LSCS</span></p>"
        },
        {
          "id": 293879,
          "text": "<p><span style=\"font-size:14.0pt;\">Emergency LSCS</span></p>"
        },
        {
          "id": 293880,
          "text": "<p><span style=\"font-size:14.0pt;\">Urgent ultrasound</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">34 weeks G2P1L1 pregnant lady complains of bleeding PV and abdominal pain since 4 hours. Hb 6gm%, PR is 120/ min, BP-80/60mmHg, P/A- FHS absent &amp; uterus tonically contracted. A PV reveals the cervix is 2 cm dilated, 70% effaced and Vx at -2. She appears distressed.&nbsp;What is the best management option?</span></p>",
      "unique_key": "Q9428822",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162838,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;Emergency LSCS</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Diagnosis: Abruptio Placentae (Severe abruption with fetal demise and maternal shock)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key findings:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Painful vaginal bleeding</span></li><li><span style=\"font-size:14.0pt;\">Uterus is hard and tender (tonically contracted)</span></li><li><span style=\"font-size:14.0pt;\">Maternal shock disproportionate to visible blood loss (concealed hemorrhage)</span></li><li><span style=\"font-size:14.0pt;\">Absent fetal heart sounds</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These findings indicate placental abruption with concealed hemorrhage causing maternal hypovolemic shock.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Immediate Management:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The management goal is to save the mother by:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Immediate resuscitation with IV fluids and blood transfusion.</span></li><li><span style=\"font-size:14.0pt;\">Expedite delivery to stop further bleeding — route depends on maternal condition and cervical status.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Here, the cervix is only 2 cm dilated, and vaginal delivery will take a long time.</span></p><p><br><span style=\"font-size:14.0pt;\">Therefore, emergency cesarean section is indicated once the mother is stabilized.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>ARM + Oxytocin:</strong> Artificial rupture of membranes and oxytocin infusion are appropriate only when the cervix is favorable and the patient is stable, allowing vaginal delivery. In this case, the cervix is minimally dilated and patient is in shock, so this is unsafe.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Steroids followed by LSCS:</strong> Corticosteroids are used before 34 weeks to enhance fetal lung maturity if delivery can be delayed safely. Here, the patient is unstable, and the fetus is already dead. Steroids have no role.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Urgent ultrasound:</strong> The diagnosis of abruption is clinical; waiting for ultrasound delays treatment and increases maternal risk. Immediate resuscitation and delivery are priorities.</span></p>",
      "correct_choice_id": 293879,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73754,
      "choices": [
        {
          "id": 293957,
          "text": "<p><span style=\"font-size:14.0pt;\">b-c-d-a</span></p>"
        },
        {
          "id": 293958,
          "text": "<p><span style=\"font-size:14.0pt;\">d-a-b-c</span></p>"
        },
        {
          "id": 293959,
          "text": "<p><span style=\"font-size:14.0pt;\">c-a-d-b</span></p>"
        },
        {
          "id": 293960,
          "text": "<p><span style=\"font-size:14.0pt;\">c-b-d-a</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Choose the order in which the following steps of total abdominal hysterectomy are done:</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:14.0pt;\">Clamp, cut &amp; ligate&nbsp;infundibulopelvic ligament</span></li><li><span style=\"font-size:14.0pt;\">Clamp, cut and ligate uterine vessels</span></li><li><span style=\"font-size:14.0pt;\">Clamp, cut and ligate&nbsp;round ligament</span></li><li><span style=\"font-size:14.0pt;\">Open uterovesical fold of peritoneum</span></li></ol>",
      "unique_key": "Q2701883",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162839,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;c-a-d-b</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Stepwise sequence in Total Abdominal Hysterectomy:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Clamp, cut, and ligate the round ligament (c): This is the first structure encountered after opening the abdomen. Cutting the round ligament allows entry into the broad ligament and facilitates further dissection.</span></li><li><span style=\"font-size:14.0pt;\">Clamp, cut, and ligate the infundibulopelvic ligament (a): This step is performed if the ovaries are being removed. It contains the ovarian vessels, which are ligated to prevent bleeding. If ovaries are conserved, the ovarian ligament is ligated instead.</span></li><li><span style=\"font-size:14.0pt;\">Open the uterovesical fold of peritoneum (d): The uterovesical pouch is opened to separate the bladder from the lower uterine segment, preventing injury during later steps.</span></li><li><span style=\"font-size:14.0pt;\">Clamp, cut, and ligate the uterine vessels (b): The uterine artery and vein, branches of the internal iliac, are ligated near the cervix. This reduces uterine blood supply before completing vaginal separation.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hence, the correct surgical sequence is: c → a → d → b</span></p>",
      "correct_choice_id": 293959,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73755,
      "choices": [
        {
          "id": 293961,
          "text": "<p><span style=\"font-size:14.0pt;\">a, b, c, d, e, f, g, h</span></p>"
        },
        {
          "id": 293962,
          "text": "<p><span style=\"font-size:14.0pt;\">a, b, c, d, e, g, h</span></p>"
        },
        {
          "id": 293963,
          "text": "<p><span style=\"font-size:14.0pt;\">a, b, e, g, h</span></p>"
        },
        {
          "id": 293964,
          "text": "<p><span style=\"font-size:14.0pt;\">a, b, c, e, g, h&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old&nbsp;G2A1 presents to the Antenatal OPD at 9 weeks. List the investigations that will be done:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-06-13%20175020.png\" width=\"499\" height=\"390\"></span></p>",
      "unique_key": "Q2410756",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162840,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) a, b, c, e, g, h&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The routine first-trimester antenatal investigations recommended for all pregnant women are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Hb (Hemoglobin): To detect anemia, a common complication in pregnancy.</span></li><li><span style=\"font-size:14.0pt;\">Urine C/S: To screen for asymptomatic bacteriuria, which can cause preterm labor and pyelonephritis.</span></li><li><span style=\"font-size:14.0pt;\">TSH: To detect hypothyroidism, which can lead to miscarriage or developmental delay.</span></li><li><span style=\"font-size:14.0pt;\">FBS (Fasting Blood Sugar): To screen for pre-existing diabetes mellitus or early-onset gestational diabetes.</span></li><li><span style=\"font-size:14.0pt;\">Blood group &amp; Rh typing: To detect Rh-negative mothers and plan for anti-D prophylaxis if required.</span></li><li><span style=\"font-size:14.0pt;\">VDRL (Venereal Disease Research Laboratory test): To screen for syphilis, which can cause congenital infection.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Tests Not Routinely Recommended:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">d. TORCH: Not part of routine screening. Performed only if there is bad obstetric history, fetal anomalies, or intrauterine growth restriction.</span></li><li><span style=\"font-size:14.0pt;\">f. APLA (Antiphospholipid antibody): Not routine; indicated only if the woman has recurrent pregnancy losses, thrombosis, or stillbirths.</span></li></ul>",
      "correct_choice_id": 293964,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73769,
      "choices": [
        {
          "id": 294017,
          "text": "<p><span style=\"font-size:14.0pt;\">Clean the wound, administer tetanus and rabies vaccine</span></p>"
        },
        {
          "id": 294018,
          "text": "<p><span style=\"font-size:14.0pt;\">Clean the wound, administer only tetanus vaccine</span></p>"
        },
        {
          "id": 294019,
          "text": "<p><span style=\"font-size:14.0pt;\">Clean the wound, administer antibiotics</span></p>"
        },
        {
          "id": 294020,
          "text": "<p><span style=\"font-size:14.0pt;\">Clean the wound, reassure her</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old primigravida presents to the OPD with a history of a dog bite. Her neighbor’s pet dog has bit her on the leg. She is currently 10 weeks pregnant. What is the next best step?</span></p>",
      "unique_key": "Q8470418",
      "question_audio": null,
      "question_video": null,
      "map_id": 35162841,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)&nbsp;Clean the wound, administer tetanus and rabies vaccine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Dog bite management during pregnancy:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Wound care: Immediate and thorough washing with soap and water for at least 15 minutes is crucial. Apply povidone-iodine for local disinfection.</span></li><li><span style=\"font-size:14.0pt;\">Tetanus prophylaxis: Given based on immunization history. A pregnant woman should receive TT or Td vaccine if not previously immunized or if more than 5 years have passed since the last dose.</span></li><li><span style=\"font-size:14.0pt;\">Rabies prophylaxis: Rabies vaccine is absolutely safe in pregnancy and must not be withheld. Post-exposure prophylaxis includes:</span></li></ol><ul style=\"list-style-type:square;\"><li><span style=\"font-size:14.0pt;\">Rabies vaccine on days 0, 3, 7, and 14 (and day 28 if needed).</span></li><li><span style=\"font-size:14.0pt;\">Rabies immunoglobulin (RIG) if the wound is Category III (deep bite, multiple wounds, or exposure to mucosa).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Rationale:</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The risk of rabies transmission is fatal and outweighs any theoretical risk of vaccination during pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Only tetanus vaccine:</strong> Incomplete protection. Rabies prophylaxis is mandatory after dog bite exposure, regardless of pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Antibiotics:</strong> Adjunctive measure only; not a substitute for tetanus and rabies prevention.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Reassurance alone:</strong> Unsafe and inappropriate; rabies is nearly always fatal once symptoms develop.</span></p>",
      "correct_choice_id": 294017,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 95061,
      "choices": [
        {
          "id": 378432,
          "text": "<p><span style=\"font-size:18px;\">2 and 4 only</span></p>"
        },
        {
          "id": 378433,
          "text": "<p><span style=\"font-size:18px;\">1 and 2 only</span></p>"
        },
        {
          "id": 378434,
          "text": "<p><span style=\"font-size:18px;\">1, 2, 4</span></p>"
        },
        {
          "id": 378435,
          "text": "<p><span style=\"font-size:18px;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A pregnant woman at 36 weeks gestation is found to have high blood pressure recording and a urine protein of 3+. Concomitant presence of which of the following symptoms would make you suspect imminent eclampsia?</span></p><p><span style=\"font-size:18px;\">1. Headache</span></p><p><span style=\"font-size:18px;\">2. Blurred vision</span></p><p><span style=\"font-size:18px;\">3. Persistent pedal edema</span></p><p><span style=\"font-size:18px;\">4. Epigastric pain</span></p>",
      "unique_key": "Q1031811",
      "question_audio": null,
      "question_video": null,
      "map_id": 35176316,
      "difficulty_level": "intermediate",
      "subjects_id": [
        43
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) 1, 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Diagnosis: This patient has preeclampsia (hypertension + proteinuria after 20 weeks).</span></p><p><br><span style=\"font-size:14.0pt;\">When neurological or hepatic symptoms develop, it suggests severe preeclampsia or imminent eclampsia — a stage preceding seizure onset.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Symptoms Suggesting Imminent Eclampsia:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Headache:</strong> due to cerebral edema or vasospasm, a common prodromal symptom before seizure.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Blurred vision:</strong> indicates retinal arteriolar spasm or cerebral edema, a warning sign of impending eclamptic convulsions.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Persistent pedal edema:</strong> though nonspecific, in the presence of other severe features it indicates worsening fluid retention and endothelial dysfunction.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Epigastric or right upper quadrant pain:</strong> from hepatic involvement (stretching of Glisson’s capsule due to periportal hemorrhage or subcapsular hematoma), seen in severe preeclampsia and HELLP syndrome.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The presence of any of these symptoms signifies imminent eclampsia and requires urgent management to prevent seizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathophysiology:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Endothelial dysfunction and vasospasm cause hypertension, cerebral edema, and hepatic ischemia. This results in neurological and visual symptoms that precede seizures.</span></li><li><span style=\"font-size:14.0pt;\">Eclampsia = onset of generalized tonic-clonic seizures in a woman with preeclampsia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management of Imminent Eclampsia:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Stabilize the mother: Magnesium sulfate – to prevent convulsions (drug of choice). Labetalol or hydralazine – to control BP.</span></li><li><span style=\"font-size:14.0pt;\">Expedite delivery – once the patient is stable, as this is the only definitive cure.</span></li></ol>",
      "correct_choice_id": 378435,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}